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The 2019 edition of the EU Industrial R&D Investment 
Scoreboard (the Scoreboard) comprises the 2500 com-
panies investing the largest sums in R&D in the world in 
2018. These companies, based in 44 countries, each in-
vested over €30 million in R&D for a total of €823.4 billion 
which is approximately 90% of the world’s business-fund-
ed R&D. They include 551 EU companies accounting for 
25% of the total, 769 US companies for 38%, 318 Japa-
nese companies for 13%, 507 Chinese for 12% and 355 
from the rest-of-the-world (RoW) for 12%.
This report analyses the main changes in companies’ 
R&D and economic indicators over the past year and 
their performance over the past ten years. It also includes 
patent-based analyses aimed at characterising further 
the R&D efficiency of the business health sector and 
the activity of the Scoreboard companies in the field of 
environmental technologies.
Summary
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Highlights
 1 In 2018 the 2500 Scoreboard companies invested a total of €823.4 billion, 8.9% more than in 2017. The major contributors were the US with 38% of total R&D, the EU (25.3%), Japan (13.3%), China (11.7%), S. Ko-
rea (3.8%) and Switzerland (3.5%). The main change over the last few years has been China’s increasing R&D 
share of the total. However, this is to be expected since China still has only 88% of Japan’s R&D whereas its 
GDP is nearly three times that of Japan.
 2 R&D is very concentrated in the larger companies with the top 10, top 50 and top 100 accounting for 15%, 40% and 52% of the total. Within the top 50 there are 17 from the EU, 22 from the US, 6 from Japan, 2 
each from China and Switzerland and one from S. Korea. R&D is also concentrated by sector with three broad 
sectors accounting for 76.6% of the total: ICT for 38.7%, health for 20.7% and automotive for 17.2%.
 3 The R&D sector specialisations of the four main regions are very different. The EU has 20% in ICT, 21.6% in health but 31% in automotive in contrast to the US with 52.8% of its R&D in ICT, 26.7% in health and only 
7.6% in automotive. Japan has many similarities with the EU having 24.9% in ICT, 31% in automotive but 
only 12.1% in health. China has some similarities with the US having 47.1% in ICT and 11.5% in automotive 
but differs markedly in having only 4.8% in health.
 4 These different regional sector specialisations lead to big differences in average R&D intensity (R&D/sales ratio) for the major regions. This is because three sectors have much higher intensities than the others – phar-
maceuticals with 15.4%, software with 10.8% and IT hardware with 8.0% whereas automotive, for example, 
has an intensity of only 4.7%. Average R&D intensity for the EU is 3.4%, for the US 6.6%, for Japan 3.5% and 
China 2.7%. A region’s R&D intensity depends on its sector mix. – China’s average R&D intensity, for example, 
is low primarily because of its small pharmaceuticals sector and large low technology sectors which are not 
compensated for by its large ICT sector.
 5 Worldwide R&D growth over the past year was 8.9% and driven by ICT services (16.9%), ICT producers (8.2%) and health (7.6%). Regional sector specialisation led to the EU growing R&D by 4.7%, the US by 10.3%, and 
Japan by 3.9%. China’s R&D grew by 26.7% with big contributions from some of its largest companies. Av-
erage profitability also differs markedly between regions with the US leading with 13.7% followed by the EU 
(10.3%), Japan (7.8%) and China (7.4%).
 6 The four largest companies by R&D investment are Alphabet, Samsung Electronics, Microsoft and Volkswa-gen. Amazon would have been in first place had its annual report given a figure for R&D alone so it could be 
included in the Scoreboard. Over the last 15 years 8 companies have moved up in the global ranking by 70 or 
more places. These are Alphabet, Huawei, Apple, Facebook, Alibaba, Celgene, Gilead Sciences and Continental 
indicating the rising importance of ICT and biotechnology. The ranking of the top 50 large global companies by 
R&D intensity (all with intensity of 13.3% or more) also highlights the importance of these two technologies 
with 23 companies from biopharmaceuticals and 24 from ICT.
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 7 The Scoreboard contains a separate listing of the top 1,000 EU companies, all with R&D of at least €8.6m. R&D is highly concentrated with the top three EU countries (Germany, UK, France) accounting for 68.4% of 
EU R&D and the top 10 for 97%. Germany leads in automotive and industrial engineering with 37.4% of the 
EU 1000 companies while the UK leads in biopharmaceuticals, software and IT hardware with 35.9% of the 
companies. In 2018, R&D growth in the EU was driven first and foremost by the automotive sector, namely by 
French and German companies, and to a lesser extent by companies from the Health and ICT industries.
 8 The 2019 Scoreboard includes a patent analysis for the R&D-intensive biotech & pharma sector. R&D in this sector has increased substantially over the last 10 years although the number of patents filed per year has 
declined. This reflects sector specific issues such as the move from small molecule drugs to biologic drugs 
which are more difficult to develop and obtain regulatory approval for. This trend has also driven a wave of 
mergers and acquisitions in the biotech & pharma sector. The analysis also shows a difference in the pharma 
and biotech sector between EU and US firms in terms of technological profile and is mainly driven by the low 
number of biotech companies in the EU compared to the US.
 9 The 2019 Scoreboard highlights the important role industrial R&D is playing in the drive to meet the UN’s sus-tainable development goals (SDGs). Specific examples are given of the way in which technologies such as AI, 
biotechnology, nanotechnology, graphene and improved clean energy generation & storage technologies are 
contributing to meeting most of the SDGs. In this context, a patent analysis included in this report shows that 
of all patents filed in the EPO and USPTO from 2012-2015, 50% belong to the Scoreboard companies and 
9% of these are ‘green’ patents. Toyota had most green patents but the top 25 global companies by number 
of green patents comprise EU firms such as Bosch, Volkswagen, Airbus and Rolls-Royce.
10 Finally, the report also includes a patent analysis of the global automotive sector which accounts for 13% of total patents for the global Scoreboard companies. Of these, 35% are held by EU com-
panies. Most of these patents refer to current automotive technologies but an increasing proportion 
refer to ‘green’ technologies including electric and autonomous vehicles and newer components 
such as novel batteries and fuel cells. For these technologies, the current automotive companies 
are being joined in patent filing by companies from the software, technology hardware, electronics 
and chemicals sectors.
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The top 2500 Scoreboard companies invested €823.4 
billion in R&D during 2018, an increase of 8.9% with 
respect to the previous period. Companies also raised 
most of their financial indicators: net sales and profits 
grew at a similar rate to R&D investment (8.4% and 9.1% 
respectively); capital expenditures increased significantly 
(7.6%) and the number of employees continued to 
increase at a moderate pace (3.7%). See the evolution of 
key parameters over the past 10 years shown in Figure S1.
Key findings
A. Worldwide, companies continued to increase significantly their R&D investments 
in 2018 for the ninth consecutive year while showing good performance in most 
financial indicators.
B. The global technology race intensified in 2018with US and Chinese companies 
increasing sharply their R&D investments and EU companies following behind.
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FIGURE S1: GLOBAL GROWTH RATE OF R&D AND NET SALES AND PROFITABILITY FOR THE PERIOD 2009-2018.
Note: Growth rates for the three variables have been computed on 1650 out of the 2500 companies for which data on R&D, Net Sales and Operating Profits are available for the 
entire period 2009-2018. These companies represent 84.6% of R&D, 84.1% of Net Sales and 79.8% of Operating Profits of the total sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Just as in the previous Scoreboard, the considerable 
increase of industrial R&D in 2018 (8.9%) was mostly 
due to the performance of US and Chinese companies 
that raised their R&D investment by 10.3% and 26.7% 
respectively. Companies from the other countries/regions 
increased R&D below the world’s average rate with the EU 
4.7%, Japan 3.9% and the rest of the world 4.8%.
Global R&D was driven by the ICT services sector (17%), 
followed by the ICT producers sector (8.2%) and the Health 
sector (7.6%). The lowest R&D growth was shown by the 
Aerospace & Defence sector (4%) across most countries.
For the EU sample of companies, the largest 
contribution to R&D growth (weighed by R&D size) 
was made by the Automobiles & other transport sector 
(6.4%), Health industries (3.8%) and ICT producers 
(5.5%). By member states, the largest contribution 
to the R&D growth was provided by the French and 
German companies (10.6% and 3.6% respectively) 
followed by companies from Sweden (11.9%), UK 
(3.6%) and Denmark (13.5%). Companies showing the 
highest R&D growth were automotive companies, e.g. 
BMW (13%), PEUGEOT (25%), RENAULT (19%) and 
VALEO 37%) and from other sectors SANOFI (8%), 
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ERICSSON (11%) and SIEMENS (7%). The poorest R&D 
performance was shown by TELECOM ITALIA (-39%), 
FIAT CHRYSLER (-14%), BARCLAYS (-58%) and NOKIA 
(-6%). Acquisitions contributed to growth in several 
cases (e.g. Peugeot acquiring General Motors’ European 
operations in November 2017).
For the non-EU sample of companies, R&D growth was 
driven by the high tech industries, especially by large R&D 
increases from US and Chinese companies, i.e. ICT services 
(US 17%, China 39%), ICT producers (US 9%, China 15%) 
and Health industries (US 9%, China 57%). Companies 
showing the best R&D performance were all ICT companies, 
ALPHABET (30%), APPLE (23%), FACEBOOK (32%), 
MICROSOFT (15%), ALIBABA (64%) and HUAWEI (13%). 
The poorest performance was shown by SNAP (-51%), 
GENERAL ELECTRIC (-14%) and TEVA PHARMACEUTICAL 
(-34%). Divestments were a major factor in the negative 
R&D growth of GENERAL ELECTRIC.
See comparison of EU, US and Chinese companies’ R&D 
performance in Figure S2.
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FIGURE S2: R&D INVESTMENT AND R&D ONE-YEAR GROWTH FOR THE EU, US AND CHINESE SAMPLES OF COMPANIES.
Note: R&D investment and growth rates (between brackets) have been computed for 549 EU, 760 US and 487 Chinese companies for which R&D data are available for years 
2017 and 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
C. Companies’ key economic indicators showed good performance in 2018.
The main economic indicators of the Scoreboard companies 
showed good results in 2018 across most countries/
regions. The overall growth of net sales (8.4%) and 
profits (9.1%) continued the positive trend of the previous 
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year, increasing at a similar rate to R&D investment. As 
observed in 2017, the growth in net sales and profits 
was mostly led by oil-related companies due to high oil 
prices, and, to a lesser extent, by the ICT and Industrials 
sectors. In the same vein, companies’ capital investments 
(Capex) continued the significant recovery seen in the 
previous year. Capex increases are observed especially 
in oil-related companies, ICT services and Industrials. The 
number of employees for the 2500 companies continued 
to increase at a moderate pace (3.6%).
The net sales of the 551 companies based in the EU 
reached €6.0trillion, 4.7% more than in the previous year. 
Net sales increases were in oil-related sectors but also 
in other sectors such as Industrials (5.9%), Aerospace & 
Defence (6.1%) and Chemicals (3.6%). The EU companies 
continued to increase modestly capital expenditures and 
profits (2.0% and 3.2% respectively). The 551 companies 
based in the EU employed 19.4 million, 3.9% more than 
the year before.
D. Over the past 10 years, the rapid R&D growth in the Health, Automotive and ICT 
sectors reshaped the global industrial R&D landscape.
EU companies have maintained a stable share of global 
R&D around 25-27% over the past ten years. They have 
strengthened their position in medium-high tech sectors 
such as automotive and industrials, they have maintained 
their position in health but have lost ground in ICT (almost 
doubling the medium-high tech sector while growing the 
high-tech sector more slowly). The EU’s lead in medium-
high tech is challenged as ICT takes a higher proportion of 
the value added in sectors such as automotive with the 
advent of new developments such as electric self-driving 
cars (see H below on the results of a patent analysis for 
the automotive sector).
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FIGURE S3: R&D INVESTMENT IN 2009 AND 2018 BY MAIN REGION AND SECTOR GROUPS.
Note: Figures displayed refer only to the 1460 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2018 and 2009). These 
companies represent 77.0% of R&D of the total sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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The profile of the group of top 100 Scoreboard 
companies reflects the concentration of global industrial 
R&D in a few companies, industries and countries. In 
the 2019 Scoreboard, this group accounts for 52% of 
the total R&D, 82 companies are from the three major 
sectors (ICT 34, Health 26 and Automotive 22) and 80 
companies from 3 regions (EU 29, US 36 and Japan 15). 
Comparing with the first Scoreboard edition in 2004, the 
top 100 sample then comprised 8 less companies from 
the 3 largest sectors (ICT 34, Health 21 and Automotive 
19) but 14 more companies from the main regions (EU 
35, US 37, Japan 22).
In the past 15 years, most leavers from the top 100 group 
are from Japan and the EU (7 and 6 respectively) and 
newcomers are companies based in Asia (China 9, Taiwan 
3 and S. Korea 2). See the profile of the top 100 group of 
companies in Figure S4.
E. Over the past 15 years, three major industries continue to provide most of the R&D 
players in the top 100 group but newcomers in this group are mainly companies 
based in Asia.
F. A patent analysis for the Scoreboard companies in the biotech & pharma sector 
shows a substantial increase of R&D investment over the last 10 years although the 
number of patents filed per year has declined.
US companies have been steadily increasing their share of 
global R&D to reach 38% in 2018 (doubling their high tech 
R&D from 2009 to 2018). The big driver for the US has been 
growth in its ICT sectors (particularly ICT services) and, to a 
lesser extent, in health. The US is well placed for the future 
in health as it is the clear world leader in biotechnology 
which is the basis of more and more new drugs. Chinese 
companies have been increasing their global R&D share 
at a fast rate but from a very low base to reach an 11.7% 
world share in 2018. China has grown its low, medium 
and high tech groups, especially the ICT sector. Japanese 
companies have an even larger proportion of their R&D in 
medium-high tech sectors and less in high-tech than the 
EU companies (growing significantly their medium-high 
tech group but barely changing the size of their high-tech 
group). See Figure S3.
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FIGURE S4: DISTRIBUTION OF THE TOP 100 R&D INVESTORS IN THE 2004 AND 2019 SCOREBOARDS BY MAIN REGION AND SECTOR GROUPS.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
The 2019 Scoreboard includes a patent analysis in the 
R&D-intensive biotech & pharma sector. R&D in this 
sector has increased substantially over the last 10 years 
although the number of patents filed per year has declined 
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(see Figure S5). This reflects sector specific issues such as 
the move from small molecule drugs to biologic drugs 
which are more difficult to develop and obtain regulatory 
approval for. This trend has also driven a wave of mergers 
and acquisitions in the biotech & pharma sector.
The analysis also shows a difference in the pharma and 
biotech sector between EU and US firms in terms of 
technological profile which is mainly driven by the low 
number of biotech companies in the EU compared to 
the US. The US leadership in biotechnology is a main 
challenge for the EU, as this subsector is the basis of 
more and more new drugs. Moreover, many of the larger 
US pharmaceutical companies are acquiring smaller US 
biotech firms to strengthen their new drug pipelines.
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FIGURE S5: EVOLUTION OF THE R&D INVESTMENT AND NUMBER OF PATENTS IN THE PHARMA AND BIOTECH SECTORS FOR EU AND US COMPANIES (BASE 
YEAR 2007 = 1.0).
Note: Data computed 41 out of the 73 EU and 52 out of the 152 US Pharma and Biotech companies in the top 2000 for which data are available for the entire period 2007-2016.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
A patent analysis included in this report shows that the 
top R&D investors own 50% of patents filed in the EPO 
and USPTO offices from 2012 to 2015. The share of green 
patents in the total is 9% of which 53% belong to the top 
R&D companies.
The highest shares of green patents are held by companies 
from regulatory driven sectors, energy and transport, but 
ICT producers follow a short distance behind. The bulk 
of green patents owned by the Scoreboard companies 
(about 80%) is concentrated in companies headquartered 
in Japan (30.9%), the US (26.8%), Germany (11.8%) and 
South Korea (10.5%).
EU companies show comparative advantages in 
most green technologies, with the exception of ICT 
applications for energy. Toyota had most green patents 
but the top 25 global companies by number of green 
G. The analysis of patents filed in the EPO and USPTO offices from 2012-2015 shows 
that 50% are owned by the Scoreboard companies and 9% are green1 patents.
1 According to WIPO’s “IPC Green Inventory”, developed to facilitate searches for patent information relating to Environmentally Sound Technologies (ESTs). https://www.
wipo.int/classifications/ipc/en/green_inventory/.
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The Scoreboard includes a patent analysis of the global 
automotive sector which accounts for 13% of total patents 
filed by the global Scoreboard companies. Most of these 
patents refer to current automotive technologies but an 
increasing proportion refer to green technologies including 
electric and autonomous vehicles and newer components 
such as novel batteries and fuel cells. Of these patents, 35% 
are held by EU companies which appear highly diversified 
and competitive in most technological fields. But in green 
technologies related to hybrid cars, batteries and fuel cells 
their Japanese counterparts are leading the race. See patents 
of the automotive sector for main regions in Figure S7.
For emerging technologies, the current automotive 
companies are being joined in patent filing by companies 
from the software, IT hardware, electronics and chemicals 
H. The automotive sector has 13% of total patents belonging to the Scoreboard 
companies of which 35% are held by EU companies. Green technologies in this sector 
are led by Japanese companies.
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Figure caption:
Top left: Patents filed by Scoreboard (SB) and non-Scoreboard (Non-SB) companies and share of green patents (according to CPC classification)2.
Top right: Green patents filed by Scoreboard and non-Scoreboard companies.
Bottom left: Scoreboard companies’ green patents by technological classes (CCS= carbon capture and storage; CCAT= Climate Change Adaptation Technologies).
Bottom right: Scoreboard companies’ green patents by country.
FIGURE S6: DISTRIBUTION OF TOTAL PATENTS FILED IN THE USPTO AND EPO OFFICES, 2012-2015.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
2 The Cooperative Patent Classification (CPC) is an extension of the IPC and is jointly managed by the EPO and the US Patent and Trademark Office. https://www.epo.org/
searching-for-patents/helpful-resources/first-time-here/classification/cpc.html.
patents comprise EU firms such as Bosch, Volkswagen, 
Airbus and Rolls-Royce.
Figure S6 shows the total number of patents and the 
distribution of Scoreboard companies’ green patents by 
technological field and country.
14 The 2019 EU Industrial R&D Investment Scoreboard
0 
5000 
10000 
15000 
20000 
25000 
EU JP US RoW 
n 
of
 p
at
en
ts
  
non green patents green patents 
FIGURE S7: NUMBER OF PATENTS FILED BY SCOREBOARD COMPANIES IN THE USPTO AND EPO OFFICES, 2012-2015 FOR THE AUTOMOTIVE SECTOR.
Note: Data computed for 116 out of the 137 companies in the Automobiles & other transport sector for which patent data are available.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
sectors. This is a major challenge for the EU, whose 
lead in the automotive sector may be eroded as digital 
technologies take a higher proportion of the value added 
in this sector with the advent of new developments such 
as electric self-driving cars fitted with more electronics 
and communications accessories.
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Introduction
The 2019 edition of the “EU Industrial R&D Investment 
Scoreboard” (the Scoreboard)3 comprises this analysis 
report and the related dataset on top R&D investors 
worldwide. The Scoreboard dataset consists of the ranking 
of the 2500 companies investing the largest sums 
in R&D in the world and a ranking of the top 1000 
R&D investing companies based in the EU4. The 
latter consists of 551 EU companies included in the global 
ranking and an additional 449 companies, making a total 
of 2949 companies in the 2019 Scoreboard.
The Scoreboard is based on information taken from the 
companies’ latest published accounts. For most companies 
these correspond to calendar year 2018, but a significant 
number of companies have financial years ending on 31 
March 2018 (Japanese companies in particular but also 
many UK firms). There are few companies included with 
financial years ending as late as end June 2019 and a few 
for which only accounts to end 2017 were available5.
In order to avoid double counting, The Scoreboard 
considers only data from parent or independent 
companies. Normally, these companies integrate into 
their consolidated accounts the data of their subsidiary 
companies.
It should be noted that the Scoreboard relies on the 
disclosure of R&D investment in companies’ published 
annual reports and accounts and that due to different 
national accounting and disclosure practices, companies 
of some countries are less likely than others to disclose 
R&D investment consistently. For example, it is a legal 
requirement in some countries that R&D investment is 
disclosed in company annual reports. For these reasons, 
companies from some countries such as Southern or 
Eastern European countries might be under-represented 
while others such as companies from the UK could be 
over-represented.
The overall coverage in terms of R&D is similar to 
previous editions. The total amount of R&D investment 
of companies included in the 2019 Scoreboard (€823.4 
billion) is equivalent to almost 90% of the total expenditure 
on R&D financed by the business sector worldwide6.
The Scoreboard collects key information to enable the 
assessment of the R&D and economic performance of 
companies. The main indicators, namely R&D investment, 
net sales, capital expenditures, operating profits, number 
of employees and market capitalisation are collected 
following the same methodology, definitions and 
assumptions applied in previous editions. This ensures 
comparability so that the companies’ economic and 
financial data can be analysed across countries and 
industries and over a longer period of time.
The capacity of data collection is enhanced by information 
gathered about the ownership structure of the Scoreboard 
parent companies and the main indicators for their 
subsidiaries. In 2019, we have collected available indicators 
reported by about 700.000 subsidiary companies of the 
2500 parent companies comprised in this Scoreboard 
edition. This allows a better characterisation of companies, 
in particular regarding the sectoral and geographic 
distribution of their research and production activities and 
the related patterns of growth and employment.
As shown in last year’s Scoreboard, the analysis of key 
indicators such as the patent data of parent companies 
and their subsidiaries allows the reassignment of many 
companies to countries where they perform their actual 
economic or innovation activity.
3 The EU Industrial R&D Investment Scoreboard is published annually by the European Commission (JRC-Seville/DG RTD) as part of the GLORIA project (Global Industrial 
Research & Innovation Analyses). GLORIA is the follow-up of the IRIMA project (Industrial Research and Innovation Monitoring and Analysis). See:  http://iri.jrc.ec.europa.
eu/home/.
4 In this report, the term EU company refers to companies whose ultimate parent has its registered office in a Member State of the EU. Likewise, non-EU company applies 
when the ultimate parent company is located outside the EU (see also the glossary and definitions in Annex 2 as well as the handling of parent companies and subsidiaries).
5 This is why we should refer to the data of the last available year as 2018/19, those of the previous one as 2017/18 and so on. However, and as stated in the text, for 
the majority of companies the last available year corresponds to calendar year 2018, the previous year to the calendar year 2017 (and so on). For reasons of clarity and 
consistency, we decide to refer to the last available year as 2018, the previous year as 2017 (and so on).
6 According to the latest figures reported by Eurostat, (see Figure 1.1 in Chapter 1).
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Report structure
In this edition, we follow a similar structure to that of 
previous Scoreboard reports. It includes an extensive 
description of the 2019 dataset, an overview of main 
changes in companies’ R&D and economic performance 
over the past year and ten-year description of trends for 
main world regions and industrial sectors, benchmarking 
EU companies against their global counterparts. This year 
edition includes also three chapters, supported by the 
analysis of the patent activity of companies, aimed at 
examining sustainability issues and particularly the role of 
the Scoreboard companies in developing environmental 
technologies.
In chapter 1 we provide an overview of the main 
characteristics of the industrial R&D, including the main 
economic factors that have shaped R&D investments 
over the past year. This section comprises a description 
of the role of R&D in achieving sustainability goals and 
summarises related technology trends. The 2019 dataset 
is described in detail and, in particular, the geographic and 
sectoral distribution of R&D and its typical concentration 
at company, industry and country levels.
Chapter 2 presents a description of industrial R&D trends 
for the 2500 companies aggregated by main world region 
and industrial sector. It describes the main changes in R&D 
and economic indicators that took place over the past 
year and gives a ten-year analysis of their performance in 
terms of R&D, net sales, profitability and employment over 
the past 10 years.
The performance of individual companies among the top 
R&D investors is analysed in chapter 3. The list of the top 
50 and top 100 R&D companies is examined highlighting 
those companies showing remarkable R&D and economic 
results and improvement in their R&D ranking over the last 
15 years. It also includes an analysis of the ranking of the 
top 50 large companies by R&D intensity.
Chapter 4 discusses trends in the R&D and economic 
performance of companies included in the extended 
sample comprising the top 1000 R&D investors based in 
the EU and focused on the ten largest countries of the EU, 
accounting for more than 98% of the total R&D of the 
sample of all 1000 companies based in the EU.
Chapter 5 presents the results of a patent-based study 
aimed at analysing the performance of companies from 
the Automobiles & other transport sector in terms of 
technological developments and particularly from an 
environmental viewpoint. This analysis underlines the 
capability of EU companies to develop sustainable 
technologies and includes a comparison of them against 
the main global players.
Chapter 6 analyses the economic and innovation 
performance of companies operating in the health sector 
over the past ten years. The objective is to assess the 
efficiency of R&D investments in these industries by 
comparing the trends in R&D investment against company 
results in terms of number of patents and profitability. The 
analysis focuses on pharma and biotech industries and 
compares the performance of EU companies against their 
US counterparts.
Finally, chapter 7 analyses the technological profile 
of the Scoreboard companies from an environmental 
technology viewpoint. It is based on an examination 
of the patent portfolio of the top R&D investors and 
focusses on assessing the capacity of EU companies 
to develop environmental technologies, to analyse their 
strengths and weaknesses in specific sub-fields and to 
compare them with companies from other economic 
areas.
The data have been collected by Bureau van Dijk – A 
Moody’s Analytics Company, following the same approach 
and methodology applied since the first Scoreboard edition 
in 2004. For background information please see Annex 1.
The methodological approach of the Scoreboard, its 
scope and limitations are described in Annex 2. Users of 
the Scoreboard data are advised to read in particular the 
summary of the methodological caveats explained in Box 
A2.1.
Annex 3 provides two complementary tables. The first 
one regarding main statistics for the world sample of 
companies aggregated by industrial sectors and the 
second one about the sector and country composition of 
the EU 1000 sample. The access to the full dataset is 
shown in Annex 4.
The complete data set is freely accessible online at: 
https://iri.jrc.ec.europa.eu/scoreboard/2019-eu-industri-
al-rd-investment-scoreboard#field_data.
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This chapter provides an overview of global industrial R&D 
issues and the main factors that are shaping corporate R&D 
investments, including the sustainability context. The last 
part of the chapter summarises the main characteristics of 
the 2019 Scoreboard dataset, comprising the distribution 
of companies and their R&D investments by country, world 
region and industrial sector.
The industrial R&D landscape1
The 2019 Scoreboard comprises the top 2500 global companies that invested 
€823.4bn in R&D in 2018, accounting for 90% of the world’s business-funded R&D. 
The Scoreboard 2500 sample includes companies based in the EU (551), the US (769), 
China (507), Japan (318) and a further 23 countries.
Industrial R&D is very concentrated in a few companies, industries and countries. The 
top 100 R&D investing companies are responsible for half of the total R&D and the 
four largest R&D investing sectors and countries account for about three quarters of 
the global 2500 R&D.
EU companies account for 25% of the total R&D, those from the US 38%, Japan 13% 
and China 12%.
The main change in the 2019 Scoreboard sample is the higher number of companies 
from China that becomes the 2nd country by number of companies and the 3rd by level 
of R&D investment.
Industrial R&D plays an important role in the drive to meet the UN’s sustainable 
development goals (SDGs). Specific examples are given of the way in which technologies 
such as AI, biotechnology, nanotechnology, graphene and improved clean energy 
generation & storage technologies are contributing to meeting SDGs.
1.1 | Economic context, sustainability goals and technology 
trends
This section summarises the main economic factors and 
technological trends that influenced companies’ R&D 
investment in the period 2018 covered by this report. It 
comprises a section describing the sustainability context 
and the role that R&D-active companies are playing in 
tackling these issues as well as examples of the way 
in which companies’ R&D investments contribute to 
achieving sustainability goals.
1.1.1 Economic context
The four major factors affecting Scoreboard companies 
in 2018 were interest rates, global GDP growth rates, 
oil prices and the trade dispute between the world’s two 
largest economies – the US and China. Interest rates 
govern companies’ cost of raising funds, GDP growth 
rates and oil prices influence company revenue growth 
and the likelihood of companies making new investments 
while the US/China trade tensions have raised tariffs, 
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affected supply chains and clouded the growth outlook. 
We will take a brief look at each of these factors and then 
summarise their combined effect on companies and their 
R&D budgets.
The ECB is concerned about the health of the global 
economy and, at its September meeting, cut its forecast 
for Eurozone growth to 1.1% for 2019 and 1.2% for 2020 
with forecasts for inflation of 1.2% and 1.0% for 2019 and 
2020. The ECB deposit rate was cut from -0.4% to -0.5% 
in September 2019 and its QE programme of bond buying 
restarted for an unlimited period.
By September 2018, the Fed (US Federal Reserve) had 
ended QE and raised interest rates three times during 2018 
following three rises in 2017. The rate was 2.25-2.5% in 
September 2018 and the Fed’s aim had been to normalize 
rates to provide the ammunition to lower rates to help 
alleviate the effects of any future financial crisis. The Fed 
was expected to raise rates at least once more in 2019 
but, instead, it cut its rate by 0.25% in July, September and 
October 2019 to reach 1.5-1.75% aiming to extend the 
record economic expansion in an increasingly uncertain 
economic environment where global growth is slackening 
and trade tensions with China are rising. These were the 
first rate cuts since the financial crisis of 2008 and Fed 
officials do not now foresee any more cuts. The Bank of 
England has kept its interest rate at 0.75% while the Bank 
of Japan at its July meeting left its key short-term interest 
rate unchanged at -0.1%. However, the IMF has warned 
that current low interest rates mean that central banks 
have little scope to fight any new financial crisis.
The interest rate environment for companies has therefore 
become benign and is likely to remain benign and this 
is helpful for companies wishing to raise funds to invest 
in new products and expansion. However, whether they 
choose to invest or not also depend on the outlook for 
growth and the likelihood of a recession. There are now 
serious concerns about the outlook for growth, on oil prices 
and over trade tensions and these are discussed further 
below.
Interest rates and exchange rates
Global growth forecasts
The IMF’s October 2019 update on the world economy 
warned of a ‘synchronised slowdown’ and ‘precarious 
outlook’ with global growth estimated as 3.0% for 2019, 
the lowest since the financial crisis, with 3.4% for 2020. 
These growth figures are further downgrades from the 
IMF’s April outlook because of rising trade barriers and 
increasing geopolitical tensions. The major country 
growth figures for 2019/2020 are US 2.4/2.1%, Euro Area 
1.2/1.4%, Japan 0.9/0.5% and China 6.1/5.8%. However, 
the latest IMF growth estimates are still in most cases 
significantly more optimistic than the OECD’s September 
outlook which saw global growth of 2.9% for 2019 and 
3.0% for 2020 with the US at 2.4%/2.0%, the Eurozone 
1.1%/1.0% (with the German government recently cutting 
its forecast for 2020 to 1%), Japan 1.0%/0.6% and China 
6.1%/5.7%. In respect of China, Brookings Institution 
research reveals that Beijing statisticians do not correct 
inflated local figures so China’s economy is 12% smaller 
than official figures suggest. Furthermore, Brookings found 
that China’s growth rate has been overstated by around 
2% in recent years so the 6.1/5.7% estimate quoted 
above may really be 4.1/3.7%. The OECD comments 
that the global outlook has become ‘increasingly fragile 
& uncertain’ with subdued GDP growth and global trade 
contracting.
It is apparent that the 0.1% increase predicted by the OECD 
for world 2020 growth depends on several fair winds most 
of which are looking increasingly doubtful. These include 
financial market sentiment remaining supportive, the 
Eurozone stabilising, stressed emerging market economies 
stabilising, China applying policy stimulus, US/China 
trade tensions not escalating, no disorderly Brexit and no 
substantial rise in oil prices. The risks to global growth are 
therefore clearly on the downside.
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Trade tensions
Summary
Oil prices
A substantial rise in oil prices can reduce global growth as 
happened with the oil crises of the 1970s. The situation 
is better now both because of the large output from 
US fracking (which makes the world less dependent on 
Middle East oil) and the greater energy contribution now 
made by renewables. The oil price (Brent crude) was in 
the range $71-80 from May to October 2018, fell sharply 
from October to December and then stayed in the range 
$60-74 from January to September 2019. However, the 
attack on Saudi Arabia’s oil fields and processing facilities 
in September, reduced global output by around 5% and 
caused a sharp spike in oil prices in mid-September 
although the price was back around $60 in late October. 
This attack provided a warning that serious conflict in the 
Middle East and/or blockage of the Strait of Hormuz could 
substantially reduce oil supplies. That is another downside 
risk for the global economy.
The US/China trade tensions arose because the US felt 
that US companies were treated less fairly in China that 
Chinese companies were in the US where they raise 
substantial sums on US stock markets. Specific US concerns 
include asymmetrical tariffs, government subsidies to 
Chinese companies, restrictions on foreign investment 
in Chinese companies and the requirement that US 
companies are forced to hand over technology to Chinese 
partners. In addition, China does not enforce protection 
of US intellectual property rights (IPR) and fails to curb 
gross Chinese piracy of branded and copyrighted goods. 
The US claims theft of its intellectual property including 
by state-sponsored hacking. Both IPR theft and forced 
technology transfer are against WTO rules. Nor are these 
new problems – for example, the Obama administration in 
2010 challenged illegal Chinese government subsidies to 
Chinese alternative energy companies.
By October, the US had put tariffs on $550bn of Chinese 
exports with China placing retaliatory tariffs on $185bn 
of US exports. The difference reflects the trade imbalance 
which the US says reflects the problems listed above 
together with currency manipulation by China. It is still 
possible that the dispute can be settled by negotiation 
and, at the time of writing (October) there is talk of a 
Phase I mini-agreement possibly being signed soon. 
However, if there is no early agreement or a very modest 
one, there will be further risks to global growth. These risks 
would increase due to trade friction between the US and 
EU caused by the recent WTO ruling authorising the US 
to put 100% tariffs on $7.5bn of EU goods because of 
‘illegal’ EU support to Airbus. The EU is expecting a WTO 
decision in early 2020 over its contention that the US gave 
illegal aid to Boeing.
The discussion in the sections above shows that the risks 
to the global economy are now almost all to the down-
side and this will still be true even if there is a prelimi-
nary Brexit deal and a Phase I mini-agreement between 
the US and China. Company CEOs are therefore likely to 
be planning their 2020 budgets under the assumption of 
slowing growth with higher tariffs for at least some major 
countries and are therefore likely to focus on cost-cutting. 
In this environment many R&D directors are likely to find 
it difficult to persuade their CEOs to increase 2020 R&D 
budgets significantly. Such an outcome would be mistaken 
since history shows that those companies that raise R&D 
investment in difficult economic times to fund worthwhile 
projects reap the benefits during the next upturn. This is 
because the new and improved products and services such 
companies launch as a result of their increased R&D give 
them a competitive edge as their markets improve and 
sales rise.
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Growing sustainability concerns comprise a wide range of 
issues from climate change and environment protection 
to human rights and governance. These issues are at 
the top of policy agendas such as the United Nations’ 
2030 sustainable development goals (SDGs)7, the Paris 
Agreement8 and the EU environment and climate action 
framework9.
Two key EU policy tools in this context are the EU 
Taxonomy10 that allows corporations and investors to 
identify businesses opportunities that contribute to 
environmental policy objectives and the Circular Economy 
Action Plan11 aimed at boosting growth and investment 
while developing a carbon-neutral, resource-efficient and 
competitive economy.
Companies have a key role to play to address sustainability 
challenges as is increasingly recognised by managers 
and investors12. Business leaders are becoming aware 
of the importance of delivering not only profits and 
wealth creation but of contributing positively to society. 
In line with this, there are a number of initiatives aimed 
at setting standards to measure effectively companies’ 
contributions to sustainability. For example, in a similar 
vein to the UN’s SDGs, there is the Global Compact 
Initiative encouraging businesses to adopt sustainable 
policies and to report on their implementation and the 
Global Reporting Initiative (GRI) aiming to help businesses 
to understand and communicate their impacts on ESG 
issues (environment, social and governance). Another 
organisation is the Sustainability Accounting Standards 
Board (SASB) which has developed standards adapted 
to each sector and industry to connect businesses and 
investors on the financial aspects and materiality of ESG 
issues raised by the sector/industry. In some countries 
companies are required to include sections on corporate 
social responsibility and corporate governance in their 
annual reports.
Beyond the need to meet corporate responsibility 
standards or to comply with stricter regulations, 
companies can take advantage of the many business 
and investment opportunities arising from the need to 
adopt more sustainable business practices. In particular, 
tackling environmental problems creates market needs 
requiring new innovative and technological solutions. 
For example, digital and communication technologies, 
artificial intelligence (AI), big data, nanotechnology, 
internet of things and advanced manufacturing show great 
potential for the development of clean technologies13. 
AI offers a wide range of applications for environment 
protection, health care and agriculture; Nanotech is 
applied for developing new batteries, water treatment 
tech, desalination processes and lower cost clean energy. 
See specific examples of company innovations aimed at 
improving sustainability issues in the next section.
1.1.2 Sustainability goals
1.1.3 Technology trends
7 The 17 Sustainable Development Goals are a blueprint to achieve a better and more sustainable future for all (https://www.un.org/sustainabledevelopment/sustain-
able-development-goals/).
8 Agreement signed by 195 countries within the United Nations Framework Convention on Climate Change (UNFCCC), dealing with greenhouse-gas-emissions mitiga-
tion, adaptation, and finance, signed in 2016.
9 The Treaty of the Functioning of the European Union requires “Environmental protection requirements must be integrated into the definition and implementation of the 
Union’s policies and activities, in particular with a view to promoting sustainable development”.
10 Financing a Sustainable European Economy ‘TAXONOMY’, Technical Report, June 2019.
11 COM (2019) 190 final.
12 The Investor Revolution, Eccles R.G. and Klimenko S., Harvard Business Review, July 2019. 
13 Financing for Sustainable Development Report 2019, United Nations, New York 2019.
This section highlights key technological trends being 
developed by Scoreboard companies and gives examples 
of the role of companies’ R&D in achieving sustainability 
goals.
The two main technological areas showing both fast growth 
and a wide range of applications are biotechnology and 
software/AI (artificial intelligence). They are supported by 
developments in new materials and materials processing 
23The 2019 EU Industrial R&D Investment Scoreboard
such as novel battery materials, graphene products and 
3D printing. In addition, global R&D investment has led 
to a whole range of new products, processes & services 
that are contributing to most of the UN’s 17 sustainable 
development goals. We briefly discuss these four topics 
below.
Artificial intelligence and quantum computing
Biotechnology
AI has an increasing number of applications in a 
wide range of sectors. Examples include agriculture 
(e.g. predicting ripening time for crops or automated 
greenhouses), education (e.g. personal AI tutors, adaptive 
learning), finance (e.g. algorithmic trading, data mining, 
robo-advisers), health (e.g. AI diagnostics, data mining 
of medical records, companion robots for elderly care), 
cybersecurity, intelligent robots and transport (e.g. self-
driving cars, optimized traffic systems). Just one example 
is the use of AI in diagnosing idiopathic pulmonary fibrosis 
from CT scans – the AI software equals the performance 
of a group of 91 world-leading specialists. And DeepMind’s 
AI is better than experts at diagnosing eye diseases. Many 
Scoreboard companies are working on one or more of 
these AI applications.
Some AI applications are beyond the capabilities of 
conventional computers and this is one of the drivers for 
work on quantum computers. For example, Google AI 
Quantum is developing quantum processors and quantum 
algorithms for the AI of tomorrow. Google’s prototype 
Sycamore quantum computer recently achieved ‘quantum 
supremacy’ when it solved a test problem in 3 minutes that 
would take most supercomputers 10,000 years. There is, 
however, a long way to go before quantum computers can 
solve real-world problems. But the hope is that quantum 
computers will revolutionise chemistry, materials science 
and pharmaceuticals by performing simulations that are too 
complex for classical computers and hence enabling new 
drugs and new materials. There will also be applications in 
encryption, code breaking and financial modelling.
The rapid development of biotechnology has led to 
advances in agriculture, animal genetics and a series 
of new treatments that are saving lives and giving 
new hope to seriously ill patients. Examples are 
immunotherapy, gene therapy and stem cell 
therapy. Cancer immunotherapies remove the cloak of 
invisibility which cancer cells use to hide from the body’s 
immune system and thus enable the body’s immune 
system to attack the cancer. The first modern cancer 
Immunotherapy was Bristol-Myers Squibb’s Yervoy 
first approved by the FDA in 2011 to treat metastatic 
melanoma. Since then a growing range of other 
immunotherapies have been approved to treat a wide 
range of cancers. The FDA has granted new approvals 
for seven cancer immunotherapies in the last year or 
so. Gene therapy is the process of replacing missing, 
defective or mutated genes and is particularly useful 
for treating inherited diseases. The EMA (European 
Medicines Agency) recommended approval of UniQure’s 
Glybera in 2012 for the treatment of the rare disease 
LPLD (lipoprotein lipase deficiency). Since then interest 
has intensified with 372 clinical trials of gene therapies 
ongoing in Q1 2019 and 9% of these in Phase III.
Stem cells are cells that have the ability to develop into 
most other types of cell in the body and stem cell therapies 
are another very promising area. The only FDA approved 
stem cell treatment is the use of cord blood products 
for patients suffering from blood or immune disorders. 
Also, bone marrow stem cell transplants are used in the 
treatment of blood disorders such as lymphoma and 
leukaemia. Osiris’s Prochymal was approved in 2012 to 
treat graft-vs-host disease, a severe complication of bone 
marrow transplants. Promising new stem cell clinical trials 
have been reported for heart tissue regeneration, eye 
tissue regeneration (e.g. treating macular degeneration 
and retinitis pigmentosa) and skin tissue regeneration. 
Imperial college, London reported in June that a 3cmx2cm 
patch grown in a lab from a rabbit’s own stem cells had 
turned itself into healthy working heart muscle and that it 
also released chemicals that repair existing heart cells. It 
is hoped to start patient trials in the next two years.
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The Nobel Prize for chemistry this year was awarded 
for work on developing the first lithium ion battery – 
batteries that now power everything from smartphones 
to electric cars. New materials R&D includes work on 
improved lithium batteries, solid state batteries, fuel cells, 
applications of graphene, nanomaterials, high temperature 
superconductors, higher efficiency photovoltaics and 
4Dprinting (3Dprinting with multi-materials to make 
objects that can adapt to their environment). The cost/
Megawatt of installed solar has fallen by a factor of five 
over the last 8 years and electric vehicle battery costs 
are expected to more than halve from 2015 to 2025. An 
example of a company active in some of these areas is 
Johnson Matthey which has developed next generation 
high energy density lithium battery electrodes and is 
also working on hydrogen-powered fuel cells as well 
as improved vehicle catalysts. And Versarien PLC is 
developing graphene materials & applications such as 
graphene-enhanced composite materials and graphene 
ultracapacitors.
New Materials
The role of R&D in achieving the UN’s sustainable development goals
The aim of this section is to give examples of technologies 
and companies in the Scoreboard (or those likely to join 
it as they grow) which contribute to the UN’s sustainable 
development goals. The two key technologies of AI and 
biotech feature in many of the SDGs. We start with the 
second UN SDG, zero hunger.
1. Zero hunger (UN goal 2): The key R&D contribution 
here is the use of biotechnology in animal and plant 
genetics to improve farming productivity. Examples 
are genetically improved crops with higher yields that 
are drought resistant and can be grown on poorer 
soils. In addition, improved animal genetics can make 
farm animals resistant to disease and provide higher 
yields. Examples of companies involved include BASF 
(which acquired Monsanto’s seeds business from 
Bayer) for crops and Genus for animal genetics. Then 
there are companies such as Gamaya using AI and 
remote sensing to increase farming efficiency.
2. Good health & wellbeing (UN goal 3): this area 
includes biotechnology, health and pharmaceuticals 
which are together enabling people to live longer, 
healthier lives. Big advances have been made in 
treating cancer with immunotherapy drugs and R&D 
on new antibiotics will be essential in protecting pop-
ulations against the growing threat of antibiotic-re-
sistant superbugs. Examples of major companies 
in this area are Medtronic (health devices), Amgen 
& Gilead Sciences (biotechnology) and AstraZeneca, 
Bristol-Myers Squibb, Merck and Novartis (biophar-
maceuticals). The last four companies (and several 
others) all have approved cancer immunotherapy 
drugs for treating a wide range of different cancers. 
There are 9 Phase III clinical trials in progress for new 
antibiotics against WHO critical threat pathogens 
with Merck & Co having applied to the FDA for ap-
proval of a tenth.
3. Quality education (UN goal 4): AI enables more 
personalized education and training, can bring material 
prepared by the best educators to wide audiences 
and can lower costs. Companies such as Knewton 
(adaptive learning technology for higher education), 
Century Tech (personalized learning plans), Blippar 
(computer vision & intelligence and augmented 
reality to enhance the learning experience), Learning 
Technologies Group (online learning & talent 
management) and CTI (customisable textbooks) are 
examples.
4. Clean water & sanitation (UN goal 6): Key 
areas here are water treatment and purification, 
wastewater and desalination. Given the increasing 
demand for clean water and the scarcity of water 
in some areas of the world, desalination is likely to 
become more and more important. Reverse osmosis 
is one of the key technologies for desalination and 
is the subject of much R&D. For example, Lockheed 
Martin has developed a graphene composite reverse 
osmosis system which it claims will be ‘a game 
changer’ with higher efficiency and lower cost than 
existing systems.
5.	 Affordable	 &	 clean	 energy	 (UN	 goal	 7):	 The 
major role for R&D here is in reducing the cost of clean 
renewable energy to enable it to play an increasing 
role in transport and energy generation and increase 
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its penetration in poorer countries. R&D is key to 
the development of larger and more efficient wind 
turbines that can generate more energy. GE claims 
the world’s largest – a 12MW turbine with a 220m 
rotor diameter. R&D is also enabling increases in the 
efficiency of solar panels; this is currently just over 
20% for commercial panels from SunPower, LG, REC 
Solar & Panasonic but concentrator photovoltaics 
have achieved over 40% with the EU-funded CPV-
Match project achieving module efficiencies of 
41.4%. There is also promising work using carbon 
nanotube composites. Many companies are raising 
the percentage of renewable energy they use – 
Google, for example, claimed that it had reached its 
target of using 100% renewable energy by 2017. 
R&D on better batteries for electric cars will increase 
range and lower cost to increase clean energy electric 
cars’ market share and make them a more viable 
option for poorer countries. In the long-term fusion 
power may provide a massive new source of clean 
energy.
6. Decent work & economic growth (UN goal 8): 
R&D can assist with this objective by creating new 
products offering new employment opportunities, 
by increasing productivity to accelerate economic 
growth and by providing products to improve safety 
at work. Mobile/smart phones are an example of a 
new product area, robotics and IT (companies such as 
Fanuc, Teradyne, SAP and Microsoft) are technologies 
that have increased productivity and Halma is just 
one example of a company involved in process and 
environmental safety.
7. Industry, innovation & infrastructure (UN goal 
9): The aim here is to build resilient infrastructure, 
promote sustainable industrialisation and foster 
innovation. The R&D Scoreboard is a key tool in 
raising awareness of R&D investment (innovation) 
and in enabling lagging companies in each sector to 
see the higher percentages of sales that their more 
innovative competitors are investing in R&D. Some of 
them may then increase their own R&D investments 
with the aim of developing new products and services 
to become more competitive. With over 80% of 
world trade volume going by sea, efficient maritime 
transport is a key enabler of trade & globalisation. 
In this context, AI is being used to improve logistics 
and experiments are in progress on autonomous 
shipping (the first successful autonomous crossing of 
the English Channel with its busy shipping lanes was 
reported in May 2019 by the unmanned British ship 
Sea-Kit Maxlimer).
8. Sustainable cities & communities (UN goal 
11): R&D can contribute to this goal in two main 
ways – improving air quality in cities through the 
development of affordable electric vehicles and 
less use of fossil fuels for heating buildings aided 
by designing buildings that are much more energy 
efficient and, in some cases, of zero net energy. For 
example, NetZero Buildings Limited uses off-site 
manufacture to build efficient schools and homes 
and has to date completed over 100 school projects.
9. Responsible consumption & production (UN 
goal 12): The key actions here are the more efficient 
use of resources, reduction of waste and more 
recycling. Good design and process R&D can reduce 
the amount of material used during production and 
reduce the associated waste and scrap. Accurate 
measurement during production plays an important 
part in this. Companies involved range from 
Renishaw (precision metrology) to Johnson Matthey 
(recovery of precious metals from exhaust catalysts). 
Responsible consumption is reflected in the targets 
many companies have adopted to increase the 
percentage of renewable energy they use. Over 90 
global companies have committed to the RE100 
campaign to reach a 100% renewables target. Vestas 
reached this target in 2013, SAP in 2014, Google & 
Wells Fargo in 2017.
10. Climate action (UN goal 13): R&D has a 
major role in reducing greenhouse gas emissions. 
Examples are the development of cost-effective 
electric vehicles to reduce transport emissions, 
more efficient wind and solar energy generation 
to reduce the need to use fossil fuels for transport 
and energy generation. R&D is lowering the cost of 
solar power and is extending the range and lowering 
the cost of electric cars. Work is well advanced on 
short-range electric aircraft and electric air taxis 
(both battery and hydrogen-fuel cell prototypes). 
In total 150 companies are working on aspects of 
electric air taxis. And hydrogen fuel cell trains are 
planned to enable dirty diesels to be phased out. In 
agriculture, which is estimated to cause around 9% 
of greenhouse emissions, meat substitutes reduce 
animal emissions of methane which is 23 times more 
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polluting than CO2. Examples of companies involved 
include Vestas Wind systems, Tesla and many major 
car manufacturers (electric vehicles), Beyond Meat 
and Impossible Foods (making plant-based ‘meat’ 
– and Burger King sells the Impossible Burger). It 
is estimated that plant-based ‘meats’ require one-
twentieth of the land, one quarter of the water and 
one-twelfth of the fertilizer needed for animal meat 
products. R&D to extend product lives also generates 
considerable savings – for example, extending the life 
of European smartphones by one year would save 2 
million tonnes of carbon emissions. And emissions 
from homes can be reduced by better insulation, 
electrification and air & ground force heating.
11. Life below water (UN goal 14): Biotechnology 
is being used in the sustainable development of 
aquaculture, fisheries and also in the food industry. 
This contributes to meeting the increasing demand 
for seafood and to meeting the aims of 1 above (zero 
hunger). Biotech is helping to improve the quality 
and quantity of fish reared in aquaculture through 
induced breeding, genetic modification and enhanced 
disease resistance. Much of this research is carried 
out by Institutes such as Nofima AS, the Norwegian 
institute for fisheries and aquaculture. One of its 
board members is the MD of Milarex, the seafood 
company.
12. Life on land (UN goal 15): With world consumption 
of materials expanding it is important not to over-
extract resources or damage the environment. 
Responsible consumption and production (9 above) 
are important for this as is the reduction of emissions 
and pollution (5 & 8 above). More efficient farming 
(see 1 above) and plant-based ‘meats’ (see 10 
above) together mean less land for the same food 
output and should also help to protect biodiversity 
by reducing the demand to clear rain forests and 
other ‘wild’ areas for farming use. Climate change 
is leading to more volatile weather patterns and 
AI is now being used to predict flash flooding years 
before it occurs so that preventive measures can be 
taken and building permission refused for land at 
risk. Responsible production (9 above) and increased 
recycling both help to reduce resource extraction as 
does the use of renewable energy to replace fossil 
fuels.
1.2 | Characterisation of the R&D investment
This section outlines the main characteristics of the 2019 
Scoreboard dataset and highlights, in particular, the con-
centration of industrial R&D at company, industry and 
country levels.
The top 2500 global companies each invested more than 
€30 million in R&D in 2018, accounting together for a to-
tal of €823.4 billion.
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FIGURE 1.1: COMPARISON OF R&D FIGURES OF THE SCOREBOARD AND TERRITORIAL STATISTICS.
Note: Total R&D expenditure (GERD) and R&D financed by the business sector (BES-R&D) in 2017 (red dark overlapping bar represent the BES-R&D).
Sources: Latest figures reported by Eurostat including most countries reporting R&D.
The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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The amount of R&D investment by these 2500 companies 
is equivalent to 54% of the total expenditure on R&D 
worldwide (GERD) and about 90% of the R&D expenditure 
financed by the business sector worldwide.
This is illustrated in Figure 1.1 where the latest 2017 
territorial statistics are compared with the corresponding 
figures from the previous 2018 Scoreboard (GERD 
€1264.7bn, of which R&D financed by the business 
enterprise sector “BES-R&D” was €828.8bn and the 
2018 Scoreboard €736.4bn or 88.9% of global business-
financed R&D).
The 2500 company global dataset is complemented with 
additional companies in order to cover the top 1000 R&D 
investing companies based in the EU, all of them having 
invested more than €8.5 million in R&D in 2018. Of these 
1000, 551 appear in the world top 2,500 and another 
449 are added with R&D between €8.5m and €30m. The 
total R&D for the EU1000 is €215.6bn in 2018 which is 
only €7.2bn larger than the €208.4bn total for the 551 EU 
companies included in the global 2500.
This additional sample of 1000 companies is analysed 
separately in chapter 4.
1.2.1 Companies’ distribution by country
The 2019 Scoreboard comprises companies with 
headquarters in 44 countries of which 18 are member 
states of the EU. The sample includes companies based 
in the EU (551), the US (769), China (507), Japan (318), 
Taiwan (89), South Korea (70), Switzerland (58), India (32), 
Canada (28), Israel (22) and a further 17 countries (see 
Table 1.1 and Figure 1.2a). Note that just 5 EU countries 
account for 72% of the EU companies and 5 non-EU 
countries account for 90% of the non-EU companies. If we 
take into account their subsidiaries, Scoreboard companies 
are present virtually in every country of the world (Figure 
1.2b).
Number of companies by country
EU non-EU
Germany 130 US 769
UK 127 China 507
France 68 Japan 318
Netherlands 39 Taiwan 89
Sweden 33 South Korea 70
Denmark 30 Switzerland 58
Ireland 27 India 32
Italy 26 Canada 28
Finland 17 Israel 22
Austria 17 Australia 12
Spain 14 Norway 10
Belgium 12 Brazil 6
Luxembourg 4 Singapore 6
Greece 2 Turkey 5
Portugal 2 New Zealand 3
Hungary 1 Saudi Arabia 3
Slovenia 1 South Africa 2
Poland 1 Further 9 countries 9
Total 551 Total 1949
TABLE 1.1: DISTRIBUTION OF COMPANIES BY COUNTRY.
Note: the 2500 companies all have R&D investment above €30 million.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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FIGURE 1.2A: DISTRIBUTION OF THE 2500 COMPANIES IN THE 2018 SCOREBOARD BY HEADQUARTERS COUNTRY.
Note: Number of companies indicated besides the country code (the world map includes only countries with at least 10 companies). R&D is represented with a bubble whose 
size is proportional to R&D in 2018 in the country.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
FIGURE 1.2B: DISTRIBUTION OF THE SUBSIDIARIES OF THE 2500 PARENT COMPANIES IN THE 2019 SCOREBOARD.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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Assigning companies to industrial sectors according to 
existing classification systems is not a straightforward 
task. In fact, sector definitions often do not fit 
unambiguously with actual company activities that may 
also change over time, and in addition, many companies 
operate in two or more very different industrial sectors. 
However companies usually indicate their main sector 
of activity in their annual reports; for example, public 
companies use taxonomy such as the International 
Classification Benchmark (ICB)14.
According to the ICB, the Scoreboard comprises 
companies operating in a wide range of manufacturing 
and services sectors, including more than 50 industries 
with a special concentration on the most innovative ones 
such as ICT, health, transport and the engineering related 
industries. In the Scoreboard we use different levels of 
sector aggregation to describe the sectoral distribution 
of companies’ R&D. Tables 1.2 and 1.3 describe two 
typical classifications of industrial activities applied 
in the Scoreboard. The R&D is highly concentrated by 
sector, the 76.6% of total R&D is accounted for by just 
four of the sectors in table 1.2 (automotive, health, ICT 
producers & ICT services) and in Table 1.3, the high and 
medium-high R&D-intensity sectors account for 90% of 
total Scoreboard R&D.
Please note that these broad industrial classifications are 
not sufficient to characterise the technological profile of 
companies. To analyse the technological development 
of companies we need additional indicators comprising 
detailed technological classifications, for example patent 
or bibliometric analyses. This is shown in this Scoreboard 
edition, in chapters 5, 6 and 7, where the patent portfolios 
of companies are examined to describe their activities in 
technological terms. For example, the focus of chapters 
6 and 7 on environmental technologies shows how the 
companies from regulatory-driven sectors such as those 
related with transport and energy activities are more 
active in developing such technologies.
1.2.2 Companies’ aggregation by industrial sector
14 http://www.ftse.com/products/downloads/ICBStructure-Eng.pdf.
Industrial 
Sector Sector	classification	ICB4	digits N	of	firms
% of total 
R&D
Aerospace  
& Defence Aerospace; Defence 50 2.5
Automobiles & 
other transport Auto Parts; Automobiles; Commercial Vehicles & Trucks; Tires 185 17.2
Chemicals Commodity Chemicals; Specialty Chemicals 129 2.7
Health industries Biotechnology; Health Care Providers; Medical Equipment; Pharmaceuticals 515 20.7
ICT producers Computer Hardware; Electrical Components & Equipment; Electronic Equipment; Electronic Office Equipment; Semiconductors; Telecommunications Equipment 477 23.3
ICT services Computer Services; Internet; Software 320 15.4
Industrials Aluminium; Containers & Packaging; Diversified Industrials; Industrial Machinery; Iron & Steel; Nonferrous Metals; Transportation Services 295 5.5
Others*
Alternative Energy; Banks; Beverages; Construction & Materials; Electricity; Financial 
Services; Food & Drug Retailers; Food Producers; Forestry & Paper; Gas, Water & 
Multiutilities; General Retailers; Household Goods & Home Construction; Leisure 
Goods; Life Insurance; Media; Mining; Nonlife Insurance; Oil & Gas Producers; Oil 
Equipment, Services & Distribution; Personal Goods; Real Estate Investment & 
Services; Support Services; Tobacco; Travel & Leisure
529 12.7
Total 2500 100
TABLE 1.2: INDUSTRIAL CLASSIFICATIONS APPLIED IN THE SCOREBOARD - 8 INDUSTRIAL GROUPS.
* Sectors in the “Others” group are presented at ICB-3 digits level.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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Sector R&D 
intensity* Sector	classification	ICB4	digits**
N of 
firms
% of total 
R&D
high
Aerospace; Biotechnology; Computer Hardware; Computer Services; Defence; Electronic 
Office Equipment; Health Care Providers; Internet; Leisure Goods; Medical Equipment; 
Pharmaceuticals; Semiconductors; Software; Technology Hardware & Equipment; 
Telecommunications Equipment
1142 54.9
medium-high
Auto Parts; Automobiles; Commercial Vehicles & Trucks; Commodity Chemicals; Containers 
& Packaging; Diversified Industrials; Electrical Components & Equipment; Electronic 
Equipment; Financial Services; Household Goods & Home Construction; Industrial Machinery; 
Personal Goods; Specialty Chemicals; Support Services; Tires; Travel & Leisure
932 35.1
medium-low
Alternative Energy; Beverages; Fixed Line Telecommunications; Food Producers; General 
Retailers; Media; Oil Equipment, Services & Distribution; Tobacco
152 3.5
low
Aluminium; Banks; Construction & Materials; Electricity; Food & Drug Retailers; Forestry 
& Paper; Gas, Water & Multi-utilities; Iron & Steel; Life Insurance; Mining; Mobile 
Telecommunications; Nonferrous Metals; Nonlife Insurance; Oil & Gas Producers; Real Estate 
Investment & Services; Transportation Services
274 6.5
Total 2500 100
TABLE 1.3: INDUSTRIAL CLASSIFICATIONS APPLIED IN THE SCOREBOARD – THE 4 SECTOR GROUPS OF DIFFERENT R&D INTENSITY.
Note: This classification takes into account the average R&D intensity of all companies aggregated by ICB 3-digits sectors: High above 5%; Medium-high between 2% and 5%; 
Medium-low between 1% and 2% and Low below 1%. Some sectors are adjusted to compensate for the insufficient representativeness of the Scoreboard in those sectors using 
the OECD definition of technology intensity for manufacturing sectors.
* For simplification, in this report these 4 groups are also referred to as high tech, medium-high tech, medium-low tech and low tech.
**Sectors included in the “Others” group in table 1.2 are presented at ICB3 level
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
The number of companies by industry for the EU and non-
EU regions is shown in Table 1.4. The top 3 companies 
by level of R&D investment for each type of industry are 
presented in Table 1.5. The top3 companies are the same 
as last year in each sector except for Chemicals: BASF was 
first last year, followed by DOWDUPONT and MONSANTO 
(acquired by BAYERN in 2018).
Industry EU non-EU Total
Aerospace & Defence 16 (32.0%) 34 (68.0%) 50
Automobiles & other transport 46 (24.9%) 139 (75.1%) 185
Chemicals 21 (16.3%) 108 (83.7%) 129
Health industries 110 (21.4%) 405 (78.6%) 515
ICT producers 63 (13.2%) 414 (86.8%) 477
ICT services 49 (15.3%) 271 (84.7%) 320
Industrials 82 (27.8%) 213 (72.2%) 295
Others 164 (31.0%) 365 (69.0%) 529
Total 551 (22.0%) 1949 (78.0%) 2500
TABLE 1.4: DISTRIBUTION OF GLOBAL 2500 COMPANIES BY INDUSTRIAL SECTOR AND REGION.
Note: The figures in brackets show each sector’s EU & non-EU percentages of the total number of companies in each sector.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
The 551 EU companies comprise 22% of the total 
of 2500 global companies. The industry groups with 
higher percentages than this are Aerospace & Defence, 
Automobiles, Industrials and Others. ICT producers have a 
much lower percentage while Chemicals and ICT services 
are lower and Health is similar. The reverse is true for non-
EU with ICT producers, ICT services and Chemicals, for 
example, having much higher percentages than the overall 
78% while automotive and industrials are somewhat 
lower and aerospace & others significantly lower.
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Industrial R&D is highly concentrated. A small subset of 
companies, industries and countries account for a large 
share of the total R&D investment of the 2500 sample. 
As observed in all the Scoreboards since the first in 2004, 
this characteristic R&D concentration remains practically 
unchanged from year to year.
Figure 1.3 presents the distribution of the 2500 compa-
nies ranked by their level of R&D investment. 
The R&D concentration (% of total R&D) for the top 10, 
top 50, top 100 and top 500 companies is respectively 
15%, 40%, 52% and 80%. 
There are 7 companies having an R&D investment of more 
than €10bn, 73 more than €2bn and 159 more than €1bn. 
The latter group of companies comprises 41 from the EU, 
58 from the US, 26 Japanese, 19 Chinese, 5 each from 
South Korea & Switzerland, 3 from Taiwan and 1 each 
Health industries Automobiles & other transport
ROCHE Switzerland VOLKSWAGEN Germany
JOHNSON & JOHNSON US DAIMLER Germany
MERCK US US TOYOTA MOTOR Japan
ICT services* ICT producers
ALPHABET US SAMSUNG South Korea
MICROSOFT US HUAWEI China
FACEBOOK US APPLE US
Aerospace & Defence Industrials
AIRBUS Netherlands GENERAL ELECTRIC US
BOEING US PHILIPS Netherlands
UNITED TECHNOLOGIES US HONEYWELL US
Chemicals Others
DOWDUPONT US PANASONIC Japan
BASF Germany SONY Japan
SUMITOMO CHEMICAL Japan LG ELECTRONICS South Korea
TABLE 1.5: TOP 3 COMPANIES BY R&D FOR THE MAIN INDUSTRIES COMPRISED IN THE 2019 SCOREBOARD.
*Amazon would be included as #1 in this group if it had reported its technology investment separately rather than combining it with ‘content’ (see box 3.1 in chapter 3 for more 
details of this).
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
1.2.3 Distribution of the R&D investment by company, sector and country
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FIGURE 1.3: COMPANIES OF THE 2019 SCOREBOARD RANKED BY R&D.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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from India and Israel. The majority of top 100 companies 
(82) operate in three sectors: 26 in Health industries (EU
9), 22 in Automobiles & other transport (EU 11) and 34 in
ICT industries (EU 5).
R&D is very much concentrated by country and world 
region. This is illustrated by Figure 1.4 which shows the 
R&D shares of the main countries and regions.
The top 3 (US, China, Japan), top 5 and top 10 countries 
account respectively for 63%, 77% and 92% of the 
total R&D investment. Within the EU, the R&D is even 
more concentrated, the top 3 (Germany, UK, France), 
top 5 and top 10 countries account respectively for 
69%, 82% and 97% of the total R&D invested by the 
companies based in the 18 EU countries represented in 
the Scoreboard.
Japan 13.3%
(318) 
USA 38.0%
(769) 
Other EU countries 1,9% 
Italy 0,7% 
Denmark 0,7% 
Ireland 1,1% 
Sweden 1,2% 
Netherlands 2,3% 
UK 3,6% 
France 3,7% 
Germany 10,1% 
South Korea 3,8% 
Switzerland 3,5% Taiwan 2,0% 
Other RoW 2,5% 
China 11.7%
   (507) 
EU Total 25.3%
(551)
Row 11.7% (355)
FIGURE 1.4: R&D INVESTMENT BY THE 2500 COMPANIES BY MAIN COUNTRY/REGION (% OF TOTAL €823.4BN).
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
The R&D is also largely concentrated by industrial sector, 
as illustrated in Figure 1.5 presenting the distribution of 
R&D by industry for the main countries/regions. The four 
largest R&D investing sectors (ICT producers, Health 
industries, Automobiles & other transport and ICT services) 
account for 77% of the total R&D of the 2500 companies. 
The main contributions to the total Scoreboard R&D are:
• By EU companies: 46% to Automobiles & other
transport, 46% to Aerospace & Defence and 27% to
Health industries;
• By US companies: 67% to ICT services, 49% to health
industries, 41% to ICT producers and 39% to Aerospace 
& Defence;
• By Japanese companies is 34% to Chemicals, 24% to
Automobiles & other transport and 21% to Industrials;
• By Chinese companies is 20% to Industrials, 15% to
ICT producers and 23% to other sectors.
Finally, the R&D shares of industrial sectors for each main 
country/region are presented in Figure 1.6. This Figure 
shows that each country/region has a characteristic R&D 
specialisation. The top three sectors by level of R&D 
investment for each region account for:
• 67% within the EU (Automobiles & other transport
31%; Health industries 22% and ICT producers 14%);
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Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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•	 79% within the US (Health industries 27%; ICT services 
27% and ICT producers 25%);
•	 68% within Japan (Automobiles & other transport 
31%; ICT producers 20% and Others 17%);
•	 73% within China (ICT producers 29%; Others 26% 
and ICT services 18%).
Note the similarities in sector structure between the EU and 
Japan (both have 31% automotive) and between the US and 
China (both have over 50% in ICT producers & services). The 
proportion of US R&D in ICT services would be even larger 
if Amazon could have been included in the Scoreboard (see 
Box 3.1 in chapter 3 for further details of this).
Whereas the top five companies in the EU and the US 
both account for 20% of the total R&D of those regions, 
the top five in China and Japan account for 25%. The top 
five companies in the EU and Japan contain four from the 
Automobiles sector whereas the top five from the US have 
four from the ICT sector.

2 GLOBAL R&D TRENDS BY INDUSTRY AND 
WORLD REGION
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This chapter analyses the main trends in R&D and 
economic indicators for the world’s top 2500 companies 
that each invested more than €30 million in R&D in 2018. 
The first part concentrates on the evolution of companies’ 
main performance indicators over the previous year and 
the second section analyses the long-term performance 
of companies aggregated by industry and main world 
regions.
The 2500 companies are grouped into five main sets: the 
top 551 companies from the EU, 769 companies from the 
US, 318 from Japan, 507 Chinese companies and 355 
companies from the Rest of the World group (RoW). The 
RoW group includes companies from Taiwan (89), South 
Korea (70), Switzerland (58), India (32), Canada (28), 
Israel (22) and companies based in a further 17 countries.
Companies are aggregated into 8 industrial sectors 
(defined in Chapter 1 – Table 1.2). More disaggregated 
information (at sector level, ICB 3-digits) is found in Annex 
A3 – Table A3.1, including the main statistics for the world 
2500 sample.
Global R&D trends by industry  
and world region
2
The ongoing global technology race intensified in 2018 with US and Chinese companies 
increasing sharply their R&D investments by 10.3% and 26.7% respectively and EU 
companies following behind with 4.7%.
Over the past 10 years, the rapid R&D growth in the ICT, health and Automotive 
industries has reshaped the global industrial structure with EU companies increasing 
their share in Automobiles and US and Chinese companies’ increasing their share 
in the ICT industries. These changes are magnified by regional differences in R&D 
intensity where EU companies appear to be lagging compared to the US and are now 
challenged by their Chinese counterparts.
Two particular challenges are posed for the EU:
- EU’s lead in medium-high tech may be eroded as ICT takes a higher proportion of the 
value added in sectors such as automotive with the advent of new developments such 
as electric self-driving cars.
- US’ increasing leadership in health biotechnology which is the basis of more and 
more new drugs.
2.1 | Changes in companies’ indicators in 2018
In 2018, the 2500 companies as a whole increased 
significantly their R&D investments and showed good 
results across most performance indicators, especially in 
terms of net sales that have increased at a similar rate to 
the R&D investment. However, as shown in this chapter, 
companies’ results vary greatly across world regions and 
industries. Tables 2.1 and 2.2 present the one-year change 
of main indicators for the whole set of companies by main 
region and country. Figure 2.1 provides an overview of the 
R&D investment by the main world regions and Figures 2.2 
and 2.3 show the one-year change of R&D and net sales 
for the main world regions and industrial sectors15.
15 Data are aggregated into 8 industrial groups (defined in Chapter 1 – Table 1.2). More disaggregated information (at sector level, ICB 3-digits) is found in Annex A3 – 
Table A3.1, including main statistics for the world 2500 sample.
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•	 Overall R&D investment continued to increase 
significantly in 2018 for the ninth consecutive year. The 
2500 Scoreboard companies invested €823.4 billion 
in R&D, 8.9% more than in 2017, improving slightly on 
the increase of 8.6 % in the year before.
•	 Worldwide R&D growth was driven by the ICT services 
sector (+16.9%), followed by the ICT producers sector 
(+8.2%) and the Health sector (+7.6%). The lowest R&D 
growth was shown by Aerospace & Defence (+4.3%).
•	 The 551 companies based in the EU invested €208.3bn 
in R&D, an important increase in this period (+4.7%) 
but at a lower rate than in the previous year (+5.3%). 
The Japanese companies presented a lower R&D 
growth rate than their EU counterparts (+3.9%) and, 
as observed in the previous period, companies based 
in the US and China showed much higher R&D growth 
rates (+10.3% and +26.7% respectively).
•	 For the EU sample, the top 3 sectors in terms of their 
contribution16 to R&D growth (weighed by R&D size) were 
Automobiles (+6.4%), Health industries (+3.8%) and ICT 
producers (+5.5%) with the lowest contribution was made 
by Chemicals (-2.6%), mostly due to the performance of 
the largest R&D investor of the group, BASF (-11.6%).
 Among the largest member states, German and French 
companies showed the highest R&D growth (3.6% and 
10.6% respectively) whereas companies based in the 
Netherlands increased R&D by 2.7%.
•	 For the non-EU sample of companies, R&D growth was 
driven by the high tech industries, especially by high 
R&D increases in the US and China, i.e. ICT services (US 
17%, China 39%), ICT producers (US 9%, China 15%), 
Health industries (US 9%, China 57%). The poorest 
performance was shown by the Aerospace & Defence 
sector across most countries.
2.1.1 R&D trends
16 The net company or sector contribution to the R&D growth of the sample is the nominal growth rate of the company or sector weighed by the R&D share of the company 
or sector.
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FIGURE 2.1: R&D INVESTMENT BY MAIN WORLD REGION IN THE LATEST TWO YEARS.
Note: Growth rates have been computed for 549 EU, 760 US, 318 Japanese, 487 Chinese and 353 RoW companies for with data are available for both years 2017 and 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
2.1.2 Trends in key economic indicators
•	 The overall growth of net sales continued the positive 
trend shown in the past year, increasing significantly at 
a similar rate to R&D investment (8.4%). As observed 
in 2017, the growth in net sales was led by oil-related 
companies due to high oil prices, besides significant 
increases are shown also in ICT and the Industrials 
sectors. The overall profits of companies continued to 
growth at a high rate (9.1%) also due to oil-related 
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companies and, to a lesser extent, due to the ICT and 
Chemicals industries. In the same vein, companies’ 
capital investments (Capex) continued the significant 
recovery seen in the previous year. Capex increases 
are observed especially in oil-related companies, ICT 
services and Industrials. The number of employees 
for the 2500 companies continued to increase at a 
moderate pace (3.6%).
•	 The net sales of the 551 companies based in the 
EU reached €6.0trillion, 4.7% more than in the 
previous year. Net sales increases were registered 
in most industries (except in Health). The best sales 
performance was shown in oil-related sectors but 
other sectors such as Industrials (5.9%), Aerospace 
& Defence (6.1%) and Chemicals (3.6%) showed also 
sales performance above the EU’s average.
•	 The EU companies continued to increase modestly 
capital expenditures and profits (2.0% and 3.2% 
respectively). The 551 companies based in the EU 
employed 19.4 million, 3.9% more than the year before.
•	 The 769 companies based in the US increased 
significantly most financial indicators. Net sales 
increased by 10.4% and capital expenditures increased 
sharply by 15.8%. US companies showed also a high 
increase in profits (9.2%) and a fair increase in numbers 
of employees (4.1%) to reach 11 million.
•	 The 318 companies based in Japan raised net sales 
by 3.2% and capital expenditures by 9.0%. They 
decreased slightly profits (-0.8%) and maintained 
practically unchanged the number of employees at 9 
million.
•	 The 507 Chinese companies showed a robust growth 
in net sales (14.5%) driven by PetroChina and 
China Petroleum and a significant increase in net 
profits (10.3%). Chinese companies showed better 
performance than their counterparts in terms of 
capital expenditure (17.4%) and in terms of growth in 
the number of employees (5.1%).
•	 In 2018 sales per employee (a rough measure of 
productivity) were highest for the US group at €438k 
followed by the RoW group (€424k), Japan (€352k), 
the EU (€311k) and China (€282k).
•	 Values of R&D and Net sales are positively correlated 
in the sample (54.1%). The value of this correlation 
for the EU companies is in line with the overall value 
(54.8%), while is above average for the US and 
especially Japanese companies (62.1% and 83.6% 
respectively). For the Chinese and RoW groups R&D 
and Net sales correlation is still positive but weaker 
(40.7% and 49.9%). These differences are probably 
due to the industries in which companies in these 
regions operate.
Factor World 2500
R&D in 2018, € bn 823.4
One-year change, % 8.9
Net Sales, € bn 20351.6
One-year change, % 8.4
R&D intensity, % 4.0
Operating profits, € bn 2275.7
One-year change , % 9.1
Profitability, % 11.2
Capex, € bn 1317.3
One-year change , % 7.6
Capex / net sales, % 6.6
Employees, million 55.6
One-year change, % 3.6
Market Cap, € bn 27163.0
One-year change, % 9.2
TABLE 2.1: OVERALL PERFORMANCE OF THE 2500 COMPANIES IN THE 2019 SCOREBOARD.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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Factor EU US Japan China RoW
No. of companies 551 769 318 507 355
R&D in 2018, € bn 208.3 312.5 109.4 96.4 96.7
World R&D share, % 25.3 38.0 13.3 11.7 11.7
One-year change, % 4.7 10.3 3.9 26.7 4.8
Net Sales, € bn 6037.9 4708.9 3151.2 3169.5 3284.1
One-year change, % 4.7 10.4 3.2 14.5 12.3
R&D intensity, % 3.4 6.6 3.5 3.0 2.9
Operating profits, € bn 618.0 640.8 245.2 237.2 534.5
One-year change, % 3.2 9.2 -0.8 10.3 21.8
Profitability, % 10.3 13.7 7.8 7.5 16.3
Capex, € bn 346.5 291.2 208.4 221.7 249.5
One-year change , % 2.0 15.8 9.0 17.4 -1.5
Capex / net sales, % 5.9 6.2 6.7 7.0 7.7
Employees, million 19.4 10.8 9.0 11.2 5.3
One-year change, % 3.9 4.1 1.0 5.1 2.5
Sales/employee, k€ 311.2 437.8 351.9 282.5 424.2
TABLE 2.2A: OVERALL PERFORMANCE OF THE 2500 COMPANIES IN THE 2019 SCOREBOARD.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Factor Germany UK France Netherlands*
No. of companies 130 127 68 39
R&D in 2018, €bn 82.9 29.3 30.9 19.1
World R&D share, % 10.1 3.6 3.7 2.3
One year change, % 3.6 3.6 10.5 2.7
Net Sales, €bn 1840.4 1265.4 1109.0 465.5
One year change, % -0.3 12.7 6.6 1.5
R&D intensity, % 4.5 2.3 2.8 4.1
TABLE 2.2B: PERFORMANCE OF COMPANIES BASED IN THE LARGEST R&D COUNTRIES OF THE EU.
*The Netherlands companies include Airbus and Fiat Chrysler whose registered offices are in The Netherlands but whose major business activities are in other countries. These two 
companies account for 37% of Netherlands R&D in the Scoreboard.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Factor South Korea Switzerland* Taiwan India
No. of companies 70 58 89 32
R&D in 2018, € bn 31.3 28.6 16.2 4.6
World R&D share, % 3.8 3.5 2.0 0.6
One year change, % 8.0 4.3 5.2 -3.2
Net Sales, € bn 999.3 396.8 551.1 367.6
One year change, % 4.1 6.5 7.1 22.8
R&D intensity, % 3.1 7.2 2.9 1.3
TABLE 2.2C: PERFORMANCE OF COMPANIES BASED IN THE LARGEST COUNTRIES OF THE ROW GROUP.
Note: The RoW group comprises companies based in Taiwan, South Korea, Switzerland, India and a further 19 countries.
*Novartis & Roche account for 62% of Swiss R&D and this explains the high overall R&D intensity
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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38,7% 
41,4% 
23,9% 
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Total EU (€206.2bn)
Aerospace & Defence (€9.3bn)
Automobiles & other transport (€64.6bn)
Chemicals (€5.2bn)
Health industries (€45.3bn)
ICT producers (€26.8bn)
ICT services (€14.2bn)
Industrials (€12.1bn)
Others (€28.6bn)
Total US (€311.7bn)
Aerospace & Defence (€8.4bn)
Automobiles & other transport (€23.7bn)
Chemicals (€5bn)
Health industries (€82.6bn)
ICT producers (€79.7bn)
ICT services (€85.2bn)
Industrials (€9.2bn)
Others (€17.9bn)
Total Japan (€109.4bn)
Aerospace & Defence (€bn)
Automobiles & other transport (€34bn)
Chemicals (€7.6bn)
Health industries (€13.2bn)
ICT producers (€21.6bn)
ICT services (€5.2bn)
Industrials (€9.7bn)
Others (€18.2bn)
Total China (€95.4bn)
Aerospace & Defence (€0.3bn)
Automobiles & other transport (€11bn)
Chemicals (€1.4bn)
Health industries (€4.7bn)
ICT producers (€28.2bn)
ICT services (€16.9bn)
Industrials (€8.7bn)
Others (€24.3bn)
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FIGURE 2.2: NOMINAL CHANGE OF R&D OVER THE PAST YEAR FOR MAIN INDUSTRIES AND REGIONS.
Note: growth rates have been computed for 549 EU, 760 US, 318 Japanese, 487 Chinese and 353 RoW companies for which R&D data are available for both years 2017 and 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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Total EU (€6023.9bn)
Aerospace & Defence (€176.5bn)
Automobiles & other transport (€1151.9bn)
Chemicals (€255.1bn)
Health industries (€371bn)
ICT producers (€299.4bn)
ICT services (€309.8bn)
Industrials (€612.4bn)
Others (€2847.8bn)
Total US (€4708.7bn)
Aerospace & Defence (€278.6bn)
Automobiles & other transport (€545.4bn)
Chemicals (€183.5bn)
Health industries (€669.5bn)
ICT producers (€906.7bn)
ICT services (€742.5bn)
Industrials (€318.3bn)
Others (€1064.2bn)
Total Japan (€3151.2bn)
Aerospace & Defence (€bn)
Automobiles & other transport (€811.1bn)
Chemicals (€201.9bn)
Health industries (€109.1bn)
ICT producers (€448.2bn)
ICT services (€230.9bn)
Industrials (€389.9bn)
Others (€960.2bn)
Total China (€3168.8bn)
Aerospace & Defence (€12.9bn)
Automobiles & other transport (€294.8bn)
Chemicals (€83.5bn)
Health industries (€105.4bn)
ICT producers (€446bn)
ICT services (€203.1bn)
Industrials (€368.2bn)
Others (€1655bn)
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FIGURE 2.3: NOMINAL CHANGE OF NET SALES OVER THE PAST YEAR FOR MAIN INDUSTRIES AND REGIONS.
Note: growth rates have been computed for 540 EU, 703 US, 317 Japanese, 504 Chinese and 349 RoW companies for which Net Sales data are available for both years 2017 
and 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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The Figures below illustrate the evolution of R&D and 
the main financial indicators over a 10-year period for 
companies based in the EU, US, Japan and China. Figure 
2.4 shows the world R&D share of each region and Figures 
2.5 to 2.8 present the annual growth rates of R&D and 
net sales and profitability. These Figures are based on 
our history database comprising the R&D and economic 
indicators over the whole 2009-2018 period for 1650 
companies (EU 386, US 480, Japan 310, China 199 and 
RoW 275). Since companies need to have been present 
for the whole 10-year period, this analysis excludes 
companies that have failed, been acquired or entered the 
Scoreboard during the 10 years.
Over the past 10 years, the R&D share of EU companies in 
the total R&D declined slightly (from 27.4% to 25.4%. This 
figure directly depends on the exchange rate of the Euro 
against main currencies. Last year the share was about 
26% and the decrease mostly reflects the depreciation of 
the Euro against the US$ over the last period (see Box 
A2.1 in the methodological notes). The main change in this 
indicator is observed for the Japanese companies whose 
R&D share fell by ca. 6 percentage points. The loss of R&D 
share by Japanese companies corresponds to increases in 
R&D shares for the companies based in China and the US.
Companies based in the EU have shown positive R&D trends 
for most of the 10-year period. From 2012 to 2016, the 
growth rate of EU R&D has been positive despite the decline 
in net sales. For the last two years, net sales in the EU sample 
have recovered significantly. In the last period, EU companies’ 
capital expenditures continued to improve following several 
years of negative performance or stagnation. In terms of 
profitability the EU companies showed a stable behaviour 
(with a significant increase over the past two years) although 
the level of profitability remains well below than that of US 
companies (10% vs 15%).
Companies based in the US sustained significant R&D 
investment growth, especially in the past three years, 
that showed higher R&D growth than the world’s average. 
The level of capital expenditures of US companies fell 
significantly over previous years but also recovered 
significantly in recent years, showing an especially strong 
increase in 2018. In terms of net sales, US companies 
continue to recover the negative figures of 2015 recording 
strong growth in the last two periods, similar to the level 
of R&D growth. The US-based companies have continued 
to show a stable high level of profitability since 2010. As 
said above, the profitability of the US companies is higher 
than their EU counterparts and especially higher than the 
Japanese and Chinese ones.
Japanese companies, hit hard by the crisis in 2008-
2009 and by the earthquake in 2011, showed a two year 
positive trend for both R&D investment and net sales. 
However, in 2015 and 2016 the growth rates of R&D and 
especially that of net sales decelerated again. Finally, 
in the last two periods, Japanese companies showed a 
recovery for R&D, net sales and also capital expenditures. 
The profitability of Japanese companies continued its 
slightly upward trend observed since 2013, but remained 
at low levels, especially compared with that of the US 
companies.
The Chinese companies show a strong R&D trend over 
the whole 10 year period and their level of capital 
expenditures that decreased in 2015 recovered robustly 
in 2017. In terms of net sales, they have had high 
positive growth rates, except over 2015 where net sales 
significantly fell but then recovered considerably over 
the last two years. The China-based companies have 
decreased profitability slightly at the beginning of the 
ten-year period but remained stable over the last 5 years 
at the low level of 6%.
2.2 | Ten-year performance of companies
This section presents the evolution of the main company indicators over the past 10 years for the industrial sectors and 
major world regions.
2.2.1 R&D trends
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FIGURE 2.4: EVOLUTION OF R&D SHARES OF MAIN REGIONS.
Note: Figures displayed refer only to the 1650 companies (386 EU; 480 US; 310 Japan; 199 China; 275 RoW) for which data on R&D, Net Sales and Operating Profits are available 
for the entire period 2009-2018. These companies represent 84.6% of R&D, 84.1% of Net Sales and 79.8% of Operating Profits of the whole sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 2.5: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY FOR THE EU COMPANIES.
Note: Growth rates for the three variables have been computed on 386 out of the 551 EU companies for which data on R&D, Net Sales and Operating Profits are available for 
the entire period 2009-2018. These companies represent 86.6% of R&D, 86.4% of Net Sales and 82.0% of Operating Profits of the EU companies in the whole sample in 2018.
Source: The 2019EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 2.6: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY FOR THE US COMPANIES.
Note: Growth rates for the three variables have been computed on 480 out of the 769 US companies for which data on R&D, Net Sales and Operating Profits are available for 
the entire period 2009-2018. These companies represent 87.9% of R&D, 92.4% of Net Sales and 101.2% of Operating Profits of the US companies in the whole sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 2.7: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY FOR THE JAPANESE COMPANIES.
Note: Growth rates for the three variables have been computed on 310 out of the 318 Japanese companies for which data are available for the entire period 2009-2018. These 
companies represent 99.2% of R&D, 96.7% of Net Sales and 97.5% of Operating Profits of the Japaniese companies in the whole sample in 2018.
Source: The 2019EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 2.8: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE CHINESE COMPANIES.
Note: Growth rates for the three variables have been computed on 199 out of the 507 Chinese companies for which data are available for the entire period 2009-2018. These 
companies represent 46.3% of R&D, 60.0% of Net Sales and 50.1% of Operating Profits of the Chinese companies in the whole sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
2.3 | Change in R&D, net sales and employees over 2009-2018
The changes in R&D, net sales and number of employ-
ees over the past 10 years are presented respectively in 
Figures 2.9, 2.10 and 2.11. Companies are aggregated by 
main region and by the four main groups of industrial sec-
tors with characteristic R&D intensities17 (see definition in 
Chapter 1 – Table 1.3).
These Figures refer to a set of 1460 companies that 
reported R&D, net sales and employees in the first 
and last year of the  period 2009-2018 (EU-389, US-
453, Japan-310, China-181 and RoW group-127). 
The analysis necessarily excludes companies for 
which data are missing for one of these variables in 
one of the two years considered.
17 For simplification, in this section these groups may be also referred to as high tech, medium-high tech, medium-low tech and low-tech.
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•	 Worldwide companies increased R&D by 67%:
– By sector, high tech 73%, medium-high tech 69%, 
medium-low tech 14% and low tech 65%;
– By region, EU 59%, US 83%, Japan 27% and China 
439%.
•	 For EU companies, R&D increased in medium-high tech 
sectors (84%), high tech (48%) and low tech (28%).
•	 The US companies increased significantly R&D in high 
tech (97%) and medium-low tech (48%) and de-
creased R&D in low tech sectors by 1%.
•	 The Japanese companies increased R&D in medi-
um-high tech (39%) and high tech sectors (12%) and 
decreased it in medium-low tech sectors (-2%).
•	 For the companies based in China, all sectors showed 
3-digit increases in R&D, mainly in high tech (621%) 
and medium-high tech (509%).
2.3.1 Ten-year changes in R&D
2.3.2 Ten-year changes in net sales
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FIGURE 2.9: R&D INVESTMENT IN 2009 AND 2018 BY MAIN REGION AND SECTOR GROUPS.
Note: Figures displayed refer only to the 1460 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2018 and 2009). These 
companies represent 77.0% of R&D of the whole sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
•	 Worldwide companies increased net sales by 
47%:
– By sector, high tech 62%, medium-high tech 59%, 
medium-low tech 16% and low tech 36%;
– By region, EU 38%, US 38%, Japan 38% and China 
154%.
•	 For the EU companies, net sales increased in medi-
um-high tech (69%), high tech (42%) and low tech (26%).
•	 For the US companies, net sales increased in high tech 
(74%) and medium-high tech (34%) and decreased in 
low tech (-21%).
•	 For the Japanese companies, net sales increased in 
medium-high tech (50%) and low tech sectors (35%).
•	 The companies based in China showed 3-digits rise in 
net sales for most sectors. Net sales went up in medi-
um-low tech sectors (309%), high tech (208%), medi-
um-high (201%) and low tech (127%).
47The 2019 EU Industrial R&D Investment Scoreboard
Low Medium-low Medium-high High R&D intensity 
0 1.000 2.000 3.000 4.000 5.000 6.000 
2018 
2009 
2018 
2009 
2018 
2009 
2018 
2009 
2018 
2009 
EU
 - 
38
9 
US
 - 
45
3 
Ja
pa
n 
- 3
10
 
Ch
ina
 - 
18
1 
Ro
W
 - 
12
7 W
or
ld
 r
eg
io
n 
- 
N
um
be
r 
of
 c
om
pa
ni
es
 
 Net Sales (€bn)
FIGURE 2.10: NET SALES IN 2009 AND 2018 BY MAIN REGION AND SECTOR GROUPS.
Note: Figures displayed refer only to the 1460 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2018 and 2009). These 
companies represent 76.7% of Net Sales of the whole sample in 2018.The large proportion of sales in the low-tech sector group for the EU and China reflect the large sales of 
major oil companies in these two regions (4 companies for the EU and 3 for China.)
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
2.3.3 Ten-year changes in employment
•	 Worldwide companies increased employment by 
21%:
– By sector, high tech 28%, medium-high tech 31%, 
medium-low tech -1% and low tech 6%;
– By region, EU 17%, US 18%, Japan 16% and China 
52%.
•	 The EU companies increased employment in high 
tech (36%), medium-high tech (35%), low tech 
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FIGURE 2.11: EMPLOYMENT IN 2009 AND 2018 BY MAIN REGION AND SECTOR GROUPS.
Note: Figures displayed refer only to the 1460 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2018 and 2009). These 
companies represent 79.8% of Employment of the whole sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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sectors (3%) and drop it considerably in medi-
um-low tech (-20%).
•	 For the US companies, employment increased in 
medium-high tech (21%), high tech (20%) and 
decreased significantly in low tech (-14%).
•	 For the Japanese companies, employment in-
creased in medium-low tech (39%), medium-high 
tech (21%) and decreased in high tech (-4%).
•	 For the companies based in China, main employ-
ment increases were in medium-low tech (277%), 
medium-high tech (94%) and high tech (75%).
It is important to remember that data reported by 
the Scoreboard companies do not inform about 
the actual geographic distribution of the number of 
employees. A detailed geographic analysis should 
take into account the location of subsidiaries of 
the parent Scoreboard companies (see for example 
in the 2015 Scoreboard report, an analysis of the 
location of companies’ economic and innovation 
activities).
2.4 | Change in sector composition over 2009-2018
This section examines the changes in the distribution of 
the R&D investment of the Scoreboard companies across 
regions and industrial sectors over the past 10 years. The 
analysis shows characteristic differences and changes 
in global R&D shares, reflecting the R&D specialities of 
regions and structural changes occurring over 2009-2018. 
The Figures 2.12 shows the evolution of the R&D shares 
for the main industries and Figures 2.13 and 2.14 show 
the R&D weight of the EU and US companies in the global 
composition of each industry.
On the whole, the main sector shift in the past 10 years is 
observed in ICT industries. In ICT services the R&D share 
increased from 10.7% to 15.0% and for ICT producers 
from 22.9% to 23.6%. On the other hand, sectors that 
underwent decreases in R&D shares were mainly low-tech 
sectors and also, to a lesser extent, Industrials, Aerospace 
& Defence and Chemicals.
EU companies reinforced their specialisation in medium-
high tech sectors, increasing significantly their R&D 
0,0% 
5,0% 
10,0% 
15,0% 
20,0% 
25,0% 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Aerospace & Defence Automobiles & other transport Chemicals Health industries 
ICT producers ICT services Industrials Others 
FIGURE 2.12: EVOLUTION OF GLOBAL R&D SHARES FOR INDUSTRIAL SECTORS.
Note: Calculated for a sample of 1650 companies for which data on R&D, Net Sales and Operating Profits are available for the entire period 2009-2018. These companies 
represent 84.6% of R&D of the whole sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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contribution to the global R&D of Automobiles by more 
than 6 percentage points (from 41.6% to 45.3%). On the 
other side, EU companies reduced significantly their global 
R&D share in ICT industries, in ICT services from 18.2% 
to 11.8% and ICT producers from 21.2% to 15.8%. EU 
companies also decreased slightly their weight in low tech 
and Chemicals sectors.
US companies strengthened their position in high tech 
sectors, increasing substantially their global R&D weight 
in ICT services and Health (respectively by 10 and 5 
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20,0% 
30,0% 
40,0% 
50,0% 
60,0% 
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FIGURE 2.13: EVOLUTION OF THE GLOBAL R&D SHARE OF EU COMPANIES FOR THE MAIN INDUSTRIAL SECTORS.
Note: Figures displayed refer only to the 386 out of the 551 EU companies with R&D data available for the all period 2009-2018. These companies represent 86.6% of R&D 
whole sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
0,0% 
10,0% 
20,0% 
30,0% 
40,0% 
50,0% 
60,0% 
70,0% 
80,0% 
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Aerospace & Defence Automobiles & other transport Chemicals Health industries 
ICT producers ICT services Industrials Others 
FIGURE 2.14: EVOLUTION OF THE GLOBAL R&D SHARE OF THE US COMPANIES FOR THE MAIN INDUSTRIAL SECTORS.
Note: Figures displayed refer only to the 480 US companies with R&D data available for the all period 2009-2018. These companies represent 87.2% of R&D whole sample in 
2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
percentage points). At the other extreme, US companies 
reduced their R&D share in Automobiles by 3 percentage 
points and by 2% in Industrials and low-tech sectors.
For Asian companies, contrasting changes in global R&D 
shares are observed for those based in China and Japan. 
Chinese companies increased their global R&D shares for 
all sectors (mostly in low tech, ICT services and Industrials) 
whereas Japanese companies’ global R&D shares fell 
across the board (mostly in ICT industries, low tech sectors 
and Automobiles).
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1. EU companies have strengthened their position in 
medium-high tech sectors such as automotive and in-
dustrials, they have maintained their position in health 
but have lost ground in ICT (almost doubling the me-
dium-high tech sector while growing more slowly the 
high tech sector). There is a danger that the EU’s lead 
in medium-high tech may be eroded as ICT takes a 
higher proportion of the value added in sectors such 
as automotive with the advent of new developments 
such as electric self-driving cars. The EU’s overall prof-
itability is bolstered by the high profitability of many of 
its banks and chemical companies in the Scoreboard, 
but remains well below that of US companies (10.3% 
vs 13.7% respectively).
2. US companies have been steadily increasing their 
share of global R&D to reach 38% in 2018 (doubling 
their high tech R&D from 2009 to 2018). The big 
driver for the US has been growth in its ICT sectors 
(particularly ICT services) and, to a lesser extent, in 
health. The US is well placed for the future in health 
as it is the clear world leader in biotechnology which 
is the basis of more and more new drugs. The ICT and 
health sectors have high profitability and, since these 
sectors now account for around 80% of US R&D, the 
overall profitability of US Scoreboard companies is 
also very high.
3. Japanese companies have an even larger proportion 
of its R&D in medium-high tech sectors and less in 
high-tech than the EU companies (growing signif-
icantly their medium-high tech group but barely 
changing the size of their high tech group). Japanese 
companies have an overall profitability lower than 
that of the EU companies (7.8%) because of a long 
tail of low profitability companies and the absence of 
a boost from the profitability of large banks and oil 
companies.
4. Chinese companies have been increasing their global 
R&D share at a fast rate but from a very low base to 
reach an 11.7% world share in 2018. China has grown 
its low, medium and high tech groups (especially the 
ICT sector supported by the state). The Chinese group 
of companies have low profitability levels (7.4%), 
mostly due to the losses or small profits of large com-
panies such as China Petroleum, China Railway Con-
struction and China Shipbuilding that offset the large 
profitability of ICT companies (e.g. Tencent, Baidu and 
Netease).
2.5 | Concluding remarks

3 PERFORMANCE OF TOP GLOBAL R&D INVESTORS
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This chapter describes the performance of individual 
companies, with a focus on the results of companies 
at the top of the world R&D ranking, highlighting those 
companies that show considerable changes in economic 
and R&D performance. Due to data availability, R&D 
figures for some companies may be under- or over-stated. 
The most extreme example of this is Amazon which would 
be positioned at #1 in the world R&D ranking if it had 
separated its R&D and content investments in its annual 
report (see explanation in Box 3.1).
Performance of top global R&D investors3
ALPHABET is the top R&D investor worldwide, followed by SAMSUNG and MICROSOFT. 
In the fourth position is VOLKSWAGEN, top R&D investor in the EU. The other companies 
in the top-ten are, HUAWEI, APPLE, INTEL, ROCHE, JOHNSON & JOHNSON and DAIMLER. 
Within the top 50 R&D investors there are 17 based in the EU, 22 US companies, 6 
from Japan, and 2 each from Switzerland and China and one from South Korea.
Over the last 15 years:
- The 3 largest R&D sectors (ICT, health and automotive) continue to concentrate R&D 
players in the top 100 group but most new comers in this group are companies based 
in Asia.
- Eight companies have moved up in the global ranking by 70 or more places. These are 
Alphabet, Huawei, Apple, Facebook, Alibaba, Celgene, Gilead Sciences and Continental 
indicating the rising importance of ICT and biotechnology. 
The ranking of the top 50 large global companies by R&D intensity (all with intensity 
of 13.3% or more) also highlights the importance of these two technologies with 23 
companies from biopharmaceuticals and 24 from ICT.
3.1 | Main company changes at the top of the global R&D 
ranking
In this Scoreboard edition, the top R&D investor is the 
US company ALPHABET (€18.3bn) although it would 
have been Amazon if it had separated its technology 
(R&D) and content investments so it could be included 
in the Scoreboard. The 2nd position is taken by SAMSUNG 
(€14.8bn) from South Korea, MICROSOFT (€14.7bn) from 
the US takes the 3rd position and the 4th one is for the 
German company VOLKSWAGEN (€13.6bn). The other 
companies in the top-ten are HUAWEI from China, APPLE, 
INTEL and JOHNSON & JOHNSON from the US, ROCHE 
from Switzerland and DAIMLER from Germany.
In the EU sample, R&D growth was led by automotive 
companies such as BMW (13%), PEUGEOT (25%), 
RENAULT (19%) and VALEO 37%) and from other sectors 
SANOFI (8%), ERICSSON (11%) and SIEMENS (7%). The 
poorest R&D performance was shown by TELECOM ITALIA 
(-39%), FIAT CHRYSLER (-14%), BARCLAYS (-58%) and 
NOKIA (-6%). See Table 3.1.
In the non-EU group, top R&D companies showing high 
R&D growth were ICT companies from the US, ALPHABET 
(30%), APPLE (23%), FACEBOOK (32%), MICROSOFT 
(15%), and from China, ALIBABA (64%) and HUAWEI (13%). 
The poorest performance was shown by SNAP (-51%), 
GENERAL ELECTRIC (-14%) and TEVA PHARMACEUTICAL 
(-34%). See Table 3.2.
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company One-year R&D growth (%) company One-year R&D growth (%)
BMW 12.8 TELECOM ITALIA -39.2
PEUGEOT (PSA) 24.7 FIAT CHRYSLER -14.0
RENAULT 18.9 BARCLAYS -57.7
VALEO 36.5 NOKIA -5.6
VOLKSWAGEN 3.8 BASF -11.6
SANOFI 8.1 SEAGATE TECHNOLOGY -16.7
DAIMLER 4.4 OM RESIDUAL UK -74.8
SIEMENS 6.7 GLAXOSMITHKLINE -3.3
ERICSSON 11.3 ELECTRICITE DE FRANCE -19.6
ASML HOLDING 27.1 ASTRAZENECA -2.7
AIRBUS 9.3 DEUTSCHE BANK -8.7
SAP 8.4 COMMERZBANK -23.4
TABLE 3.1: LARGEST R&D INCREASES AND DECREASES AMONG THE EU COMPANIES IN 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Box 3.1 
Understatement or overstatement 
of R&D figures
The Scoreboard relies on consistent 
disclosure of R&D investment in published 
annual reports and accounts. However, 
due to different national accounting 
standards and disclosure practices, in some 
cases, R&D costs cannot be identified 
separately in companies’ accounts, e.g. 
appearing integrated with other operational 
expenditures such as engineering costs. To 
avoid overstatement of R&D figures, the 
Scoreboard methodology excludes R&D 
figures that are not disclosed separately (see 
methodological notes in Annex 2). Inevitably, 
the strict application of this criterion can 
lead to understating or omitting the actual 
R&D effort of some companies.
An extreme example of a possible 
understatement/omission of R&D figures 
is the US company Amazon. This company 
only quotes a figure for ‘technology & 
content’ investment in its annual report and 
nowhere does it indicate how much of this is 
technology (R&D). However, from Amazon’s 
annual report for 2012-15 it is estimated 
that approximately $10.3bn of the $12.5bn 
technology & content costs (T&C) in the 
2015 income statement are technology 
(R&D). Further, Amazon states in its 2018 
annual report that the increases in T&C 
costs in 2017 and 2018 are primarily due 
to an increase in spending on technology 
infrastructure and the technical teams 
expanding existing products & services and 
introducing new ones. If we conservatively 
assign two-thirds of the $16.3bn increase in 
T&C costs from 2015 to 2018 as R&D – i.e. 
£10.9bn – then we arrive at a best estimate 
of Amazon’s 2018 R&D of $21.2bn or 
€18.4bn. This would put Amazon in the #1 
position in the Scoreboard, just ahead of 
Alphabet at #2 with R&D of €18.3bn.
The data collection methodology used for 
the Scoreboard subtracts any R&D tax 
credit disclosed in annual reports from 
the quoted R&D investment. This reduces 
the Scoreboard R&D for companies from 
countries with an R&D tax credit (such as 
Belgium, France, Japan, The Netherlands 
and the UK) compared to countries that 
do not have a credit such as Germany and 
Switzerland or those like the US which have 
a less generous credit. In addition, many 
countries have a patent box innovation 
incentive and this is not deducted from their 
R&D.
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company One-year R&D growth (%) company One-year R&D growth (%)
ALPHABET 30.3 SNAP** -51.0
APPLE 22.9 GENERAL ELECTRIC -13.9
FACEBOOK 32.5 TEVA PHARMACEUTICAL -34.4
MICROSOFT 14.6 TATA MOTORS -18.0
ALIBABA 64.5 ELI LILLY -11.6
HUAWEI 12.9 MERCK US -4.7
SAMSUNG 9.8 ZTE -18.4
DOWDUPONT* 45.0 IBM -7.1
HONDA MOTOR 12.2 AT&T -20.6
SAIC MOTOR 52.9 DAIICHI SANKYO -13.7
TENCENT 31.4 FUJITSU -15.0
GILEAD SCIENCES 19.5 SUBARU -15.2
TABLE 3.2: LARGEST R&D INCREASES AND DECREASES AMONG THE NON-EU COMPANIES IN 2018.
*Dow and DuPont completed their merger in September 2017 and the large increase reflects that.
**SNAP increased its R&D by over 8 times from 2016 to 2017 and then decreased it in 2018 to over 4 times the 2016 level.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Among the group of top 50 R&D investors, there are 17 
companies based in the EU (one less company than last 
year) and 33 non-EU companies. See the R&D ranking of 
the top 50 companies in Figure 3.1.
The table 3.3 shows changes in the R&D ranking of the 
top 50 companies since the first Scoreboard in 2004. It is 
important to note, as stated in the previous reports, that 
the growth of companies is often accompanied by mergers 
and acquisitions.
In the EU group, four companies left the top 50 (ALCATEL, 
ISTITUTO FINANZIARIO INDUSTRIALE, PHILIPS, BAE 
SYSTEMS) and three companies joined the top 50 (FIAT 
CHRYSLER, SAP and CONTINENTAL). ALCATEL first 
merged with LUCENT and the combined entity was later 
acquired by NOKIA.
In the non-EU group, fourteen companies left the top 50 
(FUJITSU, CANON, DELPHI, ELI LILLY, HITACHI, HEWLETT-
PACKARD, MATSUSHITA ELECTRIC, NEC, MOTOROLA, 
NORTEL NETWORKS (acquired), WYETH (acquired), SUN 
MICROSYSTEMS (acquired), NTT and TOSHIBA) and fifteen 
companies joined the top 50 (Alphabet, Alibaba, Amgen, 
Apple, Broadcom, Dell, Denso, Celgene, Facebook, Gilead 
Sciences, Huawei, Oracle, Panasonic, Qualcomm, and 
Abbvie-demerged from ABBOTT). Celgene is in the process 
of being acquired by Bristol-Myers Squibb.
The distribution of the top 50 companies by main industrial 
sector and region changed from 2004 to 2018 as follows:
•	 Automobiles & Parts, from 13 (EU 7) to 14 (EU 8);
•	 Health industries, from 11 (EU 3) to 14 (EU 4);
•	 ICT industries, from 13 (EU 3) to 16 (EU 3).
Three EU companies improved in the R&D ranking by at 
least 20 places – these are BAYER (NOW RANKED 26TH), 
SAP (now 43th) and CONTINENTAL (47th). Two companies 
dropped twenty or more places but remained within 
the top 50: Ericsson (now 46th) and GlaxoSmithKline 
(now 34th). Bayer completed its acquisition of Monsanto 
in June 2018 and Continental has made a total of 14 
acquisitions.
There are 10 non-EU companies that gained more 
than 20 places, Samsung (now 2nd), ALPHABET (1st), 
HUAWEI (now 5th), APPLE (now 6th), ORACLE (now 
25th), QUALCOMM (now 27th), GILEAD SCIENCES which 
acquired Pharmasset in 2011 and Kite pharma in 
2017 (now 41st), BRISTOL-MYERS SQUIBB (now 24th), 
CELGENE (now 37th) and FACEBOOK (11th). Three 
companies dropped twenty or more places but remained 
within the top 50: IBM (now 33th), SONY (now 39th) and 
PANASONIC (now 32nd).
3.1.1 Top 50 R&D investors
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FIGURE 3.1: THE WORLD’S TOP 50 COMPANIES BY THEIR TOTAL R&D INVESTMENT IN THE 2019 SCOREBOARD.
Note: between brackets the ranking the company had in the 2018 EU R&D Scoreboard.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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50. AMGEN (47), US 
49. BROADCOM (52), US 
48. AIRBUS (46), Netherlands 
47. CONTINENTAL (44), Germany 
46. ERICSSON (43), Sweden 
45. RENAULT (48), France 
44. GENERAL ELECTRIC (34), US 
43. SAP (40), Germany 
42. PEUGEOT (PSA) (50), France 
41. GILEAD SCIENCES (49), US 
40. FIAT CHRYSLER AUTOMOBILES (31), Netherlands 
39. SONY (39), Japan 
38. DENSO (42), Japan 
37. CELGENE (41), US 
36. NOKIA (27), Finland 
35. NISSAN MOTOR (37), Japan 
34. GLAXOSMITHKLINE (30), UK 
33. IBM (32), US 
32. PANASONIC (36), Japan 
31. DELL TECHNOLOGIES (35), US 
30. ABBVIE (33), US 
29. ASTRAZENECA (29), UK 
28. ALIBABA GROUP HOLDING (51), China 
27. QUALCOMM (28), US 
26. BAYER (23), Germany 
25. ORACLE (24), US 
24. BRISTOL-MYERS SQUIBB (26), US 
23. CISCO SYSTEMS (25), US 
22. SANOFI (21), France 
21. SIEMENS (20), Germany 
20. ROBERT BOSCH (19), Germany 
19. HONDA MOTOR (22), Japan 
18. GENERAL MOTORS (18), US 
17. PFIZER (16), US 
16. BMW (17), Germany 
15. FORD MOTOR (14), US 
14. NOVARTIS (13), Switzerland 
13. TOYOTA MOTOR (12), Japan 
12. MERCK US (11), US 
11. FACEBOOK (15), US 
10. DAIMLER (10), Germany 
9. JOHNSON & JOHNSON (9), US 
8. ROCHE (8), Switzerland 
7. INTEL (6), US 
6. APPLE (7), US 
5. HUAWEI INVESTEMENT & HOLDING CO (5), China 
4. VOLKSWAGEN (3), Germany 
3. MICROSOFT (4), US 
2. SAMSUNG ELECTRONICS (1), South Korea 
1. ALPHABET (2), US 
R&D investment (Euro million) 
US 
EU 
Japan 
South Korea 
Switzerland 
China 
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Rank 
2019 Company Country
R&D in 2018 
(€bn)
R&D intensity 
(%) Rank change 2004-2019
1 ALPHABET US 18.3 15.3 up > 200
2 SAMSUNG South Korea 14.8 7.8 up 31
3 MICROSOFT US 14.7 13.4 up 10
4 VOLKSWAGEN Germany 13.6 5.8 up 4
5 HUAWEI China 12.7 13.9 up > 200
6 APPLE US 12.4 5.4 up 98
7 INTEL US 11.8 19.1 up 7
8 ROCHE Switzerland 9.8 19.4 up 10
9 JOHNSON & JOHNSON US 9.4 13.2 up 3
10 DAIMLER Germany 9.0 5.4 down 7
11 FACEBOOK US 9.0 18.4 up > 200
12 MERCK US US 8.5 22.9 up 17
13 TOYOTA MOTOR Japan 8.3 3.5 down 8
14 NOVARTIS Switzerland 8.0 17.2 up 6
15 FORD MOTOR US 7.2 5.1 down 14
16 BMW Germany 6.9 7.1 up 12
17 PFIZER US 6.8 14.5 down 15
18 GENERAL MOTORS US 6.8 5.3 down 12
19 HONDA MOTOR Japan 6.6 5.3 up 12
20 ROBERT BOSCH Germany 6.2 7.9 up 8
21 SIEMENS Germany 5.9 7.1 down 16
22 SANOFI France 5.9 17.1 down 6
23 CISCO SYSTEMS US 5.5 12.8 up 7
24 BRISTOL-MYERS SQUIBB US 5.5 27.8 up 18
25 ORACLE US 5.3 15.3 up 21
26 BAYER Germany 5.1 12.9 up 34
27 QUALCOMM US 4.9 24.6 up 65
28 ALIBABA China 4.8 9.9 up > 200
29 ASTRAZENECA UK 4.6 24.0 down 4
30 ABBVIE US 4.6 16.0 New*
31 DELL TECHNOLOGIES US 4.3 5.5 New*
32 PANASONIC Japan 4.3 6.8 down 25
33 IBM US 4.2 6.0 down 23
34 GLAXOSMITHKLINE UK 4.1 12.1 down 23
35 NISSAN MOTOR Japan 4.1 4.5 down 1
36 NOKIA Finland 4.0 17.9 down 26
37 CELGENE US 4.0 29.8 up > 200
38 DENSO Japan 3.9 9.3 down 3
39 SONY Japan 3.8 5.6 down 24
40 FIAT CHRYSLER Netherlands 3.7 3.3 up 4
41 GILEAD SCIENCES US 3.7 19.0 up > 200
42 PEUGEOT (PSA) France 3.6 4.9 down 4
43 SAP Germany 3.6 14.6 up 27
44 GENERAL ELECTRIC US 3.6 3.4 down 7
45 RENAULT France 3.5 6.1 same
46 ERICSSON Sweden 3.5 16.9 down 29
47 CONTINENTAL Germany 3.4 7.6 up 70
48 AIRBUS Netherlands 3.3 5.2 down 13
49 BROADCOM US 3.3 18.1 up 67
50 AMGEN US 3.3 15.7 down 13
TABLE 3.3: THE TOP 50 COMPANIES IN THE 2019 SCOREBOARD: RANK CHANGE 2004-2019.
Note: companies in “blue” went up more than 20 ranks and in “red” lost more than 20 ranks.
*Dell Technologies was formed after Dell’s $67bn acquisition of EMC in 2015. AbbVie was formed when Abbott Laboratories spun off its pharmaceutical division as a separate 
listed company in 2013.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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The profile of the group of top 100 Scoreboard companies 
reflects the concentration of global industrial R&D in 
a few companies, industries and countries. In the 2019 
Scoreboard, this group accounts for 52% of the total R&D, 
82 companies from the 3 major sectors (ICT 34, Health 26 
and Automotive 22) and 80 companies from 3 regions (EU 
29, US 36 and Japan 15). In 2018, the top 100 companies 
showed growth of R&D (8.2%) somewhat below the world 
average (8.9%) and also lower growth of net sales (6.7% 
vs 8.4%).
Seventy-three companies in the top 100 have shown 
positive R&D investment growth. Among them, 34 
companies had double-digit R&D growth, and of these, 20 
companies also showed double-digit growth in net sales.
Most of the top 100 companies showing double-digit R&D 
increases are in Automobiles (9), ICT producers (8), ICT 
services (7) and Health industries (5). The 5 companies 
showing the largest increase in R&D are ALIBABA, SAIC 
MOTOR, DOWDUPONT, VALEO and FACEBOOK. Several of 
these large increases such as that for DowDuPont are due 
to acquisitions or mergers.
Among the companies that had double-digit growth in R&D 
and net sales, the top 5 companies are ALIBABA, MICRON 
TECHNOLOGY, DOWDUPONT, FACEBOOK and SK HYNIX.
Twenty-seven companies in the top 100 have experienced 
a decrease in R&D investment. The companies with the 
largest decrease in R&D are TATA MOTORS, FIAT CHRYSLER 
AUTOMOBILES, GENERAL ELECTRIC, DAIICHI SANKYO and 
BASF. GENERAL ELECTRIC has been divesting companies 
at part of its strategic recovery plan and this is the cause 
of its decrease in R&D.
The R&D intensity of companies in the top 100 (7.0%) 
remained practically the same of the previous year.
Among the top 100 companies, only 3 made losses 
(ALLERGAN, GENERAL ELECTRIC and BAYER) with 24 
showing profitability of only 5% or less but 31 showing 
profitability over 20%. All but one of the 31 operates in 
high R&D-intensive sectors (HSBC). ALLERGAN is in the 
process of being acquired by AbbVie for $63bn.
There have been six new entries in the top100 compared 
to last year’s edition top 100. Of these six companies, 
five were already in the Scoreboard: SAIC MOTOR 
CORPORATION (China, 71, last year 104); OTSUKA 
HOLDINGS CO (Japan, 85, last year 108); SALESFORCE.
COM (US, 90, last year 107); AISIN SEIKI (Japan, 96, 
last year 101); NXP SEMICONDUCTORS (Netherlands, 
99, last year 109); and CHINA RAILWAY CONSTRUCTION 
CORPORATION (China, 100, last year 105). HSBC (UK, 
99) was not in the Scoreboard last year given to missing 
recent R&D figures published at the time.
Five of the six companies exiting the top 100 are still 
in the Scoreboard: TELECOM ITALIA (Italy, 127, last year 
65); ZTE CORPORATION (China, 103, last year 76); TEVA 
PHARMACEUTICAL (Israel, 145, last year 90); LEONARDO 
(Italy, 107, last year 93); BANCO SANTANDER (Spain, 
102, last year 96); and DEUTSCHE BANK (Germany, 122, 
last year 100). SHIRE (UK, last year 98) is not in the 
Scoreboard anymore because have been acquired by 
TAKEDA PHARMACEUTICAL.
In the first Scoreboard edition in 2004, the top 100 
sample comprised 8 less companies from the 3 largest 
sectors (ICT 34, Health 21 and Automotive 19) however 
14 more companies from the main regions (EU 35, 
US 37, Japan 22). Most changes from 2004 to 2019 in 
the top 100 group are due to companies from Japan and 
the EU (7 and 6 leavers respectively) and new comers 
from companies based in Asia (China 9, Taiwan 3 and S. 
Korea 2).
3.1.2 Top 100 R&D investors
Companies among the top 100 R&D investors presenting 
remarkable results in terms of R&D, sales and employees 
over the past 10 years are listed in table 3.4 (ordered by 
level of R&D growth).
The high growth companies, at the top of the table, 
showed more than 3-fold increase of R&D and employees 
and more than 5-fold increase of net sales.
3.1.3 Companies showing the largest 10-years changes in R&D, net sales 
and employees
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On the other extreme, the firms at the bottom of the 
table underwent a simultaneous drop of R&D, net sales 
and employees over the past ten years. Some of these 
large changes are due to acquisitions and divestments. 
Examples are: ALLERGAN has a long record of acquisitions 
and doubled its sales and quadrupled its R&D just from 
2013 to 2016. ALLERGAN was acquired by Activis in early 
2015 and Activis then changed its name (and that of the 
combined entity) back to ALLERGAN and now it is being 
acquired by AbbVie. CELGENE is being acquired by Bristol-
Myers Squibb. Amongst the big decreases is PROCTER & 
GAMBLE which decided to divest 100 brands in 2014 and 
sold 43 of these to Coty for $12.5bn. Another big decrease 
was recorded by NOKIA which had a 49% share of the 
smartphone market in 2007 but this had dropped to 3% 
by 2013 when it sold the business to MICROSOFT (which 
itself exited that business in 2016).
Firm
R&D 
investment 
2018 (€bn) 
Change in R&D 
2009-2018 (%) 
Change in net sales 
2009-2018 (%) 
Change in 
employees 
2009-2018 (%)
High 
growth 
firms
BAIDU 2 3524 2199.5 474.8
TENCENT 2.9 2250.1 2413.6 622.7
BROADCOM 3.3 1438 1304.9 368.8
SALESFORCE.COM 1.6 1183 917.3 781.8
ALLERGAN 2 1047.1 465.2 189.9
APPLE 12.4 968 519 258.7
SAIC MOTOR 2 715.9 539.4 4874
ALPHABET 18.3 635.8 478.5 398
CELGENE 4 482.3 468.1 214.7
Low 
growth 
firms
NOKIA 4 -19.1 -44.9 -16.6
PHILIPS 1.7 -3.3 -21.9 -33.2
IBM 4.2 -3.9 -16.9 -12.2
PROCTER & GAMBLE 1.6 -4.6 -12.7 -23.6
TABLE 3.4: COMPANIES AMONG THE TOP 100 R&D INVESTORS SHOWING THE LARGEST CHANGES IN R&D, NET SALES AND EMPLOYEES.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
The previous section discussed the largest companies by 
R&D investment. However, some of these companies may 
also have very large sales so that their R&D, while large, 
may not be a substantial percentage of sales and may 
not be a key success factor for the company. Oil, telecoms 
and construction companies provide examples of this with 
China Petroleum & Chemicals (#156 in the Scoreboard) 
with an R&D intensity (R&D as % sales) of 0.3%, Petrochina 
(#81) with 0.6% intensity, AT&T (#149) with an intensity 
of 0.7% and China State Construction (#72) with intensity 
of 1.3%. In contrast, companies in the biotechnology & 
pharmaceuticals, software and technology hardware 
sectors have R&D intensities well into double figures and 
R&D is a key success factor for them.
The table 3.5 lists the top 50 large companies (those 
drawn from the 159 in the global Scoreboard having R&D 
over €1bn) ordered by R&D intensity. An R&D intensity of 
at least 13.3% is needed to enter the top 50 compared 
with 12.6% in the 2018 Scoreboard. The top 10 companies 
have intensities ranging from 24% to 63%. The main 
features of the table are:
•	 Three sectors dominate the table with 23 biopharma 
companies, 13 from technology hardware, 11 from 
software and three others. The latter three are retail 
(eBay – essentially software), travel & leisure (CTrip.
com – mainly software) and electronics (Renesas);
•	 The distribution of the 50 companies between world 
regions is US (27), Europe (13 of which 11 are EU) and 
10 from Asia (of which 6 are Japan);
•	 There are 9 new entries into the table which are 
companies whose R&D has risen above €1bn since 
last year and which are therefore now eligible for the 
3.2 | Ranking of large companies by R&D intensity
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table. The 9 companies that have left were those near 
the bottom of the 2018 table. Seven companies have 
fallen in the ranking by more than 10 places from last 
year while just one company (Gilead Sciences) has 
risen by more than 10 places – 20 places up because 
of Gilead’s acquisition of Kite Pharma, a cancer 
immunotherapy biotech.
There are some clear regional specialisations in the table 
with 9 of the 11 software companies in the table from 
the US, 7 of the 13 companies from Europe from biop-
harma and 5 of the 10 Asian companies from biopharma 
(all from Japan). Of the 50 companies in the table just 15 
have R&D intensity, sales growth and profitability all of at 
least 10%. Six of the 15 are software companies, six are 
technology hardware and three are from pharmaceuticals. 
Twelve of the 15 companies are from the US, two from 
the EU and one from China.
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Rank by
Intensity
()=2018
Company
(All have
R&D>€1bn)
Industrial sector
R&D 2018
€bn
R&D intensity
(R&D/sales)
2018 %
Rank change
from 2018 & reason
for any new entry
1 (new) Incyte Biopharma €1.03bn 62.6% New (R&D>€1bn)
2 (new) Vertex Pharma Biopharma €1.23bn 46.2% New (R&D>€1bn)
3 (new) Workday Software €1.06bn 42.9% New (R&D>€1bn)
4 (2) CTrip.com Int Travel/leisure €1.23bn 31.1% -2
5 (5) Electronic Arts Software €1.25bn 29.9% =
6 (3) Celgene Biopharma €3.97bn 28.8% -3
7 (4) Bristol-Myers Squibb Biopharma €5.47bn 27.8% -3
8 (new) UCB Biopharma €1.13bn 25.5% New (R&D>€1bn)
9 (7) Qualcomm Tech. Hardware €4.88bn 24.9% -2
10 (10) Mediatek Tech. Hardware €1.64bn 24.2% =
11 (9) AstraZeneca Biopharma €4.63bn 24.0% -2
12 (6) Merck (US) Biopharma €8.46bn 22.9% -6
13 (new) Advanced Micro Devices Tech. hardware €1.25bn 22.1% New (R&D>€1bn)
14 (8) Daiichi Sankyo Biopharma €1.61bn 21.9% -6
15 (new) Intuit Software €1.11bn 21.1% New (R&D>€1bn)
16 (16) Nvidia Tech Hardware €2.08bn 20.3% =
17 (new) Eisai Biopharma €1.01bn 20.0% New (R&D>€1bn)
18 (13) Roche Biopharma €9.80bn 19.4% -5
19 (17) Biogen Biopharma €2.27bn 19.3% -2
20 (12) Intel Tech. Hardware €11.83bn 19.1% -8
21 (41) Gilead Sciences Biopharma €3.67bn 19.0% +20
22 (new) Analog devices Tech. Hardware €1.02bn 18.8% New (R&D>€1bn)
23 (14) Facebook Software €8.97bn 18.4% -9
24= (15) Broadcom Tech. Hardware €3.29bn 18.1% -9
24= (24) NXP Semiconductors Tech. Hardware €1.48bn 18.1% =
26 (11) Nokia Tech. Hardware €4.04bn 17.9% -15
27 (18) Takeda Biopharma €2.90bn 17.6% -9
28 (21) Novartis Biopharma €8.00bn 17.2% -7
29 (28) Sanofi Biopharma €5.89bn 17.1% -1
30 (24) Adobe Software €1.34bn 17.0% -6
31= (26) Ericsson Tech. Hardware €3.48bn 16.9% +5
31= (new) Renesas Electronics €1.01bn 16.9% New (R&D>€1bn)
33 (36) Otsuka Biopharma €1.70bn 16.7% +3
34= (20) Abbvie Biopharma €4.57bn 16.0% -14
34= (22) Astellas Pharma Biopharma €1.64bn 16.0% -12
36 (27) Amgen Biopharma €3.26bn 15.7% -9
37 (30) Baidu Software €2.01bn 15.4% -7
38= (34) Alphabet Software €18.27bn 15.3% -4
38= (30) Oracle Software €5.26bn 15.3% -8
40= (19) Eli Lilly Biopharma €3.21bn 15.0% -21
40= (39) Merck (DE) Biopharma €2.23bn 15.0% -1
42 (35) SAP Software €3.61bn 14.6% -7
43 (38) Pfizer Biopharma €6.82bn 14.5% -5
44 (44) Allergan Biopharma €1.98bn 14.3% =
45 (32) Salesforce.com Software €1.65bn 14.2% -13
46 (29) ST Microelectronics Tech. Hardware €1.18bn 14.1% -17
47= (47) ASML Tech. Hardware €1.47bn 13.4% =
47= (42) Microsoft Software €14.74bn 13.4% -5
47= (44) ZTE Tech. Hardware €1.46bn 13.4% -3
50 (35) eBay Gen Retail €1.25bn 13.3% -15
TABLE 3.5: TOP 50 GLOBAL COMPANIES BY R&D INTENSITY.
Note: The colours indicate world region (red for US, blue for Europe, including two from Switzerland and green for Asia).
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
4 ANALYSIS OF THE TOP  EU 1000 R&D INVESTORS
63The 2019 EU Industrial R&D Investment Scoreboard
This chapter examines the R&D and economic trends 
of companies based in Members States of the EU. This 
specific analysis is based on an extended sample of 
companies representing the top 1000 R&D investors in 
the EU, i.e. the 551 EU companies included in the world 
top 2500 sample and 449 additional companies based 
in the EU. The EU1000 have a total R&D of €215.8bn but 
the top 551 companies alone account for €208.3bn or 
97% of this. The distribution of the EU 1000 companies 
across industrial sectors and countries can be found in 
Annex 3.
The first section presents the one-year changes in R&D 
and the financial performance indicators of companies, 
especially those based in the top 10 largest Member 
States. The second section analyses the long-term trends 
of company results, mainly in terms of R&D, net sales and 
employment.
Analysis of the top EU 1000 R&D investors4
Companies from the three largest countries (Germany, France and the UK) contribute 
two thirds of both total R&D and total sales of the EU 1000 sample. Most German R&D 
is in the automotive and industrial engineering sectors, the UK’s in pharmaceuticals 
and software while France has a more diversified R&D sector composition with a much 
smaller total number of companies than either Germany or the UK.
In 2018 R&D growth in the EU was driven first and foremost by the automotive sector, 
namely by French and German companies, and to a lesser extent by companies from 
the Health and ICT industries. Companies from Sweden and Denmark showed R&D 
growth well above the EU’s average rate. Companies showing the highest R&D growth 
were BMW (13%), PEUGEOT (25%), RENAULT (19%), VALEO 37%), SANOFI (8%), 
ERICSSON (11%) and SIEMENS (7%). The poorest R&D performance was shown by 
TELECOM ITALIA (-39%), FIAT CHRYSLER (-14%), BARCLAYS (-58%) and NOKIA (-6%).
As explained in chapter 1 for the world sample of 
companies, industrial R&D is very concentrated by country 
and sector. Among the EU 1000 sample, there are 903 
companies based in the top 10 Member States accounting 
for 96.9 % of the total R&D. Just three broad sectors 
(automotive, health and ICT) account for 72% of the 
EU1000’s total R&D. Moreover, the overall performance 
of the EU 1000 group is largely driven by the results of 
companies based in Germany, France and the UK (see 
Tables 4.1 and 4.2). These three countries account for 
60.3% of the companies, 68.4% of the total R&D and 
67.9% of total net sales.
The top 1000 R&D companies in the EU invested 
€215.8bn, 4.7% more than the previous year.
The French companies made the largest contribution 
to the growth of the EU 1000 sample. They increased 
R&D by 10.5% and net sales by 6.5%. These results 
reflect to a large extent the performance of the French 
companies in the Automobiles sector (22.7% in R&D and 
7.0% in net sales) and also good performance in other 
sectors such as Aerospace & Defence and ICT industries. 
The companies showing the highest contribution to the 
R&D growth of the French sample were PEUGEOT (which 
acquired Opel in late 2017), RENAULT, VALEO, SANOFI, 
SAFRAN, UBISOFT and SCHNEIDER (which acquired the 
IGE+XAO Group in late 2017).
The German companies showed an overall R&D growth 
below the EU’s average (3.6%), showing good performance 
4.1 | Changes in the main indicators in 2018
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in ICT and Automobiles but penalised by R&D decreases 
in Aerospace & Defence and Chemicals. The companies 
showing the highest contribution to the R&D growth of 
the German sample were BMW, VOLKSWAGEN, DAIMLER, 
SIEMENS, SAP, ROBERT BOSCH and CONTINENTAL.
The companies based in the UK increased R&D by 3.2% 
but showed a large increase in net sales (12.0%) due 
mainly to the impact of the oil price in companies such 
as SHELL and BP. The largest contributions to R&D 
growth were made by companies from several different 
sectors, e.g. APTIV, MELROSE INDUSTRIES (which 
acquired GKN in early 2018), LLOYDS BANKING, ROLLS-
ROYCE, MYOVANT SCIENCES, ATLASSIAN CORPORATION 
and ARRIS.
Apart from the three top Member States, among the group 
of largest EU countries, companies from Denmark and 
Sweden increased considerably their R&D investments 
(13.6% and 11.9% respectively). Companies that 
contributed most to the R&D growth of Denmark were 
LEO PHARMA, DANSKE BANK, VESTAS WIND SYSTEMS and 
H LUNDBECK and those from Sweden were ERICSSON, 
VOLVO, SVENSKA HANDELSBANKEN and ELECTROLUX.
Apart from the aforementioned, other companies that 
showed high R&D growth were ASML HOLDING and 
AIRBUS based in the Netherlands; ALLERGAN from Ireland 
which is being acquired by AbbVie; UCB from Belgium and 
AMADEUS from Spain.
Country No. of companies
R&D in 2018 
(€bn)
R&D Share within 
EU (%)
R&D one year 
growth (%)
Net Sales one year 
growth (%)
Germany 218 84.3 39.1 3.6 -0.6
France 112 31.6 14.7 10.5 6.5
UK 273 31.6 14.6 3.2 12.0
Netherlands 53 19.4 9.0 2.7 1.2
Sweden 78 10.4 4.8 11.9 8.8
Ireland 30 9.4 4.4 3.9 4.3
Denmark 44 6.1 2.8 13.6 0.6
Italy 39 5.9 2.7 -10.0 4.5
Finland 35 5.7 2.6 -1.9 6.0
Spain 21 4.8 2.2 5.3 2.1
Top 10 countries 903 209.2 96.9 4.6 4.4
Other EU 97 6.6 3.1 9.8 4.7
Total EU 1000 215.8 100 4.7 4.4
TABLE 4.1: R&D TRENDS FOR COMPANIES BASED IN THE TOP 10 EU MEMBER STATES.
Note: For the sample of 1000 EU companies.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Sector EU1000 R&D in 2018 (€bn)
Germany 1-year 
change (%)
France 1-year 
change (%)
UK 1-year
change (%)
R&D Net Sales R&D Net Sales R&D Net Sales 
Aerospace & Defence 9.4 -15.1 -5.1 16.0 11.2 7.2 0.9
Automobiles & other transport 64.9 4.6 1.6 22.7 7.0 20.8 -10.6
Chemicals 5.5 -5.8 3.1 1.4 3.3 1.1 12.9
Health industries 46.9 2.2 -4.5 6.4 2.7 1.4 2.0
ICT producers 27.6 7.7 2.3 9.4 3.9 5.9 0.5
ICT services 15.9 9.3 1.6 6.2 2.8 0.6 2.6
Industrials 13.0 4.2 1.3 -2.4 9.5 42.2 60.2
Others 32.6 -3.7 -4.9 1.5 6.8 0.0 13.0
Total 215.8 3.6 -0.6 10.5 6.5 3.2 12.0
TABLE 4.2: GROWTH OF R&D AND NET SALES FOR THE GERMAN, FRENCH AND UK COMPANIES - BREAK DOWN FOR 7 MAJOR INDUSTRIAL SECTORS.
Note: For the sample of 1000 EU companies.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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Among the large countries, two groups of companies 
decreased R&D, are Italy (-10.0%) and Finland (-1.9%). In 
Italy, the good performance of companies such as COFIDE, 
ENEL, PRYSMIAN, SALVATORE FERRAGAMO and KEDRION 
has been offset by the reduction of R&D by TELECOM 
ITALIA and to a lesser extent also by LEONARDO and 
RECORDATI. In Finland, the R&D decline of the sample was 
mostly due to the reduction of NOKIA’s R&D growth and its 
high weight in Finland’s sample of companies.
In 2018, the average R&D intensity of the EU-1000 
companies increased slightly because of the higher 
increase of R&D investments compared to that of net 
sales, 4.7% vs 4.4%.
It is important to remember that in many countries, 
the aggregate country indicators depend to a large 
extent on the figures of a very few firms. This is due, 
either to the country’s small number of companies 
in the Scoreboard or to the concentration of R&D 
in a few large firms. The three largest companies 
in Ireland (Medtronic, Allergan & Seagate) are US 
companies with registered offices in Ireland to take 
advantage of low Irish corporate tax rates.
The annual growth rates of R&D and net sales and 
profitability for companies based in Germany, France, the 
UK and the Netherlands over the past 10 years is provided 
respectively in Figures 4.1, 4.2, 4.3 and 4.4. These Figures 
are based on our history database comprising these 
indicators over the whole 2009-2018 period for EU 
companies based in Germany (159), France (87), UK (128) 
and NL (30)18.
Companies based in Germany showed a strong 
performance in terms of R&D from 2010 to 2017, 
recovering to and then improving on levels of R&D growth 
prior to the financial crisis, however, over the last period, 
the R&D growth of German companies was below the 
EU’s average. The growth of net sales has not followed 
the same path: a slowdown from 2010 to 2013 has been 
followed by a hesitant recovery from 2013 to 2014/15, 
then again sales decreased from 2015 to 2016 and 
recovered significantly in 2017 but then declined again 
in 2018. On the other hand, German companies have 
maintained a stable level of profitability over the past 
10 years in the 6-8% range with a stable trend over the 
past two years.
Companies based in France showed a low but positive 
trend in R&D growth after the decrease from 2013 to 
2014, but at much lower levels than their EU or non-EU 
counterparts although growth recovered significantly from 
2016 to 2017 and rose substantially in 2018. The growth 
of net sales reversed the negative trend showed over 
2010-2014 increasing significantly from 2016 to 2017 
and remaining stable over 2018. The average profitability 
of the French companies showed a negative trend from 
2011 to 2015 but it then increased from 2015 to 2016 
and remained stable in 2017 and 2018 at 9%.
Companies based in the UK showed a strong recovery of 
R&D and net sales from 2009 to 2010 that then reversed 
in 2010 to 2012. In 2012-2013 their R&D investment 
resumed growth at a significant pace but with a level of 
net sales practically unchanged. In 2014-2015 the R&D 
level remained practically unchanged although with a 
4.2 | Long-term trends for companies based in the large 
Member States
This section presents the evolution of the main company performance indicators over the past 10 years for the compa-
nies in the EU 1000 group.
4.2.1 Ten-year trends
18 The requirement for a company to be present in the Scoreboard over the whole 10-year period excludes companies that have grown quickly and entered the Scoreboard 
during this period and also companies which have failed or been acquired during that time (Alcatel-Lucent being just one example). Some of the growth may not be organic 
but due to acquisitions (e.g. Peugeot acquiring Opel in 2017 and Allergan’s many acquisitions). These exclusions and factors may affect the growth rates quoted below.
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FIGURE 4.1: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE GERMAN COMPANIES.
Note: Growth rates for the three variables have been computed on 159 out of the 218 German companies for which data are available for the entire period 2009-2018. These 
companies represent 91.5% of R&D, 89.8% of Net Sales and 92.5% of Operating Profits of the German companies in the EU1000 sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 4.2: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE FRENCH COMPANIES.
Note: Growth rates for the three variables have been computed on 87 out of the 112 French companies for which data are available for the entire period 2009-2018. These 
companies represent 94.6% of R&D, 89.7% of Net Sales and 89.0% of Operating Profits of the French companies in the EU1000 sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 4.3: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE UK COMPANIES.
Note: Growth rates for the three variables have been computed on 128 out of the 273 UK companies for which data are available for the entire period 2009-2018. These 
companies represent 68.4% of R&D, 83.5% of Net Sales and 78.6% of Operating Profits of the UK companies in the EU1000 sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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significant decrease of net sales and then both R&D and 
sales increased significantly from 2015-2017. In 2018, 
R&D rose below the EU’s average but net sales increased 
strongly (mostly due to the impact of high oil prices). The 
average profitability of the UK companies was the highest 
of the three countries throughout the period although, 
like their French counterparts, showed a decreasing trend 
from 2011-2015 but a strong increase in 2016 remaining 
stable at 10-11% over the last three years.
Companies based in the Netherlands registered an increase 
in R&D and sales over 2009-2012 and then a slowdown 
over 2012 to 2014. From 2015 to 2016, R&D and sales 
grew moderately and over 2017 R&D stagnated while 
sales grew at a significant pace. Over 2018, companies 
based in the Netherlands showed a positive growth of 
R&D and net sales, but well below the average growth of 
their EU counterparts. The profitability of companies based 
in the Netherlands remained stable at 5-6% from 2010 
to 2016, showing a slight upward trend to 7% in 2017 
and 9% in 2018. Two companies - Fiat Chrysler and Airbus 
account for 40% of Netherlands R&D in the Scoreboard, 
their headquarters are in the Netherlands but their main 
operations are located elsewhere.
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FIGURE 4.4: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE DUTCH COMPANIES.
Note: Growth rates for the three variables have been computed on 30 out of the 53 Dutch companies for which data are available for the entire period 2009-2018. These 
companies represent 85.8% of R&D, 77.3% of Net Sales and 64.0% of Operating Profits of the Dutch companies in the EU1000 sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
4.2.2 Change in R&D, net sales and employment over 2009-2018 for groups 
of sectors and top EU company aggregates
The levels of R&D, net sales and employment in 2009 and 
2018 are presented in Figures 4.5, 4.6 and 4.7 for groups 
of industrial sectors with characteristic R&D intensities19 
(see definition in Chapter 1 – Table 1.3).
These Figures refer to a set of 637 companies that re-
ported R&D, net sales and number of employees in the 
first and the last year of the period 2009-2018 (DE-164, 
FR-82, UK-130, NL-30 and Other EU-231).
Over the past 10 years, the R&D, net sales and employ-
ment changes for the whole sample of EU companies are 
very similar to those of the EU sample within the world set 
(concentration effect).
The overall changes for each indicator are:
•	 R&D increased by 58% (high tech 48%, medium-high 
tech 83%, medium-low tech 3% and low tech 22%);
19 For simplification, in this section these groups are referred to as high tech, medium-high tech, medium-low tech and low-tech.
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•	 Net sales increased by 35% (high tech 43%, medium-
high tech 67%, medium-low tech 5% and low tech 
21%);
•	 Employment increased by 17% (high tech 41%, 
medium-high tech 35%, medium-low tech -18% and 
low tech 2%).
These three indicators changed in very different proportions 
across member states and sector groups. By sector groups 
the highest increases were:
•	 In high tech (R&D - DE 81%; Net sales - DE 71%; 
Employment, FR 78%);
•	 In medium-high tech (R&D - DE 100%; Net sales - DE 
79%; Employment – UK 43%);
•	 In medium-low tech (R&D - Netherlands 41%; Net 
sales - UK 55%; Employment - UK -2%);
•	 In low tech sectors (R&D - NL 597%; Net sales - NL 
120%; Employment - NL 77%)20.
The above results analysed by member state show distinct 
characteristics of the R&D investing companies in each 
country. Germany has the largest proportion of its R&D 
in medium-high tech, with the UK having the largest 
proportion in high tech while France has almost equal 
proportions in high tech and medium-high tech.
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FIGURE 4.5: R&D INVESTMENT IN 2009 AND 2018 BY SECTOR AND MAIN EU GROUPS.
Note: Figures displayed refer only to the 637 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2018 and 2009). These 
companies represent 86.4% of R&D, 85.8% of Net Sales and 83.3% of Employment of the EU1000 sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
20 There are only two Dutch companies in the low-tech group. One of them, AHOLD, showed tenfold increase in R&D, Net sales and Employees mostly through acquisitions.
69The 2019 EU Industrial R&D Investment Scoreboard
0 1 2 3 4 5 6 7 
2018 
2009 
2018 
2009 
2018 
2009 
2018 
2009 
2018 
2009 
Ge
rm
an
y -
 1
64
 
Fra
nc
e -
 8
2 
UK
 - 
13
0 
Ne
th
erl
an
ds
 - 
30
 
Ot
he
r E
U 
- 2
31
 
Co
un
tr
y 
- 
 N
um
be
r 
of
 c
om
pa
ni
es
 
Employment (million) 
Low Medium-low Medium-high High R&D intensity 
FIGURE 4.7: EMPLOYMENT IN 2009 AND 2018 BY SECTOR AND MAIN EU GROUPS.
Note: Figures displayed refer only to the 637 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2018 and 2009). These 
companies represent 86.4% of R&D, 85.8% of Net Sales and 83.3% of Employment of the EU1000 sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 4.6: NET SALES IN 2009 AND 2018 BY SECTOR AND MAIN EU GROUPS.
Note: Figures displayed refer only to the 637 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2018 and 2009). These 
companies represent 86.4% of R&D, 85.8% of Net Sales and 83.3% of Employment of the EU1000 sample in 2018.
Source: The 2019 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
5 TEN-YEAR PERFORMANCE OF PHARMA AND BIOTECH 
COMPANIES: DECREASING 
R&D EFFICIENCY?
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As observed in past Scoreboard editions, the top R&D 
companies in the pharma and biotech sector have shown 
a robust performance in most indicators over the past 
ten years. For example, the whole sample of companies 
increased R&D by around 60% and sales by around 
50% and showed also significant increases in capital 
expenditures, number of employees, profits, and market 
capitalisation.
Nevertheless, these industries, and in particular the drug 
development, are facing serious challenges that seem to 
result in a decreasing efficiency of the R&D investments21, 
i.e. significantly higher investments per each new medicine 
approved. Indeed, the development of new medicines are 
facing ever higher effectiveness requirements, stricter 
approval regulations, complex market issues and high 
uncertainties involved in the R&D&I processes.
In this context, the objective of this chapter is to analyse 
further the economic and innovation performance of these 
industries over the past ten years and to analyse how 
the investments (input) compare to the company results 
(output) developed. The analysis is based on company 
indicators of the top industrial players including R&D 
investment, patent portfolios and main financial data.
Ten-year performance of pharma  
and biotech companies: decreasing  
R&D efficiency?
5
Top R&D investors in the pharma and biotech sector have registered significant 
performances in all financial indicators in the past 10 years. 
Despite an increasing investment in R&D in the past 10 years, the number of patents 
filed at EPO and USPTO in the same period by pharma and biotech companies has 
decreased.
There is a difference in the Pharma and Biotech sector between EU and US in terms of 
their technological profile and is mainly driven by the low number of Biotech companies 
in the EU compared to the US.
5.1 | Sluggish growth rates of R&D investments and net sales 
in pharma and biotech sector, but EU companies slowly 
catching-up
Looking at the period between 2008 and 2016 in the 
pharma and biotech sector both of the R&D investment and 
the net sales growth rates are successively slowing down 
(fig 5.1), although beyond this trend the year-by-year figures 
have been strongly influenced by the global economic 
environment (e.g. the global financial crisis between 2009 
and 2012). Another factor is the very large number of 
mergers and acquisitions in the biopharmaceutical sector 
that have occurred in the last decade. This increase in M&A 
appears to be the companies’ response to two technology 
trends. The first is the greater difficulty of developing 
biologic drugs compared to the small molecule drugs of 
21 See: a) Cséfalvay, Zoltán (2017), TECHtonic Shifts, Chapter 11 – “Efficiency of R&D investments on pharma steadily dropping since the 1950 - Eroom law”. Kairosz 
Kiadó, Budapest.; b) Deloitte Centre for Health Solutions (2018), Unlocking R&D productivity, measuring the return from the pharmaceutical innovation, UK.
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previous decades. This demands more R&D per successful 
drug and has also increased the regulatory requirements 
for new drug approval and larger companies are therefore 
more able to do this. The second trend is the emergence 
of smaller biotech companies, particularly in the US, which 
are able to raise funding to develop innovative new drugs. 
When such drugs are successful in later stage clinical trials, 
these biotech (or their lead drug candidates) are usually 
acquired by large pharmaceutical companies who complete 
Phase III clinical trials, obtain regulatory approval and use 
their extensive sales & marketing teams to achieve the new 
drug’s full potential in the market22.
22 Examples of large M&A deals in the last 10 years are: Pfizer acquiring Wyeth (2009) and Hospira (2015); Takeda acquiring Shire (2018, Shire having acquired Baxalta 
in 2016); Merck US acquiring Schering-Plough (2009); Abbvie acquiring Pharmacyclics (2015) and Allergan (2019); Gilead acquiring Pharmasset (2011) and Kite Pharma 
(2017); Johnson and Johnson acquiring Actelion (2017); Amgen acquiring Onyx (2013) and Otezla (2019); Sanofi acquiring Bioverativ (2018); Roche acquiring Genentech 
(2009); Novartis acquring Alcon (2010).
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FIGURE 5.1: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH FOR THE PHARMA AND BIOTECH SECTOR.
Note: growth rates (in percentage) of R&D and Net sales have been computed on 148 out of the 304 pharma and biotech companies in the top 2000 for which data are available 
for the entire period 2007-2016. These companies represent 87.3% of R&D,87.9% of Net Sales and 97.8% of Operating Profits of the Pharma and Biotech companies in the 
whole sample in 2016.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Nevertheless, despite the trend of sluggish growth rates 
in the past few years R&D investment and net sales in 
pharma and biotech sector were growing faster in the EU 
than in the US (fig 5.2). In addition, it seems that while 
US pharma and biotech companies spend in R&D around 
1.5 times more than their European counterparts, the EU 
companies might have started a catching-up process in 
this respect.
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FIGURE 5.2: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH FOR THE PHARMA AND BIOTECH SECTOR COMPANIES – EU VS US.
Note: growth rates (in percentage) of R&D and Net sales have been computed on 41 out of the 73 EU (representing 93.5% of the R&D of these companies in 2016) and 52 out 
of the 152 US (representing 81.0% of the R&D of these companies in 2016) pharma and biotech companies in the top 2000 for which data are available for the entire period 
2007-2016.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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This catching-up process is paramount in light of the fact 
that there are two sectors – Pharma and Biotech and 
ICT services– which have significantly higher profitability 
level compared to the other industries. Moreover, the 
profitability gap between the Pharma and Biotech and 
ICT sectors and the others industries seems to be a long-
term tendency throughout the period between 2007 and 
2016. This development is in line with the overall shift 
of the value creation to intangible assets and services 
(information, data, intellectual properties, algorithms, 
software, and applications)23 which is more prominent 
in case of R&D intensive industries, such as the Health 
sector and ICT (fig 5.3).
5.2 | Why the catching-up of EU companies in Health sector  
is important?
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FIGURE 5.3: PROFITABILITY TRENDS (ALL SECTORS).
Note: Profitability (sales as percentage of profits) has been computed on 1434 out of the top 2000 for which data are available for the entire period 2007-2016.
Data on the “Others” sector not shown. These companies represent 86.9% of R&D, 84.6% of Net Sales and 85.5% of Operating Profits of the companies in the whole sample in 2016.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
23 See: Haskel, Jonathan and Westlake, Stian 2017. Capitalism without Capital: The Rise of the Intangible Economy. Princeton University Press, Princeton, N. J.
The sectoral difference is particularly relevant to the EU, 
since in the US also the ICT producer companies are very 
profitable and the profitability gaps among the different 
industries are smaller too. Furthermore, the US companies 
on average have higher profitability in almost all sectors 
with the exception of “Automobiles & other transport”, 
where the EU companies have higher profitability levels 
(see Figures 5.4 and 5.5), but which is forming an ever 
smaller proportion of total US R&D.
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FIGURE 5.4: PROFITABILITY TRENDS (ALL SECTORS) - EU COMPANIES
Note: Profitability (sales as percentage of profits) has been computed on 344 out of the 474 EU companies in the top 2000 for which data are available for the entire period 
2007-2016. 
Data on the “Others” sector not shown. These companies represent 88.2% of R&D, 85.1% of Net Sales and 84.5% of Operating Profits of the EU companies in the whole sample 
in 2016.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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FIGURE 5.5: PROFITABILITY TRENDS (ALL SECTORS) - US COMPANIES
Note: Profitability (sales as percentage of profits) has been computed on 472 out of the 661 US companies in the top 2000 for which data are available for the entire period 
2007-2016. 
Data on the “Others” sector not shown. These companies represent 90.0% of R&D, 86.4% of Net Sales and 93.2% of Operating Profits of the US companies in the whole sample 
in 2016.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
5.3 | Declining efficiency of R&D investment in Pharmaceuticals 
and Biotechnology?
Since Pharmaceuticals and Biotechnology belong to 
the most R&D intensive sectors (see previous EU R&D 
Scoreboard editions), the long-term development of the 
R&D investment, and particularly the question, how efficient 
are these investments, is becoming of crucial importance. 
Taking, however, a simple input-output model, where R&D 
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investments are regarded as input and patents as output, 
the long-term development in Pharmaceuticals and 
Biotechnology industries shows a widening gap between 
investment and patent activities (fig 5.6). Moreover, 
this gap is much wider in case of Pharmaceuticals and 
Biotechnology than in all other sectors (fig 5.7), which are 
showing also declining paten activity despite increasing 
R&D investment, but the gap in case of Pharmaceuticals 
and Biotechnology is significantly deeper.
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FIGURE 5.6: R&D INVESTMENT AND PATENTS TRENDS FOR THE PHARMA AND BIOTECH SECTOR COMPANIES.
Note: data computed on 148 out of the 304 Pharma and Biotech companies in the top 2000 for which data are available for the entire period 2007-2016. Values in 2007 used 
as base year for both R&D and patents. These companies represent 87.3% of R&D,87.9% of Net Sales and 97.8% of Operating Profits of the Pharma and Biotech companies in 
the whole sample in 2016.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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FIGURE 5.7: R&D INVESTMENT AND PATENTS TRENDS (ALL OTHER SECTORS). 
Note: data computed on 1286 out of the 1696 non Pharma and Biotech companies in the top 2000 for which data are available for the entire period 2007-2016. These 
companies represent 86.9% of R&D of the non Pharma and Biotech companies in the whole sample in 2016.Values in 2007 used as base year for both R&D and patents.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Additionally, in Pharmaceuticals and Biotechnology the 
observed development of declining patent activity despite 
increasing R&D investment seems to be a general trend, 
since in this regard there are now significant differences 
between the US and EU companies. Nevertheless, this gap 
is currently wider in the US than in the EU, see Figures 
5.8 and 5.9. This is not surprising since the US is leading 
the world in biotechnology and hence in the development 
of more complex biologic drugs. For example, the recent 
breakthroughs in cancer immunotherapy, gene therapy and 
stem cell therapy are all being led by US companies. There 
are European companies active in cancer immunotherapy 
such as AstraZeneca, Novartis and Roche but there are 
many more US companies in this field.
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FIGURE 5.8: R&D INVESTMENT AND PATENTS TRENDS FOR THE PHARMA AND BIOTECH SECTOR COMPANIES –EU VS US.
Note: data computed on 41 out of the 73 EU (representing 93.5% of the R&D of these companies) and 52 out of the 152 US (representing 81.0% of the R&D of these companies) 
pharma and biotech companies in the top 2000 for which data are available for the entire period 2007-2016. Values in 2007 used as base year for both R&D and patents.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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FIGURE 5.9: R&D INVESTMENT AND PATENTS TRENDS (ALL OTHER SECTORS) –EU VS US.
Note: data computed 303 out of the 401 EU (representing and 420 out of the 509 US non Pharma and Biotech companies in the top 2000 for which data are available for the 
entire period 2007-2016. Values in 2007 used as base year for both R&D and patents.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
All in all, Pharma and Biotech companies are responsible 
for 20% of the total cumulative investment in R&D by the 
top 2000 R&D investors worldwide in the period 2007-
2015. In the same period, they filed only 5% of the total 
patents filed by the companies in our sample. This is to 
be expected because of the low ratio of patents to R&D 
characteristic in the biopharma sector.
Declining efficiency of R&D investment in Pharmaceuticals 
and Biotechnology has long been discussed and the 
phenomenon is popularly known as „Eroom law” (Moore’s 
law spelled backwards). This “law” intends to make 
the difference between the ICT sector, where as a sing 
for efficiency of R&D investments the performance 
of microprocessors at the heart of all ICT devices has 
increased dramatically through the past five decades, 
while in Pharmaceuticals a completely opposite process 
seems to take place, and the R&D efficiency measured as 
number of new marketable medicines per billion US$ of 
R&D investment has declined over time24.
24 See: Scannell, Jack W.–Blanckley, Alex–Boldon, Helen–Warrington, Brian (2012): Diagnosing the decline in pharmaceutical R&D efficiency. Nature Reviews Drug Discovery 
11, March, 191–200.
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Nevertheless, there might be many reasons for the declining 
efficiency of R&D investments in Pharmaceuticals and 
Biotechnology sectors, and the majority of these are 
rooted in the specific nature of the sector. For instance, in 
Pharmaceuticals and Biotechnology incremental innovation 
is rarely a viable solutions in the consumer market; e.g. the 
patients expect from the new medicine to be significantly 
more effective than the previously one. In Pharmaceuticals 
and Biotechnology the regulatory environment is more 
cautious than in other sectors in order to reduce the safety 
risks to a minimum when a new pharmaceutical product 
is introduced to the market. Furthermore, Pharmaceuticals 
and Biotechnology are typically industries where, due to 
the advanced technology and the high costs for R&D, the 
manufacturer can determine the products with which it 
enters the market. Among other factors exactly the high R&D 
intensity and high cost involved is one the reasons for the 
high concentration of the producer market. Finally, it is also a 
specific feature of these sectors that the way from invention 
and scientific discovery to the marketable products is much 
longer than in other sectors (because of long and extensive 
clinical trial procedures), in other words, the rate of return of 
investment is longer, than in many other industries.
Definitely, further research is needed to analyse in every 
aspects the role of the different factors, - such as industry 
specific factors, the role of the regulatory environment, the 
market structures – in order to get the whole picture.
5.4 | The technological profile of the Pharma and Biotech 
companies
Looking at the technological profile of companies in the 
pharma and biotech sector (fig 5.10) – i.e. the technological 
fields in which they patent – it does not surprise the bulk 
of their patents is concentrated in few technological fields.
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FIGURE 5.10: TECHNOLOGICAL PROFILE OF PHARMA AND BIOTECH COMPANIES.
Note: percentage of patents in each technological filed over the total number of patents of each sector. 
Data computed on 148 out of the 304 Pharma and Biotech companies in the top 2000 for which data are available for the entire period 2007-2016. These companies represent 
87.3% of R&D,87.9% of Net Sales and 97.8% of Operating Profits of the Pharma and Biotech companies in the whole sample in 2016.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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For the Pharma companies, almost 80% of their patents are 
in ‘Pharmaceuticals’ (30.4%), ‘Medical technology’ (19.4%), 
‘Organic fine chemistry’ (19.1) % and ‘Biotechnology’ (11.1%).
For the Biotech companies, almost 85% of their patents 
are in ‘Biotechnology’ (34.6%). ‘Pharmaceuticals’ (31.4%), 
‘Organic fine chemistry’ (15.2%), and ‘Basic materials 
chemistry’ (3.1%). Although the patents of both subsectors 
are quite contracted in few technologies, levels of concen-
tration are slightly higher in the biotechnology sector.
If we disaggregate the data and compare the EU vs 
the US pharma and biotech sectors (Figures 5.11 and 
5.12), some difference emerges. Before looking at these 
differences, we need to keep in mind that the two sectors 
are quite different in the two regions. While the Pharma 
component is comparable among the EU and US groups 
of companies, the Biotech one is very different, with EU 
companies investing in R&D around 4.5% of what the US 
biotech companies do, and filing far less patents (around 
a third of those filed by their US counterparts). The EU 
has very few of the larger biotech companies and none 
to compare with the large US biotechs such as Amgen, 
Biogen, Celgene, Gilead.
Having said that, what emerges comparing the 
technological profiles of EU and US pharma and biotech 
companies is a higher concentration of EU companies’ 
patents in few technologies. However, in both regions the 
sector is dominated by few big firms, responsible for the 
majority of both patents and R&D.
Top 3 patenting technologies for the EU Pharma compa-
nies are ‘Pharmaceuticals’ (30.7%), ‘Organic fine chemis-
try’ (20.0%), and ‘Medical technology’ (13.9%), while for US 
Pharma companies are ‘Medical technology’ (36.2%), ‘Phar-
maceuticals’ (23.9%) and ‘Organic fine chemistry’ (16.1%). 
This highlights an interesting difference: while EU pharma 
companies are more concentrated in traditional pharma 
technologies, their US counterparts are patenting in med-
ical technologies, suggesting a different development 
strategy.
Top 3 patenting technologies for the EU Biotech 
companies are ‘Biotechnology’ (60.5%), ‘Basic materials 
chemistry’ (10.8%), and ‘Food chemistry’ (7.7%), while 
those for US Biotech companies are ‘Pharmaceuticals’ 
(39.9%), ‘Biotechnology’ (26.5%) and ‘Organic fine 
chemistry’ (20.0%). In this case, it seems EU Biotech 
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FIGURE 5.11: TECHNOLOGICAL PROFILE OF EU PHARMA AND BIOTECH COMPANIES.
Note: percentage of patents in each technological filed over the total number of patents of each sector. 
Data computed on 41 out of the 73 EU (representing 93.5% of the R&D of these companies in 2016) Pharma and Biotech companies in the top 2000 for which data are available 
for the entire period 2007-2016.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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companies mainly develop biotech technologies, while in 
the US there is much more variety. This is due probably 
to the structural difference already mentioned between 
EU and US in the biotech sectors, where the US if by far 
the world leader.
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FIGURE 5.12: TECHNOLOGICAL PROFILE OF US PHARMA AND BIOTECH COMPANIES.
Note: percentage of patents in each technological filed over the total number of patents of each sector.
Data computed on 52 out of the 152 US (representing 81.0% of the R&D of these companies in 2016) Pharma and Biotech companies in the top 2000 for which data are 
available for the entire period 2007-2016.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
5.5 | Concluding remarks
•	 Albeit the good performance in financial indicators in 
the past decade, top R&D investing companies in the 
pharma and biotech sector are experiencing a decrease 
of patents filed at EPO and USPTO.
•	 This decline in R&D efficiency can be explained by multiple 
reasons, mainly connected to the specific nature of the 
sector, characterised by heavy regulation, long terms of 
return of investment and incremental innovation.
•	 Also the industry has undergone a change from 
chemicals to biological drugs. The move from the 
earlier small molecule drugs to the modern 
biologicals means that more R&D is now needed to 
achieve a granted patent in biopharma since a much 
smaller proportion of drugs are now based on small 
molecules.
•	 There is a clear difference between EU and US in 
the Pharma and Biotech sector in terms of their 
technological profile. This is mainly driven by the low 
number of Biotech companies in the EU compared to 
the US.
6 THE GREEN TECHNOLOGIES OF TOP R&D INVESTORS
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The objective of this chapter is to analyse the technologi-
cal profile of the Scoreboard companies from an environ-
mental technology viewpoint. The technological perspec-
tive allows an assessment of how the innovation activity 
of different industrial players may contribute to the reduc-
tion of the human footprint.
The chapter is based on patent analysis, focusing on 
assessing the capacity of EU companies to develop 
environmental technologies, analyse their strengths and 
weaknesses in specific sub-fields and compare this with 
other economic areas.
Accounting for 90% of the world’s business-funded R&D, 
the companies of the present Scoreboard (SB) have a 
great potential for using their resources and competencies 
to develop new technologies in the environmental domain. 
Important insights about the actual exploitation of this 
potential can be obtained by inspecting their portfolio of 
“green patents” over the period 2012-2015 (see Box 6.1 
for the methodology). The main areas defined as ‘green’ 
for this purpose are transportation (e.g. plug-in or hybrid 
vehicles), energy production and distribution (e.g. wind 
and solar electricity generation), production of goods (e.g. 
fuels from renewable energy sources), Information and 
Communication Technologies (ICT) related to energy use 
(e.g. power management systems), buildings (e.g. roof 
systems for photovoltaic cells), adaptation to climate 
change (e.g. floating houses), waste (e.g. landfill gas 
capture) and capture, storage, sequestration or disposal 
of greenhouse gases (e.g. subterranean or submarine CO2 
storage).
Green patents still represent a limited share (8.6%) of 
all the kinds of patents filed at the EPO and USPTO over 
the period 2012-2015 (Figure 6.1a). The same incidence 
is detectable for SB companies: the share of green over 
the entire spectrum of patents that SB companies have 
filed across the board is about 9%. On the other hand, the 
share of this small part of green technologies invented by 
SB companies is appreciable and larger than 52% (Figure 
6.1b). This mimics the remarkable share (50.4%) of total 
patents (green and non-green) that SB companies filed at 
the same patent offices.
The green technologies of top R&D investors6
The top R&D investors own 50% of patents filed in the EPO and USPTO offices from 
2012 to 2015. The share of green patents in the total is 9% of which 53% belong to 
the top R&D companies. 
The highest shares of green patents are held by companies from regulatory driven 
sectors, like transport-related industries, industrials, and chemicals, but ICT producers 
follow at short distance. 
EU companies show comparative advantages in most green technologies, with the 
exception of ICT for energy applications.
More than half (58%) of the green patents filed by SB 
companies refer to transportation (38.1%) and energy 
(20.6%) technologies (Figure 6.2a), while about 35% of 
them are distributed over the production of environmental 
goods (14.2%), ICTs for energy (12.3%) and buildings 
(8.1%). Climate Change Adaptation Technologies (CCAT) 
attract only 4% of the green inventive efforts of SB 
companies, while their involvement in water and waste 
(1.2%) and in Carbon Capture and Storage (CCS) (1.1%) 
is negligible.
6.1 | The green-patent breakdown of top R&D investors: 
technologies, industries and geographical areas
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The bulk of SB green patents (about 80%) is concentrat-
ed in companies headquartered in Japan (30.9%), the 
US (26.8%), Germany (11,8%) and South Korea (10.5%), 
showing an interesting “triangle” among East Asia, 
North-America, and Central Europe in the introduction of 
environmental technologies (Figure 6.2b). On the other 
hand, European countries other than Germany – France, 
the UK, the Netherlands, and Sweden, among the first – as 
well as China and Taiwan, host companies contributing to 
the total of the SB green patents to a limited extent (5% 
or even less).
Box 6.1 
Methodology for the identification 
of green patents
Following the extant research on the topic 
(Hascic and Migotto, 2015)25, green patents 
are hereby considered as a reliable proxy 
of the development/adoption of green 
technologies at the company level.
Green patents are identified by using the 
Cooperative Patent Classification (CPC) 
codes assigned to patents by the European 
Patent Office (EPO). In particular, the 
“Y02” class included in the CPC enables 
us to identify inventions related to 
technologies for mitigation or adaptation 
against climate change. Therein, the 
classification is articulated into eight 
subclasses at 4-digit level, encompassing 
a broad spectrum of environmental-related 
technologies, which will be used in the 
present analysis: transportation, energy 
production and distribution, production of 
goods, Information and Communication 
Technologies (ICT) related to energy use, 
buildings, adaptation to climate change, 
waste and capture, storage, sequestration 
or disposal of greenhouse gases. This 
classification of green technologies mirrors 
the one proposed by the OECD (Hascic 
and Migotto, 2015), whose adoption 
yields similar results to those reported in 
this chapter. The approach proposed here 
instead differs from the one adopted by 
Fiorini et al. (2017)26, which includes other 
codes (e.g. Y04) in order to embrace patent 
activity in smart grids.
The analysis refers to patent families 
- collections of patent applications for the 
same green invention, filed at different 
patent offices - and uses priority date as 
temporal reference for them. Taking stock 
of their cooperative efforts in classifying 
patents, and following recent analyses of 
the geography of green technologies, the 
analysis is performed on inventions for 
which intellectual property right protection 
has been sought at the European Patent 
Office (EPO) and/or United States Patent 
and Trademark Office (USPTO). Crossing the 
need of reducing changes in the sample of 
the 2000 observed Scoreboard companies 
with that of avoiding truncation in patent 
data, the analysis is performed over the 
period 2012-2015. With the exception of 
the number green patents, patent families 
referring to multiple technological fields are 
assigned to each of them, and the same is 
done with respect to countries (Nesta et al., 
2014)27.
25 Haščič, I.,&Migotto, M. (2015). Measuring environmental innovation using patent data (OECD Environment Working Papers No. 89).
26 Fiorini, A., Georgakaki, A., Pasimeni, F., and Tzimas, E. (2017). Monitoring R&I in Low-Carbon Energy Technologies. Methodology for the R&I indicators in the State of the 
Energy Union Report -2016 edition. JRC Science for Policy Report.
27 Nesta, L., Vona, F., & Nicolli, F. (2014). Environmental policies, competition and innovation in renewable energy. Journal of Environmental Economics and Management, 
67(3), 396-411.
83The 2019 EU Industrial R&D Investment Scoreboard
(a) Green and all (green plus non-green) (b) Top R&D investors’ share of total green 
patents patents (shares)
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FIGURE 6.1: THE GREEN PATENTS OF TOP R&D INVESTORS, 2012-2015.
Note: (a) Patents filed by Scoreboard (SB) and non-Scoreboard (Non-SB) companies and share of green patents (according to CPC classification)28; (b) Green patents filed by 
Scoreboard and non-Scoreboard companies.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
(a) Green technologies based on CPC (b) Country of SB companies’ headquarter
Transportation - 38,1% 
Energy - 20,6% 
Production of Env. Goods - 14,2% 
ICTs for Energy - 12,3% 
Buildings - 8,1% 
CCAT - 4,1% 
Water & Waste - 1,2% 
CCS - 1,1% 
JP - 30,9% 
US - 26,8% 
DE - 11,8% 
KR - 10,5% 
Others - 5,5% 
FR - 3,9% 
CN - 2,4% 
TW - 2,2% 
GB - 2,2% 
NL - 2% 
SE - 1,2% 
FIGURE 6.2: TOP R&D INVESTORS’ GREEN PATENTS BY TECHNOLOGY (A) AND COUNTRY (B), 2012-2015.
Note: (a) Caption: CCS = “Carbon Capture and Storage”, ICT = “Information and Communication Technologies”, CCAT = “Climate Change Adaptation Technologies”, ICB = “Industry 
Classification Benchmark”.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
28 The Cooperative Patent Classification (CPC) is an extension of the IPC and is jointly managed by the EPO and the US Patent and Trademark Office. https://www.epo.org/
searching-for-patents/helpful-resources/first-time-here/classification/cpc.html.
The geographical distribution of the most green-
patenting SB companies reveals interesting insights 
when their industry breakdown is considered (Figure 6.3). 
ICT producers reveal a dominant share of green patents 
(83%) of those filed by Chinese SB companies, with the 
other industries lagging substantially behind. It is instead 
automobile and other transport SB companies that show 
the highest share of green patents filed by the European, 
the US and the Japanese ones, while ICT producers follow 
a short distance behind. Finally, US and Europe are the 
only areas of the four where SB companies in aerospace 
and defence concentrate an appreciable share of green 
patents (about 17% and 14%, respectively).
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FIGURE 6.3: GREEN PATENTS OF TOP R&D INVESTORS BY GEOGRAPHICAL AREA AND INDUSTRY.
Note: Industry (ICB) shares of total green patents filed by SB companies of different geographical areas, 2012-2015. Caption: ICB = “Industry Classification Benchmark”. 
Geographical areas refer to the SB companies’ headquarter.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Interesting results emerge when, instead of looking at 
the scale of SB companies’ green patenting, its intensity 
is considered with respect to their total technological 
inventions. The highest share of green over total patents 
is revealed by SB companies operating in transport-
related industries, in which environmental regulations 
play an important driving role (Figure 6.4, central panel in 
green): aerospace & defence (23.2%), totalising almost 
3,900 green over more than 17,000 patents in the period 
2012-2015 (Figure 6.4, other panels), and automobiles 
and other transports (20.1%), overcoming the threshold 
of 10,000 green patents over a total of more than 72,000 
patents in the same period. In these two transport-
related industries, SB companies concentrate their green 
inventions in green transportation technologies, and in 
the following two of the most patented green classes 
(their CR3 is of 95.1% and 92.7%, respectively).
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FIGURE 6.4: GREEN PATENT INTENSITIES OF TOP R&D INVESTORS BY INDUSTRY AND INDUSTRY GREEN-TECH BREAKDOWN.
Note: Share (central panel) and number of green patents (other panels) by industry (ICB) and environmental technology (CPC), 2012-2015. Caption: CCS = “Carbon Capture and 
Storage”, ICT = “Information and Communication Technologies” CCAT = “Climate Change Adaptation Technologies”, ICB = “Industry Classification Benchmark”.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Industrials (13.9%), chemicals (12%), others (8.7%), 
and ICT producers (6.8%), constitute a second group of 
industries with a green-patent intensity in-between about 
5 and 10%. The focus of the relative SB companies is still 
on their most salient technologies – i.e., energy, production 
of environmentally sustainable goods and services, and 
green ICTs, respectively – though with a lower concentration 
(while still high, their CR3 is always lower than 85%). 
Overall, an expected tendency emerges for SB companies 
to intensify the green nature of their inventions in 
technologies related to their business industry, with limited 
diversification. Not surprisingly, in the heterogeneous bunch 
of sectors within the ‘others’ industry, the diversification 
of patenting across the considered green technologies is 
the highest (though with a CR3 still equal to 71%). On the 
contrary, SB companies in the provision of ICT services still 
concentrate their relatively few 1,282 green patents in 
green ICTs (Daiko et al., 2017)29. Interesting is the case 
of health industries. In spite of the intense regulation 
process that marks some industries of the sector (e.g. 
pharma), the relative companies show a very modest 
share (2.7%) and number (772) of green patents. Still, it 
is exclusively through these companies that the SB panel 
contributes to the development (about 400 patents) 
of crucial technologies for the green transition, that is, 
Climate Change Adaptation Technologies (CCAT), on which 
they concentrate their inventive outcomes in the domain 
(CR3 = 93.5%).
The extent to which SB companies diversify their 
involvement in the development of green technologies 
is also heterogeneous across the geographical areas in 
which they are headquartered (Table 6.1). On the one 
hand, SB companies based in the EU reveal, all together, 
a distributed pattern of specialisation (as measured by a 
Revealed Green-Tech Advantages indicator) in the eight 
green technologies that we consider (a specialisation is 
actually missing only in ICTs for energy). Conversely, SB 
companies with a Chinese base have a very concentrated 
pattern of specialisation, focusing in the same kind of ICTs 
and in the buildings industry. US, Japan and the Rest of the 
World stays in-between, with the relative headquartered 
SB companies specialising in about half of the eight 
green technologies. US and Japan-based companies 
show an interesting pattern in their specialisation and de-
specialisation in CCAT, CCS, ICTs, transportation, water and 
waste (in favour of the US) and buildings, CCS, energy, and 
production of environmental goods (in favour of Japan).
29 Daiko, T., Dernis, H., Dosso, M., Gkotsis, P., Squicciarini, M., and Vezzani, A. (2017). World Corporate Top R&D Investors: Industrial Property Strategies in the Digital Econ-
omy. A JRC and OECD common report. Luxembourg: Publications Office of the European Union.
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Green Technology EU US Japan China RoW
CCAT 1.38 1.18 0.794 0.285 0.635
Buildings 1.12 0.732 1.08 1.39 1.03
CCS 1.2 1.12 1.08 0.139 0.459
ICTs for energy 0.42 1.16 0.774 4.62 1.54
Energy 1.08 0.737 1.12 0.601 1.13
Production of Env. Goods 1.09 0.84 1.02 0.669 1.13
Transportation 1.02 1.18 1.01 0.233 0.761
Water & Waste 1.4 1.08 0.802 0.062 0.778
TABLE 6.1: REVEALED GREEN-TECH ADVANTAGES (>1) OF THE GEOGRAPHICAL LOCATION (HEADQUARTER) OF THE TOP R&D INVESTORS, 2012-2015.
Note: Caption: CCS = “Carbon Capture and Storage”, ICT = “Information and Communication Technologies” CCAT = “Climate Change Adaptation Technologies”. The Revealed Green-
Tech Advantage of a geographical area in a certain green technology is calculated by dividing the share of patents in that green technology filed by the SB companies of that 
area, by the share of that technology at a global level over total green patents. A greater than 1 value (in-between 0 and 1) of this share reveals that the area (in terms of SB 
companies) at stake is (is not) specialised in the considered green technology.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
(a) Average family size, EPO and USPTO patents, ICB, 2012-2015
0 
0,05 
0,1 
0,15 
0,2 
0,25 
Health 
industries 
Chemicals Others Industrials All Industries ICT 
producers 
Automobiles 
& other 
transport 
ICT services Aerospace
& Defence 
Non-Green patents EPO Green patents EPO Non-Green patents USPTO Green patents USPTO 
Non-Green patents EPO Green patents EPO Non-Green patents USPTO Green patents USPTO 
0 
0,05 
0,1 
0,15 
0,2 
0,25 
Health 
industries 
Chemicals Automobiles 
& other 
transport 
Aerospace
& Defence 
Industrials All Industries Others ICT services ICT 
producers 
(b) Average patent scope, EPO and USPTO patents, ICB, 2012-2015
 
,  
,  
,  
,  
,  
ealth 
industries 
he icals thers Industrials ll Industries I T 
producers 
uto obiles 
 other 
transport 
I T services erospace
 efence 
on- reen patents EP  reen patents EP  on- reen patents SPT  reen patents SPT  
on- reen patents EP  reen patents EP  on- reen patents SPT  reen patents SPT  
 
,  
,  
,  
,  
,  
ealth 
industries 
he icals uto obiles 
 other 
transport 
erospace
 efence 
Industrials ll Industries thers I T services I T 
producers 
FIGURE 6.5: VALUE OF GREEN- AND NON-GREEN PATENTS OF TOP R&D INVESTORS BY INDUSTRY.
Note: Caption: ICT = “Information and Communication Technologies”, ICB = “Industry Classification Benchmark”. Green (Grey) bars refer to green (non-green) patent families. Upper 
(lower) panel refers to patents filed at the EPO (USPTO). The family size indicator is normalised according to the maximum value observed for patents in the same cohorts (filing 
date and WIPO technological fields). Patent indicators are obtained from the OECD Patent Quality Indicator database (Squicciarini et al., 2013).
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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Delving into the value (or quality) of the green patents 
filed by SB companies (Squicciarini et al., 2013)30, Figure 
6.5 shows interesting differences with respect to their 
non-green ones. First of all, in as many as four of the 
eight industries in which they are classified – health, 
chemicals, ‘others’ industries, and automobiles and other 
transport – SB companies tend to file green patents 
across a higher number of patent offices (countries) 
with respect to non-green patents (Figure 6.5.a): 
their average patent size is larger. In the industries 
at stake, green inventions thus appear to have more 
geographically widespread market opportunities (and 
thus protection needs) than non-green ones. Across all 
the considered industries, instead, the green patents 
filed by SB companies are classified through a higher 
number of technological codes (Figure 6.5.b) – higher 
average scope – and thus reveal a wider need/coverage 
of relevant technological fields for their introduction. 
Results are invariant to the considered patent office and 
confirm what emerges from other studies (e.g. Barbieri 
et al., 2018)31. Green technologies appear marked by a 
higher degree of technological complexity, suggesting a 
possible interpretation of their still limited diffusion also 
across SB companies.
30 Squicciarini, M., Dernis, H. and Criscuolo, C. (2013). Measuring Patent Quality: Indicators of Technological and Economic Value. OECD Science, Technology and Industry 
Working Papers, 2013/03, OECD Publishing, Paris.
31 Barbieri, N., Marzucchi, A., and Rizzo, U. (2018). Knowledge sources and impacts on subsequent inventions: Do green technologies differ from non-green ones? SPRU 
Working Paper Series 2018-11 (http://sci-hub.tw/10.2139/ssrn.3164197).
Moving to the company level (Table 6.2), we find that, 
consistent with the previous industry-level results, five 
out of the top 10 green inventors (number of patents) 
within the SB - assignee of more than 800 green patents 
each - are in the automobiles & other transport industry. 
Toyota (head-quartered in Japan) leads this industry 
group, having filled 0.46% of the total SB companies’ 
green patents, followed by Ford (US), Hyundai Motor 
(Korea), and General Motors (also US), with the first 
European companies (Robert Bosch and Volkswagen, in 
11th position) further behind. The most green-patenting 
European company of the top 10 is Siemens, in the ICT 
producers industry, which has filled less than half the 
share of the SB green patents (0.21%) than Toyota. 
On the other hand, companies like General Electric 
(industrials) and United Technologies (Aerospace & 
Defence) make the US more represented in this “highest 
club” than Japan (including Toshiba), Korea (including 
Samsung) and, as we said, Europe. Extending the rank 
to the top 25 green inventors, Japan overtakes the US in 
terms of number of listed companies; Europe overtakes 
Korea, while Huawei (ICT producers) is the only Chinese 
company to enter the top 25.
Still in terms of rankings (Table 6.2), Toyota, with its 
notable engagement in the development of full hybrid 
electric cars (the Toyota Prius being one of the earliest 
hybrids), is also the first company in the top 25 by 
intensity of green patents (more than 35% of its total 
patents). While it is only in the 87th position in this 
respect, higher intensities than that are apparently 
revealed by companies with a relatively smaller portfolio 
of green patents over the period 2012-2015 (i.e., less 
than the 440 green patents filed by the 25th company, 
Fujitsu). At the opposite extreme, the remarkable green 
patents number of the 5th ranked, Samsung Electronics, 
is apparently explained by the large patent mass of 
the company, whose green intensity is negligible (4%), 
making it fall down at the 660th position of the total 
SB ranking in that respect. Rolls-Royce, Ford Motor and 
Mitsubishi Heavy are the only other top 25 green patent 
companies that appear in the highest quartile of the 
two distributions (green and non-green patents) with 
30% or more of green patent shares. For the remaining 
companies, such a share is lower, and one if not even 
two quartiles of difference emerge between the relative 
rankings (in terms of number of green and non-green 
patents). All in all, a thick and simultaneously non-
unbalanced portfolio of green patents is revealed by very 
few SB companies. These SB companies mainly operate 
in the automobiles & other transport industry, and mainly 
outside of European boundaries.
Confirming the conditional role that the literature on eco-
innovation has assigned to R&D as one of its drivers in 
general – that is, to non-green dedicated R&D projects 
6.2 | The green-patent ranking of top R&D investors
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(Ghisetti & Pontoni, 2015)32 – Figure 6.6 reveals that SB 
companies differ in their ranking across green patents and 
R&D expenditures, respectively. Some of the first quartile SB 
companies in terms of (number of) green patents, like for 
example Toshiba and Hyundai, are overcome by a number 
of companies of the relative third and even fourth quartile 
in terms of R&D expenditure. Conversely, while with the 10 
highest level of R&D expenditure among the top green-
inventors, BMW ranks only in the last quartile of the green 
patent distribution. In general, the correlation between the 
rankings is quite weak (with a Spearman’s rho not higher 
than 0.51). This is an interesting result, which points to 
the complex set of regulations, scientific advancements, 
demand factors, and firm capabilities that, in the case of 
green technologies, are found to substitute the linear model 
of innovation based on R&D (Horbach et al., 2012)33.
32 Ghisetti, C., Pontoni, F. (2015), Investigating policy and R&D effects on environmental innovation: A meta-analysis, Ecological Economics, 118, 57-66.
33 Horbach, J., Rammer, C. and Rennings, K. (2012). Determinants of eco-innovations by type of environmental impact — The role of regulatory push/pull, technology push 
and market pull. Ecological Economics, 78, 112-122.
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TOYOTA MOTOR Automobiles & other transport JP 2344 4272 0.46 35.43 1 87 1
GENERAL ELECTRIC Industrials US 2024 5475 0.39 26.99 2 134 0
UNITED TECHNOLOGIES Aerospace & Defence US 1577 4045 0.31 28.05 3 126 1
FORD MOTOR Automobiles & other transport US 1558 3516 0.30 30.71 4 109 1
SAMSUNG ELECTRONICS ICT producers KR 1458 29491 0.28 4.71 5 660 0
HYUNDAI MOTOR Automobiles & other transport KR 1413 4195 0.27 25.20 6 143 1
SIEMENS ICT producers DE 1087 5207 0.21 17.27 7 224 1
GENERAL MOTORS Automobiles & other transport US 941 3115 0.18 23.20 8 160 1
ROBERT BOSCH Automobiles & other transport DE 912 6419 0.18 12.44 9 328 0
TOSHIBA Industrials JP 845 8353 0.16 9.19 10 418 0
VOLKSWAGEN Automobiles & other transport DE 726 2493 0.14 22.55 11 165 2
QUALCOMM ICT producers US 720 5994 0.14 10.72 12 368 0
MITSUBISHI HEAVY Industrials JP 654 1555 0.13 29.61 13 115 2
HITACHI ICT producers JP 647 5690 0.13 10.21 14 381 -1
MITSUBISHI ELECTRIC ICT producers JP 596 4026 0.12 12.89 15 311 0
AIRBUS Aerospace & Defence NL 539 2143 0.10 20.10 16 184 1
HONDA MOTOR Automobiles & other transport JP 538 2522 0.10 17.58 17 218 1
INTEL ICT producers US 538 4809 0.10 10.06 18 384 0
SAMSUNG SDI ICT producers KR 509 1857 0.10 21.51 19 174 1
DENSO Automobiles & other transport JP 502 3656 0.10 12.07 20 333 0
ROLLS-ROYCE Aerospace & Defence GB 500 971 0.10 33.99 21 91 2
HUAWEI ICT producers CN 493 7521 0.10 6.15 22 565 -1
LG CHEM Industrials KR 477 1605 0.09 22.91 23 163 2
NISSAN MOTOR Automobiles & other transport JP 456 714 0.09 38.97 24 77 2
FUJITSU ICT services JP 440 7140 0.09 5.80 25 589 -1
TABLE 6.2: TOP 25 GREEN INVENTORS (NUMBER OF GREEN PATENTS) AMONG THE TOP R&D INVESTORS, 2012-2015.
Note: ICT = “Information and Communication Technologies”, ICB = “Industry Classification Benchmark”.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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All of these and possible other factors represent crucial 
elements to consider in further exploring the determinants 
of the green-tech portfolio of the SB companies that 
emerged from this chapter.
FIGURE 6.6: TOP 50 GREEN INVENTORS (2012-2015) VS TOP R&D INVESTORS (OF THE 50) (2016): QUARTILES AND QUARTILE SWITCHES.
Note: ICT = “Information and Communication Technologies”, ICB = “Industry Classification Benchmark”. On the left column, firms are ranked according to the number of green patent 
families. On the right column, these same firms are ranked according to their R&D expenditure in 2016. Colours refer to the quartiles of the green patent and R&D distribution.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
•	 Top R&D investors appear a major player in the 
development of green inventions at EPO and/or USPTO. 
More than half (53%) of the still limited share of green 
patents obtained at these offices in-between 2012 
and 2015 actually belongs to the top R&D companies.
•	 Environmental regulations seem to play an important 
driving role also for top R&D investors. Their intensity 
of green over total patents is actually the largest 
in regulatory driven sectors, like transport-related 
industries. Unlike with respect to other technologies 
(e.g. ICT), SB companies intensify their green inventions 
in environmental technologies related to their salient 
business, with limited diversification. Finally, also in 
the case of SB companies, green technologies appear 
marked by a higher degree of complexity than non-
green one, suggesting a possible interpretation of their 
still limited diffusion, especially in the most incipient 
6.3 | Concluding remarks
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ones, like Climate Change Adaptation Technologies 
and Carbon Capture and Storage.
•	 EU companies show comparative advantages in most 
green technologies, with the exception of ICTs for 
energy. Quite interestingly, this contrasts the patterns 
of specialisation revealed by the US, Japan and 
especially China, which instead focus on a limited set 
of green technologies.
•	 SB companies rank differently among them in terms 
of green patents and R&D expenditure, with Hyundai 
Motor and BMW providing remarkable examples of 
their relative low correlation. This suggests that other 
internal capabilities than R&D and demand-related 
factors, in addition to environmental regulations, could 
drive the development of environmental technologies 
by top R&D investors.

7 PATENTING ACTIVITY OF SCOREBOARD 
FIRMS IN THE 
AUTOMOTIVE SECTOR
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The Automobiles & other transport sector34 (automotive) 
recovered rapidly from the economic crisis in 2009 and 
then has been growing significantly its R&D investments 
for the tenth consecutive year, reaching €123bn in 2019 
– a 91% increase over the past 10 years. The technology 
race in this sector is driven by both regulatory and market 
challenges. Companies have to comply with stricter 
regulations, namely on local and global emissions (reduce 
both energy consumption and urban pollution), use of 
new materials and related recycling issues35. On the other 
hand, companies rely on innovation to keep or increase 
competitiveness, as they have to face tougher global 
competition from incumbent and new industrial players, 
especially regarding the manufacturing of alternative 
transport means and the incorporation of ICT applications 
by companies such as Tesla and Alphabet.
Past Scoreboard editions have shown how EU companies 
are specialised in this sector and outperform their non-EU 
counterparts in economic and R&D terms and in particular 
show higher R&D intensities as compared with companies 
based in China and the US. The objective of this chapter is 
to assess further the position of the EU in this sector from 
technological and environmental viewpoints, based on the 
analysis of the patent portfolio of companies.
Patenting activity of Scoreboard firms  
in the automotive sector
7
The automotive sector owns 13% of total patents belonging to the Scoreboard 
companies of which 35% are held by EU companies. 
Most of these patents refer to current automotive technologies but an increasing 
proportion refer to green technologies including electric and autonomous vehicles and 
newer components such as novel batteries and fuel cells. 
EU companies which appear highly diversified and competitive in most technological 
fields, but in green technologies related to hybrid cars, batteries and fuel cells their 
Japanese counterparts are leading the race.
For emerging technology, current automotive companies are being joined in patent 
filing by companies from the software, IT hardware, electronics and chemicals sectors. 
This is a major challenge for the EU, whose lead in the automotive sector may be eroded 
as digital technologies take a higher proportion of the value added in this sector.
34 This sector comprises companies from the following ICB 4-digits sectors: Automobiles, Auto parts, Commercial Vehicles & trucks and Tyres.
35 Alonso Raposo, M. (Ed.), Ciuffo, B. (Ed.), Ardente, F., Aurambout, J-P., Baldini, G., Braun, R., Christidis, P., Christodoulou, A., Duboz, A., Felici, S., Ferragut, J., Georgakaki, A., 
Gkoumas , K., Grosso, M., Iglesias, M., Julea, A., Krause, J., Martens, B., Mathieux, F., Menzel, G., Mondello, S., Navajas Cawood, E., Pekár, F., Raileanu, I-C., Scholz, H., Tamba, 
M., Tsakalidis, A., van Balen, M., Vandecasteele, I., The future of road transport - Implications of automated, connected, low-carbon and shared mobility, EUR 29748 EN, 
Publications Office of the European Union, Luxembourg, 2019, ISBN 978-92-76-03409-4, doi:10.2760/9247, JRC116644.
36 Patent families published in USPTO and EPO were considered. Patent families were retrieved based on the priority application date but we limit the analysis to the three 
years prior to 2017 because for this period we can assume that the subsidiary structure of the SB companies is relatively stable.
37 Sustainable technologies have been identified based on the Y02 and Y04 classes of the Cooperative Patent Classification scheme (CPC). For technologies related to 
autonomous cars see “Eight great technologies: robotics and autonomous systems, UKIPO 2014”.
7.1 | Overview
This chapter makes use of company data from the Scoreboard 
2017 edition combined with patent data retrieved from 
Patstat 2019 spring edition36 to offer deeper insights on the 
competitiveness of the EU firms in the Automobiles sector 
putting special emphasis on the development of sustainable 
technologies37. It is also attempted to identify patents related 
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to autonomous, driverless cars. There are 116 firms in the 
Automobiles sector, which represent 6.7 % of the firms with 
patent families in EPO, USPTO in the Scoreboard 2017 edition 
(1733 firms). The firms in this sector own 12.9 % of the 
patent families filed with priority between 2012 and 2015 
(65453 families) and have invested €383 billion in R&D. This 
is almost 16 % of the total R&D investment from the 1733 
Scoreboard companies of the sample.
The geographic distribution of firms comprising the sector 
based on the location of the firms’ headquarters is in Table 
7.1. The 33 EU based companies in the sector invested in 
total €176 billion during the period between 2012- 2015, 
which represents 46 % of the total R&D investment in the 
sector. These companies have filed 23339 patent families 
during this period.
38 The use of patent priority date as reference results in truncation of numbers for 2015 and data for this year are excluded from graphs on trends.
World region Number	of	firms RD EUR billions (2012-15)
Patent Families 
(2012-15)
Share R&D 
(2012-15)
Share of families 
(2012-15)
EU 33 176 23339 46.0% 35.7%
Japan 33 112 23324 26.4% 35.6%
RoW 29 29.5 7453 7.7% 11.4%
US 21 64.4 11335 16.8% 17.3%
TABLE 7.1: THE GEOGRAPHY THE SECTOR BY THE LOCATION OF FIRMS’ HEADQUARTERS.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
In Figure 7.1 the patent families owned by the companies 
in the sector are distributed across the WIPO 35 techno-
logical classes for each year of the period under study. 
Most of these families fall under the general category of 
“transport” technologies. The number of patent families 
developed annually across most fields is relatively sta-
ble38, however “transport”, “computer technologies” and 
“measurement” show clear increasing trends.
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FIGURE 7.1: DISTRIBUTION OF PATENT FAMILIES ACROSS THE WIPO 35 TECHNOLOGY CLASSES BY YEAR OF FIRST FILING.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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It is interesting to note the increased importance “computer 
technology” and “measurement” technological fields gain 
in the portfolio of firms in the sector, as they become 
crucial in the development of modern cars. In fact, the 
analysis of “ICT-related” technologies by the world top R&D 
investors39 also revealed that firms related to transport 
are developing a significant share of patents related to 
“Large-capacity information analysis”. This also holds true 
when it comes to “AI-related” scientific and technological 
developments due to the emergence of autonomous and 
driverless cars applications40.
39 Daiko T., Dernis H., Dosso M., Gkotsis P., Squicciarini M., Vezzani A. (2017). World Corporate Top R&D Investors: Industrial Property Strategies in the Digital Economy. A 
JRC and OECD common report. Luxembourg: Publications Office of the European Union.
40 Dernis H., Gkotsis P., Grassano N., Nakazato S., Squicciarini M., van Beuzekom B.,Vezzani A. (2019). World Corporate Top R&D investors: Shaping the Future of Technolo-
gies and of AI. A joint JRC and OECD report. EUR 29831 EN, Publications Office of the European Union, Luxembourg, 2019, ISBN 978-92-76-09670-2 , doi:10.2760/16575, 
JRC117068.
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FIGURE 7.2: SHARE OF FAMILIES BY WORLD REGION ACROSS THE TOP 10 WIPO 35 TECHNOLOGY CLASSES BY NUMBER OF PATENT FAMILIES.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Focusing further on the top 10 WIPO 35 technological 
fields by number of patent families from firms in the 
sector, we analyse in Figure 7.2 the shares by world region. 
The analysis is based on the location of the headquarters 
of the firms. We see that EU based firms own over 35% 
of the patent families pertaining to these fields, reaching 
as high as 50% in the case of “Machine tools”. The main 
competitor is Japan with Japanese firms owing significant 
shares of families in these fields as well.
In order to better understand and compare firms based on 
their technological competences the relative technology 
advantage (RTA) is calculated as a relative metric of 
specialisation in Table 7.2. A value of RTA above 1 in a 
specific technology field shows a relative specialisation in 
that field. From Table 7.2 we see that the patent portfolio 
of EU based firms is highly diversified as they specialise in 
13 out of 15 fields in which firms in the sector specialise 
in general.
We analyse further the technological competences of firms 
in the sector by calculating the share of patents by world 
region of firms’ headquarters, for the top 10 technological 
classes in terms of number of patent filings (CPC 3 digit 
level). The top four fields are related to “vehicles” and 
“engines” development and in particular “combustion 
engines” development. The increased importance of 
“measuring, testing” and “computing” technologies 
commented above at the WIPO 35 level analysis is 
confirmed in Table 7.3 at this level of aggregation as 
well. We see that EU and Japan based firms develop and 
own over 60% of patents pertaining to these technology 
groups (almost 80% in the case of “generation, conversion 
and distribution of energy power”). Given the contribution 
of transport in total emissions and the emphasis that 
regulations put on controlling the environmental impact 
of transport in general, firms in the sector put significant 
part of their efforts in the development of “technologies or 
applications against climate change”.
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World region
EU Japan RoW US
Electrical machinery, apparatus, energy 1.4 1.8 1.3 1.1
Measurement 1.5 0.9 1.1 0.9
Control 1.4 1.2 1.5 1.5
Macromolecular chemistry, polymers 0.4 1.4 0.5 0.3
Materials, metallurgy 0.5 0.7 1.0 0.6
Micro-structural and 0no-technology 3.2 0.3 0.6 0.1
Environmental technology 2.8 2.3 2.3 3.0
Machine tools 1.7 0.8 0.8 1.3
Engines, pumps, turbines 2.7 2.7 2.6 4.0
Other special machines 1.5 1.2 0.6 0.7
Thermal processes and apparatus 3.1 0.8 1.2 1.1
Mechanical elements 4.2 2.5 4.4 3.8
Transport 4.1 5.5 5.4 5.9
Furniture, games 1.6 2.1 0.2 0.5
Other consumer goods 2.4 0.2 0.3 0.4
TABLE 7.2: RELATIVE TECHNOLOGY ADVANTAGE BY WORLD REGION.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
World region
EU Japan RoW US
Vehicles in general 30,45% 36,39% 12,22% 20,94%
Land vehicles for travelling 23,61% 46,53% 12,97% 16,88%
Machines or engines 33,79% 32,06% 14,21% 19,94%
Combustion engines 32,35% 33,63% 8,24% 25,78%
Engineering elements and units 41,46% 24,93% 14,20% 19,41%
Measuring tesitng 47,36% 29,23% 10,73% 12,67%
Computing 34,36% 34,26% 15,60% 15,78%
Basic electric elements 27,94% 49,14% 10,66% 12,26%
Generation, conversion and distribution of electric power 35,35% 45,49% 8,34% 10,83%
Technologies or applications against climate change 26,94% 36,57% 14,06% 22,44%
TABLE 7.3: SHARE OF PATENT FAMILIES BY WORLD REGION FOR THE TOP 10 TECHNOLOGY CLASSES BY NUMBER OF PATENTS.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
In Table 7.3 the distribution of patent families on envi-
ronmental technologies across world regions based on the 
location of the Scoreboard company headquarters is also 
shown. Japanese companies own the majority of these 
patents (almost 37%) with EU and USA based firms fol-
lowing with approximately 27% and 23% respectively.
7.2 | Technologies and applications for mitigation and 
adaptation against climate change
There are 92 firms in the sector, which own 11762 patent 
families pertaining to environmental related technologies 
according to the CPC classification. These families are 
distributed over the different subclasses of the Y- section 
of the CPC scheme according to Table 7.441. The number 
of firms owing patents pertaining to the specific subclass 
is also reported. The most frequent subclass is “climate 
change mitigation technologies related to transportation” 
(Y02T) followed by “reduction of greenhouse gas emissions 
related to energy generation, transmission or distribution” 
41 Patent families are calculated based on whole counting.
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(Y02E) and “Climate change mitigation technologies 
in the production or processing of goods” (Y02P) and 
“Technologies for adaptation to climate change” (Y02A).
The companies mainly responsible for the development of 
environmental technologies are shown in table 7.5. At the 
top of the list we find Toyota Motor from JP followed by 
Ford Motor (US) and Hyundai Motor (KR). Interestingly from 
the top 10 companies in this list, four are based in JP, 2 in 
the US, 2 in the EU and 2 in KR. The EU based firms, which 
are most active in filing patents related to “technologies 
and applications for mitigation and adaptation against 
climate change”, are Robert Bosch and Volkswagen from 
Germany.
CPC4 Description Patent families Firms
Y02T Climate change mitigation technologies related to transportation 9675 84
Y02E Reduction of greenhouse gas emissions related to energy generation, transmission or distribution 995 56
Y02P Climate change mitigation technologies in the production or processing of goods 359 52
Y02A Technologies for adaptation to climate change 295 35
Y02B
Climate change mitigation technologies related to buildings, e.g. housing, house appliances or 
related end-user applications
275 41
Y02D
Climate change mitigation technologies in information and communication technologies [ICT], i.e. 
information and communication technologies aiming at the reduction of thir own energy use 
78 21
Y04S
Systems integraring technologies related to power network operation, communication or informa-
tion technologies for improving the electrical power generation, transmission, ditribution, manage-
ment or usage i.e. smart grids
40 28
Y02W Climate change mitigation technologies related to wastewater treatment or waste management 27 11
Y02C Capture, storage, sequestration or disposal of greenhouse gases 18 11
TABLE 7.4: ENVIRONMENTAL RELATED SUBCLASSES (CPC CLASSIFICATION).
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Company name Country Patent families
TOYOTA MOTOR JP 2344
FORD MOTOR US 1558
HYUNDAI MOTOR KR 1413
GENERAL  MOTORS US 941
ROBERT BOSCH DE 912
VOLKSWAGEN DE 726
HONDA MOTOR JP 538
DENSO JP 502
NISSAN MOTOR JP 456
KIA MOTORS KR 354
TABLE 7.5: TOP 10 COMPANIES BY NUMBER OF PATENT FAMILIES 
(ENVIRONMENTAL TECHNOLOGIES).
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, 
JRC/DG RTD.
7.2.1 Climate change mitigation 
technologies related to 
transportation.
Scoreboard firms in the sector own 9675 patent families 
related to “climate change mitigation technologies for 
transportation”. The top ten technologies by number of 
patent families are related to the improvement of the 
efficiency and the control of emissions of traditional 
internal combustion engines and to technologies related 
to hybrid and electric cars (Table 7.6). At the top of the 
list we find technologies of the former type, such as 
“non-naturally aspirated engines, e.g. turbocharging, 
supercharging” and “exhaust feedback” followed by “fuel 
cells for transport” and “batteries” which are technologies 
of the latter type.
We see that the sector is adapting to current developments 
related to the electrification of transport as a means of 
tackling air pollution and the associated impact on the 
climate and the environment with e.g. 46 firms active 
in developing patents relevant to “batteries”42. However, 
investment is still channelled to the development 
of technologies improving the efficiency of internal 
combustion engines, lowering the environmental footprint 
of transport in the short- medium term.
42 There are companies outside the automotive sector that are making important contributions to the technological areas described. Examples are Johnson Matthey, 
Umicore and BASF (chemical sector), which make catalysts and Panasonic (leisure goods), which makes the lithium batteries for Tesla’s electric cars.
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CPC class Technological description Patent Families
Number  
of Firms
Y02T10/144 Turbocharging, supercharging 710 36
Y02T10/47 Exhaust feedback 570 28
Y02T90/32 Fuel cells for transport 461 26
Y02T10/7005 Batteries 455 46
Y02T10/24 Selective catalytic reactors for reduction in oxygen rich atmosphere 396 23
Y02T10/6286 Control systems for power distribution between ICE and other motor or motors 351 27
Y02T10/146 Charge mixing enhancing  outside combustion chamber 335 35
Y02T10/6239 Differential gearing distribution type for hybrid vehicles 314 17
Y02T10/6221 Hybrid vehicles of parallel type 257 32
Y02T10/48 Stop and go systems 249 30
TABLE 7.6: TOP 10 CPC CLASSES AND THEIR DESCRIPTION BY NUMBER OF PATENT FAMILIES (Y02T).
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Another interesting finding is the development of 
competing technologies related to future electric vehicles. 
Although patents on batteries for storage of electric 
energy do attract a lot of research interest, important 
efforts are put on the development of fuel cells specially 
adapted to transport applications for producing electricity 
using hydrogen as an alternative. EU based firms own 
relatively high shares of patent families related to 
“Selective catalytic reactors”, “hybrid vehicles of parallel 
type” and “batteries” (Figure 7.3). On the other hand the 
share of patent families related to “fuel cell for transport”, 
“differential gearing for distribution type for hybrid vehicles” 
and “stop and go systems” is relatively low (around 10%).
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Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
In Figure 7.4 the top five patent assignees by number of 
families owned by technology field (CPC) are shown. There 
are 14 unique firms appearing in all 10 top 5 lists. Toyota 
Motors (JP) is among the top 5 firms by share of patents 
in all 10 fields followed by Ford Motors (US) (present in 
8 fields), General Motors (US), Hyundai Motors (KR) and 
Volkswagen (DE) (7 fields). The development of these 
technologies appears to be highly concentrated with the 
top 5 firms owing more than 50% of the related patent 
families.
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7.2.2 Reduction of greenhouse gas emissions related to energy generation, 
transmission or distribution
The second group of technologies and applications 
relevant to mitigation and adaptation against climate 
change which are important in terms of patent filings 
for firms in the sector are technologies for the “reduction 
of greenhouse gas emissions from energy generation 
and distribution”. Scoreboard firms in the sector filed 
995 patent families related to this group. The top 10 
technologies of this type by number of patent families 
are reported in table 7.7. At the top of the list, we find 
“lithium-ion, lead-acid or alkaline secondary batteries” 
followed by “fuel cells” and “hybrid cells”. This is in-line 
with the findings in the previous section showing the 
strong efforts in the development of novel technologies 
for electric energy production like “fuel cells” and electric 
energy storage like “batteries” with 36 firms active in 
developing patents relevant to “fuel cells” and 30 firms 
developing patents related to “lithium-ion, lead-acid or 
alkaline secondary batteries”.
EU based firms own high share of patents on “latent and 
sensible heat storage systems” as well as on “hybrid 
type cells” (Figure 7.5). On the other hand, the share of 
EU families related to “fuel cells” and “proton exchange 
membranes” is below 10%.
Top patent assignees by share of families pertaining 
to each technology are shown in Figure 7.6. There are 
17 firms within the top 5 list of the ten technologies 
for “reduction of greenhouse gas emissions related 
to production, transmission or distribution of energy”. 
Robert Bosch (DE) and Toyota Motors (JP) are present 
7 times in the top 5 list followed by Hyundai Motor (KR) 
and Honda Motor (JP) (6 times). The share of families 
owned by firms in the top 5 list is over 80% for all fields. 
Technology development is thus highly concentrated 
with few players owing a high share of patent families 
published in the two major IP offices.
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CPC class Tech description Patent families
Number 
of Firms
Y02E60/122 Lithium- ion batteries 193 30
Y02E60/50 Fuell cells 181 36
Y02E60/128 Hybrid cells composed of a half-cell of a fuel-cell type and a half-cell of the secondary-cell type 73 13
Y02E60/321 Storage of liquefied, solidified, or compressed hydrogen in containers 65 6
Y02E60/13 Ultracapacitors, supercapacitors, double-layer capacitors 45 6
Y02E10/50 Photovoltaic energy 43 7
Y02E60/145 Latent heat storage 42 7
Y02E60/521 Proton Exchange Membrane Fuel Cells 34 8
Y02E60/366 Hydrogen distribution by electrolysis of water 32 6
Y02E60/142 Sensible heat storage 19 4
TABLE 7.7: TOP 10 CPC CODES BY NUMBER OF PATENT FAMILIES (Y02E).
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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The sector undergoes a major paradigm shift not only 
due to regulatory challenges and constraints aimed at 
reducing the environmental impact of transport but also 
due to the development of disruptive technologies and 
services that are expected to minimise the negative 
impacts from traditional road transport such as 
decarbonisation, automation, connectivity and sharing. 
Automation refers to systems, which are able to perform 
part or all of the Dynamic Driving Tasks43. Depending 
on the level of automation offered and the level of 
monitoring needed by the driver these technologies can 
be classified in 5 categories: from driver-only to full 
automation.
The focus in this section is to identify patents from 
Scoreboard companies related to autonomous or driverless 
vehicles only. Based on the search strategy used the 581 
families identified should correspond to high levels off 
automation (categories 3, 4 and 5). The majority of these 
families (192) are owned by 31 EU based firms followed 
by firms based in Japan (167 families by 20 firms) and in 
the US (160 by 23 firms) as shown in table 7.8.
7.3 | Technologies related to autonomous vehicles
43 SAE International, 2016.
Region Patent Families Number of companies
EU 192 31
US 160 23
JP 167 20
CN 4 2
KR 44 8
RoW 14 7
TABLE 7.8: THE GEOGRAPHY OF PATENT FAMILIES RELATED TO AUTONOMOUS CARS.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Sector Number	of	firms Patent Families
Automobiles & Parts 24 402
Electronic & Electrical Equipment 10 42
Industrial Engineering 20 34
Aerospace & Defence 8 24
Software & Computer Services 2 20
Technology Hardware & Equipment 7 18
Leisure Goods 5 13
General Industrials 4 9
General Retailers 1 5
Oil Equipment, Services & Distribution 1 4
Household Goods & Home Construction 2 4
Chemicals 2 1
Food & Drug Retailers 1 1
Health Care Equipment & Services 1 1
Industrial Metals & Mining 1 1
Oil & Gas Producers 1 1
Support Services 1 1
TABLE 7.9: TOP 10 SECTORS BY NUMBER OF FAMILIES RELATED TO AUTONOMOUS CARS.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Twenty-four firms within the Automobiles sector own al-
most 70% of these families. There are however many 
firms in other sectors active in patenting these technol-
ogies, most notably in Electronic & Electrical Equipment 
sector with 10 firms owning 42 families and the Industri-
al Engineering and Aerospace & Defence sectors with 20 
firms and 34 families and 8 firms and 24 families respec-
tively (table 7.9).
102 The 2019 EU Industrial R&D Investment Scoreboard
Company Country Sector Patent Families
FORD MOTOR US Automobiles & Parts 71
TOYOTA MOTOR JP Automobiles & Parts 59
ROBERT BOSCH DE Automobiles & Parts 55
VOLKSWAGEN DE Automobiles & Parts 36
HYUNDAI MOTOR KR Automobiles & Parts 25
NISSAN MOTOR JP Automobiles & Parts 21
HONDA MOTOR JP Automobiles & Parts 20
HITACHI JP Electronic & Electrical Equipment 19
GENERAL MOTORS US Automobiles & Parts 19
ALPHABET US Software & Computer Services 19
TABLE 7.10: TOP 10 SCOREBOARD FIRMS BY NUMBER OF PATENT FAMILIES RELATED TO AUTONOMOUS CARS.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Focusing on the top 10 Scoreboard companies in terms 
of patents related to autonomous vehicles we find eight 
companies from the Automobiles sector among them. In 
fact the top seven out of ten firms in the list are from 
this sector with the US based Ford Motor at the top with 
71 families followed by the Japanese based Toyota 
Motor with 59, and the German Robert Bosch and 
Volkswagen with 55 and 36 patent families respectively. 
Among the non-Automobiles firms making it to the top 
10 we find Hitachi (JP) and Alphabet (US) with 19 patent 
families each (see table 7.10).
•	 Firms in the “Automobiles” sector are active in 
patenting, owing almost 13% of the patent families 
from Scoreboard firms between 2012 and 2015. R&D 
investment from these firms accounts for almost 16% 
of total R&D spending from Scoreboard companies. 
Among the most important players in the sector are EU 
and JP based firms, which are responsible for almost 
71% of total patent filings.
•	 Stricter environmental regulations and advances in 
technologies not related to conventional cars drive 
technological competition between firms in the sector 
and firms from other sectors as well. Environmental 
challenges are tackled, on one hand by developing 
technologies to improve efficiency and to better 
control emissions from conventional combustion 
engines, and on the other by technologies aiming at 
the electrification of transport.
•	 EU based Scoreboard “Automobile” firms are 
competitive, as they have invested almost 46% of 
the R&D investment reported by firms in the sector 
between 2012 and 2015, they are responsible for 
35% of the patent families of this period and they 
have highly diversified patent portfolios in terms of 
technology profiles with significant share of patents 
related to autonomous vehicles.
•	 Japanese firms are leading the race when it comes 
to environmental technologies related to hybrid cars, 
batteries and fuel cells, while among the EU based 
firms, Volkswagen and Robert Bosch are the most 
active in patenting environmental related technologies 
as well as technologies related to autonomous cars.
7.4 | Concluding remarks
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Investment in research and innovation is at the core of 
the EU policy agenda. The Europe 2020 growth strategy 
includes the Innovation Union flagship initiative44 with 
a 3 % headline target for intensity of research and 
development (R&D)45. R&D investment from the private 
sector plays also a key role for other relevant European 
initiatives such as the Industrial Policy46, Digital Agenda 
and New Skills for New Jobs flagship initiatives.
The project “Global Industrial Research & Innovation 
Analyses” (GLORIA)47 supports policymakers in these 
initiatives and monitors progress towards the 3 % headline 
target. The Scoreboard, as part of the GLORIA project, 
aims to improve the understanding of trends in R&D 
investment by the private sector and the factors affecting 
it. The Scoreboard identifies main industrial players in 
key industrial sectors, analyse their R&D investment and 
economic performance and benchmark EU companies 
against their global counterparts.
The annual publication of the Scoreboard also intends to 
raise awareness of the importance of R&D for businesses 
and to encourage firms to disclose information about their 
R&D investments and other intangible assets.
The data for the Scoreboard are taken from companies’ 
publicly available audited accounts. As in more than 99% 
of cases these accounts do not include information on the 
place where R&D is actually performed, the company’s 
whole R&D investment in the Scoreboard is attributed 
to the country in which it has its registered office48. This 
should be borne in mind when interpreting the Scoreboard’s 
country classifications and analyses.
The Scoreboard’s approach is, therefore, fundamentally 
different from that of statistical offices or the OECD when 
preparing business enterprise expenditure on R&D data, 
which are specific to a given territory. The R&D financed 
by business sector in a given territorial unit (BES-R&D) 
includes R&D performed by all sectors in that territorial 
unit49. Therefore, the Scoreboard	R&D	figures	are	
comparable to BES-R&D data only at the global 
level.
The Scoreboard data are primarily of interest to those 
concerned with benchmarking company commitments and 
performance (e.g. companies, investors and policymakers), 
while BES-R&D data are primarily used by economists, 
governments and international organisations interested 
in the R&D performance of territorial units defined by 
political boundaries. The two approaches are therefore 
complementary. The methodological approach of the 
Scoreboard, its scope and limitations are further detailed 
in Annex 2 below.
Background informationA .1
44 The Innovation Union flagship initiative aims to strengthen knowledge and innovation as drivers of future growth by refocusing R&D and innovation policies for the main 
challenges society faces.
45 This target refers to the EU’s overall (public and private) R&D investment approaching 3 % of gross domestic product (see: http://ec.europa.eu/europe2020/pdf/tar-
gets_en.pdf).
46 The Industrial Policy for the Globalisation Era flagship initiative aims to improve the business environment, notably for small and medium-sized enterprises, and support 
the development of a strong and sustainable industrial foundation for global competition.
47 GLORIA builds on the IRIMA project (Industrial Research and Innovation Monitoring and Analysis). See: http://iri.jrc.ec.europa.eu/home/. The activity is undertaken jointly 
by the Directorate General for Research (DG RTD F; see: http://ec.europa.eu/research/index.cfm?lg=en) and the Joint Research Centre, Directorate Growth and Innovation 
(JRC-Seville; see: https://ec.europa.eu/jrc/en/science-area/innovation-and-growth).
48 The registered office is the company address notified to the official company registry. It is normally the place where a company’s books are kept.
49 The Scoreboard refers to all R&D financed by a company from its own funds, regardless of where the R&D is performed. BES-R&D refers to all R&D activities funded by 
businesses and performed by all sectors within a particular territory, regardless of the location of the business’s headquarters. The sources of data also differ: the Score-
board collects data from audited financial accounts and reports whereas BES-R&D typically takes a stratified sample, covering all large companies and a representative 
sample of smaller companies. Additional differences concern the definition of R&D intensity (BES-R&D uses the percentage of R&D in value added, while the Scoreboard 
considers the R&D/Sales ratio).
Scope and target audience
The Scoreboard is a benchmarking tool which provides 
reliable up-to-date information on R&D investment and 
other economic and financial data, with a unique EU-focus. 
The 2500 companies listed in this year’s Scoreboard 
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account for more than 90%50 of worldwide R&D funded 
by the business enterprise sector and the Scoreboard data 
refer to a more recent period than the latest available 
official statistics. Furthermore, the dataset is extended to 
cover the top 1000 R&D investing companies in the EU.
The data in the Scoreboard, published since 2004, allow 
long-term trend analyses, for instance, to examine links 
between R&D and business performance.
The Scoreboard is aimed at three main audiences.
•	 Companies can use the Scoreboard to benchmark 
their R&D investments and so find where they stand 
in the EU and in the global industrial R&D landscape. 
This information could be of value in shaping business 
or R&D strategy and in considering potential mergers 
and acquisitions.
•	 Investors	 and	 financial	 analysts can use the 
Scoreboard to assess investment opportunities and 
risks.
•	 Policy-makers, government and business 
organisations can use R&D investment information 
as an input to policy formulation or other R&D-related 
actions such as R&D tax incentives.
Furthermore, the Scoreboard dataset has been made 
freely accessible so as to encourage further economic 
and financial analyses and research by any interested 
parties.
50 According to latest Eurostat statistics.
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The data for the 2019 Scoreboard have been collected 
from companies’ annual reports and accounts by Bureau 
van Dijk – A Moody’s Analytics Company (BvD). The 
source documents, annual reports & accounts, are public 
domain documents and so the Scoreboard is capable of 
independent replication. In order to ensure consistency with 
our previous Scoreboards, BvD data for the years prior to 
2012 have been checked with the corresponding data of 
the previous Scoreboards adjusted for the corresponding 
exchange rates of the annual reports.
Methodological notesA .2
The data correspond to companies’ latest published 
accounts, intended to be their 2018 fiscal year accounts, 
although due to different accounting practices throughout 
the world, they also include accounts ending on a range of 
dates between late 2017 and mid-2019. Furthermore, the 
accounts of some companies are publicly available more 
promptly than others. Therefore, the current set represents 
a heterogeneous set of timed data.
In order to maximise completeness and avoid double 
counting, the consolidated group accounts of the 
ultimate parent company are used. Companies which are 
subsidiaries of any other company are not listed separately. 
Where consolidated group accounts of the ultimate parent 
company are not available, subsidiaries are included.
In the case of a demerger, the full history of the continuing 
entity is included. The history of the demerged company 
can only go back as far as the date of the demerger to 
avoid double counting of figures.
In case of an acquisition or merger, pro forma figures for 
the year of acquisition are used along with pro-forma 
comparative figures if available.
The R&D investment included in the Scoreboard is the 
cash investment which is funded by the companies 
themselves. It excludes R&D undertaken under contract 
for customers such as governments or other companies. 
It also excludes the companies’ share of any associated 
company or joint venture R&D investment when 
disclosed. However, it includes research contracted out to 
other companies or public research organisations, such 
as universities.
Where part or all of R&D costs have been capitalised, the 
additions to the appropriate intangible assets are included 
to calculate the cash investment and any amortisation 
eliminated.
Companies are allocated to the country of their 
registered office. In some cases this is different from 
the operational or R&D headquarters. This means that 
the results are independent of the actual location of the 
R&D activity.
Companies are assigned to industry sectors according 
to the NACE Rev. 251 and the ICB (Industry Classification 
Benchmark). In the Scoreboard report we use different 
levels of sector aggregation, according to the distribution 
of companies’ R&D and depending on the issues to be 
illustrated. In chapter 1, Tables 1.2 and 1.3 describe two 
typical levels of the industrial classification applied in the 
Scoreboard.
Main characteristics of the data
Limitations
51 NACE is the acronyme for “Nomenclature statistique des activités économiques dans la Communauté européenne”.
Users of the Scoreboard data should take into account the 
methodological limitations, especially when performing 
comparative analyses (see summary of main limitation in 
Box A2.1 below).
The Scoreboard relies on disclosure of R&D investment 
in published annual reports and accounts. Therefore, 
companies which do not disclose figures for R&D 
investment or which disclose only figures which are not 
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material enough are not included in the Scoreboard. Due 
to different national accounting standards and disclosure 
practice, companies of some countries are less likely than 
others to disclose R&D investment consistently. There is 
a legal requirement to disclose R&D in company annual 
reports in some countries.
In some countries, R&D costs are very often integrated with 
other operational costs and can therefore not be identified 
separately. For example, companies from many Southern 
European countries or the new Member States are under-
represented in the Scoreboard. On the other side, UK 
companies could be over-represented in the Scoreboard.
For listed companies, country representation will improve 
with IFRS adoption.
The R&D investment disclosed in some companies’ 
accounts follows the US practice of including engineering 
costs relating to product improvement. Where these 
engineering costs have been disclosed separately, they 
have been excluded from the Scoreboard. However, the 
incidence of non-disclosure is uncertain and the impact of 
this practice is a possible overstatement of some overseas 
R&D investment figures in comparison with the EU.
Where R&D income can be clearly identified as a result of 
customer contracts it is deducted from the R&D expense 
stated in the annual report, so that the R&D investment 
included in the Scoreboard excludes R&D undertaken 
under contract for customers such as governments or 
other companies. However, the disclosure practise differs 
and R&D income from customer contracts cannot always 
be clearly identified. This means a possible overstatement 
of some R&D investment figures in the Scoreboard for 
companies with directly R&D related income where this is 
not disclosed in the annual report.
In implementing the definition of R&D, companies exhibit 
variability arising from a number of sources: i) different 
interpretations of the R&D definition. Some companies 
view a process as an R&D process while other companies 
may view the same process as an engineering or other 
process; ii) different companies’ information systems for 
measuring the costs associated with R&D processes; iii) 
different countries’ fiscal treatment of costs.
Interpretation
There are some fundamental aspects of the Scoreboard 
which affect their interpretation.
The focus of the Scoreboard on R&D investment as reported 
in group accounts means that the results can be independent 
of the location of the R&D activity. The Scoreboard indicates 
the level of R&D funded by companies, not all of which is 
carried out in the country in which the company is registered. 
This enables inputs such as R&D and Capex investment to 
be related to outputs such as Sales, Profits, productivity 
ratios and market capitalisation.
The data used for the Scoreboard are different from data 
provided by statistical offices, e.g. the R&D expenditures 
funded by the business enterprise sector and performed 
by all sectors within a given territorial unit (BES-R&D). 
The Scoreboard refers to all R&D financed by a particular 
company from its own funds, regardless of where that 
R&D activity is performed. BES-R&D refers to all R&D 
activities funded by businesses and performed within 
a particular territory, regardless of the location of the 
business’s headquarters. Therefore, the Scoreboard 
R&D figures are directly comparable to BES-R&D 
data only at the global level.
Further, the Scoreboard collects data from audited 
financial accounts and reports. BES-R&D typically takes 
a stratified sample, covering all large companies and a 
representative sample of smaller companies. Additional 
differences concern the definition of R&D intensity (BES-
R&D uses the percentage of value added, while the 
Scoreboard measures it as the R&D/Sales ratio) and the 
sectoral classification they use (BES-R&D follows NACE, 
the European statistical classification of economic sectors, 
while the Scoreboard classifies companies’ economic 
activities according to the ICB classification).
Sudden changes in R&D figures may arise because a 
change in company accounting standards. For example, 
the first time adoption of IFRS52, may lead to information 
52 Since 2005, the European Union requires all listed companies in the EU to prepare their consolidated financial statements according to IFRS (International Financial 
Reporting Standards, see: http://www.iasb.org/).
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discontinuities due to the different treatment of R&D, 
i.e. R&D capitalisation criteria are stricter and, where the 
criteria are met, the amounts must be capitalised.
For many highly diversified companies, the R&D investment 
disclosed in their accounts relates only to part of their ac-
tivities, whereas sales and profits are in respect of all their 
activities. Unless such groups disclose their R&D investment 
additional to the other information in segmental analyses, it 
is not possible to relate the R&D more closely to the results 
of the individual activities which give rise to it. The impact 
of this is that some statistics for these groups, e.g. R&D as 
a percentage of sales, are possibly underestimated and so 
comparisons with non-diversified groups are limited.
At the aggregate level, the growth statistics reflect the 
growth of the set of companies in the current year set. 
Companies which may have existed in the base year but 
which are not represented in the current year set are not 
part of the Scoreboard (a company may continue to be 
represented in the current year set if it has been acquired 
by or merged with another but will be removed for the 
following year’s Scoreboard).
For companies outside the Euro area, all currency amounts 
have been translated at the Euro exchange rates ruling at 31 
December 2018 as shown in Table A2.153. The exchange rate 
conversion also applies to the historical data. The result is that 
over time the Scoreboard reflects the domestic currency results 
of the companies rather than economic estimates of current 
purchasing parity results. The original domestic currency data 
can be derived simply by reversing the translations at the 
rates above. Users can then apply their own preferred current 
purchasing parity transformation models.
53 Companies from some countries report their data in US dollars, e.g. in this edition, all companies based in Israel present their results in US dollars.
Country As of 31 Dec 2017 As of 31 Dec 2018
Australia $ 1.54 $ 1.62
Brazil 3.97 Brazilian real 4.44 Brazilian real
Canada $ 1.51 $ 1.56
China 7.81 Renminbi 7.85 Renminbi
Czech Republic 25.54 Koruna 25.73 Koruna
Denmark 7.44 Danish Kronor 7.46 Danish Kronor
Hungary 310.6 Forint 321.54 Forint
Hong Kong 9.37 HKD 8.97 HKD
India 76.69 Indiana Rupee 79.94 Indiana Rupee
Iraq 1428.57 IQD 1351.35 IQD
Israel 4.16 shekel 4.29 shekel
Japan 135.32 Yen 126.9 Yen
Malaysia 4.87 Ringgit 4.74 Ringgit
Mexico 23.73 Mexican Peso 22.54 Mexican Peso
New Zeland 1.69 NZD 1.71 NZD
Norway 9.85 Norwegian Kronor 9.95 Norwegian Kronor
Poland 4.18 Zloty 4.30 Zloty
Russia 69.06 Rouble 79.55 Rouble
Saudi Arabia 4.50 SAR 4.29 SAR
Singapore 1.60 SGD 1.56 SGD
South Africa 14.79 ZAR 16.48 ZAR
South Korea 1282.05 Won 1277.14 Won
Sweden 9.84 Swedish Kronor 10.26 Swedish Kronor
Switzerland 1.17 Swiss Franc 1.13 Swiss Franc
Taiwan $ 35.79 new dollar $ 35.19 new dollar
Thailand 39.20 THB 39.20 THB
Turkey 4.53 Turkish lira 6.03 Turkish lira
UK £ 0.89 £ 0.9
US $ 1.20 $ 1.15
United Arab Emirates 4.40 dirham 4.21 dirham
TABLE A2.1: EURO EXCHANGE RATES APPLIED TO SCOREBOARD DATA FOR COMPANIES REPORTING IN DIFFERENT CURRENCIES (AS OF 31 DEC 2018).
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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Box A2.1 
Methodological caveats
Users of Scoreboard data should take into account 
the methodological limitations summarised here, 
especially when performing comparative analyses:
A typical problem arises when comparing data 
from different currency areas. The Scoreboard data 
are nominal and expressed in Euros with all foreign 
currencies converted at the exchange rate of the 
year-end closing date (31.12.2018). The variation 
in the exchange rates from the previous year directly 
affects the ranking of companies, favouring those 
based in countries whose currency has appreciated 
with respect to the other currencies. In this reporting 
period, the exchange rate of the Euro depreciated 
by 5% and 6% against the US dollar and the 
Japanese Yen respectively, and appreciated by 1% 
against the pound sterling. However, ratios such as 
R&D intensity or profitability (profit as % sales) are 
based on the ratio of two quantities taken from a 
company report where they are both expressed in 
the same currency and are therefore less affected 
by currency changes.
The growth rate of the different indicators for 
companies operating in markets with different 
currencies is affected in a different manner. In fact, 
companies’ consolidated accounts have to include 
the benefits and/or losses due to the appreciation 
and/or depreciation of their investments abroad. 
The result is an ‘apparent’ rate of growth of the 
given indicator that understates or overstates the 
actual rate of change. For example, this year the 
R&D growth rate of companies based in the Euro 
area with R&D investments in the US is partly 
overstated because the ‘benefits’ of their overseas 
investments due to the appreciation of the US 
dollar against the Euro (from $1.20 to $1.15). 
Conversely, the R&D growth rate of US companies 
is partly understated due to the ‘losses’ of their 
investments in the Euro area. Similar effects of 
understating or overstating figures would happen 
for the growth rates of other indicators, such as net 
sales.
When analysing data aggregated by country or 
sector, be aware that in many cases, the aggregate 
indicator depends on the figures of a few firms. 
This is due, either to the country’s or sector’s 
small number of firms in the Scoreboard or to the 
indicator dominated by a few large firms.
The different editions of the Scoreboard are not 
directly comparable because of the year-on-
year change in the composition of the sample of 
companies, i.e. due to newcomers and leavers. 
Every Scoreboard comprises data of several 
financial years (8 years since 2012 and 10 years 
since 2017) allowing analysis of trends for the 
same sample of companies.
In most cases companies’ accounts do not include 
information on the place where R&D is actually 
performed; consequently the approach taken in 
the Scoreboard is to attribute each company’s 
total R&D investment to the country in which the 
company has its registered office or shows its 
main economic activity. This should be borne in 
mind when interpreting the Scoreboard’s country 
classification and analyses.
Growth in R&D can either be organic, the outcome 
of acquisitions or a combination of the two. 
Consequently, mergers and acquisitions (or de-
mergers) may sometimes underlie sudden changes 
in specific companies’ R&D and sales growth rates 
and/or positions in the rankings.
Other important factors to take into account 
include the difference in the various countries’ 
(or sectors’) business cycles which may have a 
significant impact on companies’ investment 
decisions, and the initial adoption or stricter 
application of the International Financial 
Reporting Standards (IFRS)54. 
54 Since 2005, the European Union requires all listed companies in the EU to prepare their consolidated financial statements according to IFRS (see: EC Regulation No 
1606/2002 of the European Parliament and of the Council of 19 July 2002 on the application of international accounting standards at http://eur-lex.europa.eu/LexUriServ/
LexUriServ.do?uri=CELEX:32002R1606:EN:HTML).
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1. Research and Development (R&D) investment 
in the Scoreboard is the cash investment funded 
by the companies themselves. It excludes R&D 
undertaken under contract for customers such as 
governments or other companies. It also excludes 
the companies’ share of any associated company or 
joint venture R&D investment. However, it includes 
research contracted out to other companies or public 
research organisations, such as universities. Being 
that disclosed in the annual report and accounts, 
it is subject to the accounting definitions of R&D. 
For example, a definition is set out in International 
Accounting Standard (IAS) 38 “Intangible assets” and 
is based on the OECD “Frascati” manual. Research 
is defined as original and planned investigation 
undertaken with the prospect of gaining new scientific 
or technical knowledge and understanding. Expenditure 
on research is recognised as an expense when it is 
incurred. Development is the application of research 
findings or other knowledge to a plan or design for 
the production of new or substantially improved 
materials, devices, products, processes, systems or 
services before the start of commercial production 
or use. Development costs are capitalised when they 
meet certain criteria and when it can be demonstrated 
that the asset will generate probable future economic 
benefits. Where part or all of R&D costs have been 
capitalised, the additions to the appropriate intangible 
assets are included to calculate the cash investment 
and any amortisation eliminated.
2. R&D expenditures funded by the business enterprise 
sector (BES-R&D), provided by official statistics, refer 
to the total R&D performed within a territorial unit that 
has been funded by the business enterprise sector 
(private or public companies).
3. Net sales follow the usual accounting definition of 
sales, excluding sales taxes and shares of sales of joint 
ventures & associates. For banks, sales are defined 
as the “Total (operating) income” plus any insurance 
income. For insurance companies, sales are defined as 
“Gross premiums written” plus any banking income.
4. R&D intensity is the ratio between R&D investment 
and net sales of a given company or group of 
companies. At the aggregate level, R&D intensity is 
calculated only by those companies for which data 
exist for both R&D and net sales in the specified year. 
The calculation of R&D intensity in the Scoreboard is 
different from than in official statistics, e.g. BES-R&D, 
where R&D intensity is based on value added instead 
of net sales.
5. Operating	 profit is calculated as profit (or loss) 
before taxation, plus net interest cost (or minus net 
interest income) minus government grants, less gains 
(or plus losses) arising from the sale/disposal of 
businesses or fixed assets.
6. One-year growth is simple growth over the 
previous year, expressed as a percentage: 1 yr growth 
= 100*((C/B)-1); where C = current year amount and 
B = previous year amount. 1yr growth is calculated 
only if data exist for both the current and previous year. 
At the aggregate level, 1yr growth is calculated only by 
aggregating those companies for which data exist for 
both the current and previous year.
7. Capital expenditure (Capex) is expenditure used 
by a company to acquire or upgrade physical assets 
such as equipment, property, industrial buildings. In 
accounts capital expenditure is added to an asset 
account (i.e. capitalised), thus increasing the asset’s 
base. It is disclosed in accounts as additions to tangible 
fixed assets.
8. Number of employees is the total consolidated 
average employees or year-end employees if average 
not stated.
Glossary
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Rank Sector
R&D in 
2018, € 
billion
One-
year 
change, 
%
Net 
Sales, € 
billion
One-
year 
change, 
%
R&D 
intensity, 
%
Operating 
profits,	€	
billion
One-
year 
change 
, %
Profita-
bility, %
Employees, 
million
One-
year 
change, 
%
1
Pharmaceuticals  
& Biotechnology
153.8 7.3 967.8 4.8 15.4 130.4 -2.8 14.1 2.6 4.5
2
Technology Hardware 
& Equipment
127.8 7.4 1522.3 9.1 8.4 237.9 21.8 15.6 3.5 2.0
3 Automobiles & Parts 127.8 6.8 2708.3 2.5 4.7 149.0 -13.4 5.5 7.6 4.1
4
Software & Computer 
Services
117.7 19.3 1085.8 15.0 10.8 186.1 10.5 17.3 3.7 9.2
5
Electronic & Electrical 
Equipment
64.2 10.0 1282.3 6.1 5.0 136.0 3.3 10.6 5.4 4.2
6 Industrial Engineering 29.9 10.2 924.0 10.5 3.2 91.3 16.9 9.9 3.5 5.1
7 Chemicals 22.5 8.4 1010.4 11.2 2.2 115.0 11.0 11.4 1.7 5.0
8 General Industrials 20.4 -0.2 700.7 5.5 2.9 39.3 -12.7 5.7 2.2 -1.3
9 Aerospace & Defence 20.2 4.1 506.0 7.6 4.0 52.7 13.8 10.4 1.7 8.1
10
Health Care 
Equipment  
& Services
16.6 9.8 444.1 5.8 3.7 36.7 2.7 8.4 1.5 10.9
11
Construction & 
Materials
15.7 16.4 907.6 7.3 1.7 63.8 11.0 7.0 2.8 4.3
12 Leisure Goods 15.7 5.4 270.4 2.0 5.8 24.7 9.4 9.1 0.8 -3.7
13 Banks 10.7 -2.4 393.9 1.7 2.7 104.8 3.4 26.6 1.7 8.1
14 Oil & Gas Producers 9.3 9.4 2812.5 22.0 0.3 392.6 52.9 14.0 1.8 -2.3
15
Household Goods  
& Home Construction
8.5 6.8 337.1 4.1 2.5 24.1 -37.5 7.2 1.2 2.0
Total 38 industries 823.4 8.9 20351.6 8.4 4.0 2275.7 9.1 11.2 55.6 3.6
TABLE A3.1: MAIN STATISTICS FOR THE 2019 SCOREBOARD SAMPLE OF 2500 WORLD COMPANIES AGGREGATED BY INDUSTRIAL SECTORS (TOP 15 SECTORS, 
ICB 3-DIGITS).
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Complementary tablesA .3
The analysis of chapter 4 applies an extended sample 
of 1000 companies based in the EU. It consists of 551 
companies included in the world R&D ranking of top 2500 
companies and additional 449 companies also ranked by 
level of R&D investment. The composition by country and 
industry of the EU 1000 sample is presented in the table 
A3.2 below.
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Industry
Country codes
AT BE CZ DE DK ES FI FR GR HU IE IT LU NL PL PT SE SI UK Total
Aerospace & Defence    3  1  5   1 1  2   1  8 22
Alternative Energy    3 2   1            6
Automobiles & Parts 3   19  1 1 5   1 5  3   4  6 48
Banks  2  4 2 1   1  2 2  2  2 2  4 24
Beverages  1   1              2 4
Chemicals 2 3  14   2 2     2 3 1  3  8 40
Construction & Materials 2 2  6 1 5 2 3   2   1   2  3 29
Electricity 1 1 1 1  2 1 1    2    1 1  2 14
Electronic & Electrical Equipment 3 3  18 2  3 8   2 4  4   4  14 65
Financial Services    5 1   1         3  4 14
Fixed Line Telecommunications    1 1 1  1    1  1   1  1 8
Food & Drug Retailers     1         1     3 5
Food Producers 1   2 1  3 3   2   5     6 23
Forestry & Paper       3            1 4
Gas, Water & Multiutilities 1   2 1   3    2       3 12
General Industrials 1 1  13 1  1 1   1 1 1 3   3  6 33
General Retailers  2  5    2        1   8 18
Health Care Equipment & Services 1 2  11 3  1 3   2   2   3  11 39
Household Goods & Home Construction    6 1  1 3    1 1 1   1 1 2 18
Industrial Engineering 4 1  33 2 2 7 6   2 7 2 4   11  10 91
Industrial Metals & Mining 2 4  4  1 1 1     2 1   2   18
Industrial Transportation    1 1   3    2     1  2 10
Leisure Goods    1 2  1        1  1  3 9
Life Insurance                   2 2
Media 1       6         1  7 15
Mining             1    2  2 5
Mobile Telecommunications 1 1  2             1  3 8
Nonequity Investment Instruments     1               1
Nonlife Insurance    3    1           1 5
Oil & Gas Producers 1     1 1 1    1       3 8
Oil Equipment, Services & Distribution        1   1  1 1      4
Personal Goods    4    2    5 1      3 15
Pharmaceuticals & Biotechnology 1 7  16 12 4 2 23 1 1 11 5  10 1 1 13 1 57 166
Real Estate Investment & Services 1   5 2        2      4 14
Software & Computer Services 2 1  18 4 2 4 18     1 3 1  7  45 106
Support Services 1   10    3   1  1 1   2  22 41
Technology Hardware & Equipment 3 2  5 2  1 5 1  1   5   7  11 43
Tobacco                 1  1 2
Travel & Leisure 1   3       1      1  5 11
Total 33 33 1 218 44 21 35 112 3 1 30 39 15 53 4 5 78 2 273 1000
TABLE A3.2: DISTRIBUTION OF THE SAMPLE OF 1000 COMPANIES BASED IN THE EU BY COUNTRY AND INDUSTRY.
Source: The 2019 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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The 2019 Scoreboard comprises two data samples:
• The world’s top 2500 companies that invested 
more than €30 million in R&D in 2018.
• The top 1000 R&D investing companies based 
in the EU with R&D investment exceeding 
€8.5 million.
For each company the following information is availa- 
ble:
• Company identification (name, country of regis-
tration and sector of declared activity according 
to the Scoreboard sector classification).
• R&D investment
• Net Sales
• Capital expenditure
• Operating profit or loss
• Total number of employees
• Market capitalisation (for listed companies)
• Main company indicators (R&D intensity, Capex 
intensity, Profitability)
• Growth rates of main indicators over one year.
The following links provide access to the two Score-
board data samples containing the main economic 
and financial indicators and main statistics over the 
past year.
 R&D ranking of world top 2500 companies:
 https://iri.jrc.ec.europa.eu/scoreboard/2019-eu-
industrial-rd-investment-scoreboard#field_data
 R&D ranking of EU top 1000 companies:
 https://iri.jrc.ec.europa.eu/scoreboard/2019-eu-
industrial-rd-investment-scoreboard#field_data
Access to the full datasetA .4
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